Section 68

EurekaMag PDF full texts Chapter 67,075


Cho, K.H.; Lee, M.J.; Park, H.M.; Im, W.; Choi, S. 2014: Sa2037 Effect of Da-6886 on Gastrointestinal Transit and Defecation in Mice. Gastroenterology 146(5): S-360
Rhee, K.; Lee, Y.J.; Park, H. 2014: Sa2038 Effect of Da-9701 in Opioid-Induced Bowel Dysfunction Model of Guinea Pig. Gastroenterology 146(5): S-360
Staller, K.; Khalili, H.; Kuo, B. 2014: Sa2039 Inpatient Bowel Prophylaxis With Sennosides and Docusate Combination Therapy Reduces the In-Hospital Incidence of Constipation in Heart Failure Patients: A Retrospective Cohort Analysis. Gastroenterology 146(5): S-361
Toto, E.; Soota, K.; Salieb, L.A.; Ikonomi, E.; Malik, Z.A.; Friedenberg, F.K.; Parkman, H.P. 2014: Sa2040 Role of Ethnicity in the Presentation, Evaluation, and Etiology of Severe Constipation. Gastroenterology 146(5): S-361
Takahashi, N.; Obata, K.; Kuroda, M.; Yamada, A.; Iwata, Y. 2014: Sa2041 Rq-00432933, a Novel Orally Active Small Molecule Ghrelin Receptor Agonist for Potential Use in Cancer Patients With Gastrointestinal Dysmotility and Anorexia/Cachexia. Gastroenterology 146(5): S-361
Broad, J.; Kung, V.W.; Greene-Diniz, R.; Knowles, C.H.; Sanger, G.J. 2014: Sa2043 Regionally-Specific Changes in Human Colonic Neuromuscular Activity With Advanced Age. Gastroenterology 146(5): S-362
Hellström, P.M.; Halim, M.A.; Boghos, S.; Gillberg, L.; Sundbom, M.; Karlbom, U.; Webb, D.-L. 2014: Sa2044 Direct Smooth Muscle Stimulatory Effect of L-Nmma on the Migrating Motor Complex Modulated by Muscarinic and 5-Ht3 Receptor Blockade. Gastroenterology 146(5): S-362
Jiang, Y.; Dong, H.; Hanson, E.; Eckmann, L.; Mittal, R.K. 2014: Sa2045 Excitatory and Inhibitory Motor Neurons of the Esophageal Myenteric Plexus: A Study Using Genetically Altered Double Reporter Mice. Gastroenterology 146(5): S-362
Sha, L.; van der Ploeg, L.H.; Szurszewski, J.H. 2014: Sa2046 Effect of Rm-131 on Circular Smooth Muscle Cells in Human and Mouse Colon and on Colonic Intraluminal Pressure in Conscious Mice. Gastroenterology 146(5): S-363
Lee, M.-C.; Yang, Y.-C.; Chen, Y.-C.; Huang, S.-C. 2014: Sa2047 Estrogen Causes Relaxation of Human Gallbladder via G Protein-Coupled Estrogen Receptors. Gastroenterology 146(5): S-363
Beyder, A.; Strege, P.R.; Rainey, J.F.; Bernard, C.E.; Giandomenico, V.; Kashyap, P.C.; Farrugia, G. 2014: Sa2048 Shear Sensitivity of the Voltage-Gated Sodium Selective Ion Channels (NaV) in the Neuroendocrine Cell Line Qgp-1. Gastroenterology 146(5): S-363
Pellegrini, C.; Fornai, M.; Antonioli, L.; Colucci, R.; Sacco, D.; Ippolito, C.; Segnani, C.; Levandis, G.; Cerri, S.; Blandini, F.; Bernardini, N.; Blandizzi, C. 2014: Sa2049 Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease. Gastroenterology 146(5): S-363
Pham, H.; Wu, S.S.; Eslami, P.; Harris-White, M.E.; Million, M. 2014: Sa2050 Corticotropin-Releasing Factor (Crf) Peptides Modulates Rat Colonic Neuronal Tau Phosphorylation: Differential Role of Crf Receptors. Gastroenterology 146(5): S-364
Acosta, A.; Kolar, G.; Iturrino, J.; Szarka, L.A.; Boldingh, A.; Burton, D.D.; Ryks, M.; Rhoten, D.L.; Zinsmeister, A.R.; Camilleri, M. 2014: Sa2051 A Phase Ii, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of Rm-131 in Patients With Chronic Constipation. Gastroenterology 146(5): S-364
Dong, H.; Jiang, Y.; Mittal, R.K. 2014: Sa2052 Role of Stretch-Activated Ion Channels in Esophageal Inhibitory Motor Neurons. Gastroenterology 146(5): S-364
Rainey, J.F.; Linden, D.R.; Grover, M.; Salmonson, C.E.; Bernard, C.E.; Szurszewski, J.H.; Farrugia, G.; Kashyap, P.C. 2014: Sa2054 Germ Free Mice Have Normal Epithelial Responses to Serotonin and Acetylcholine in the Proximal Colon. Gastroenterology 146(5): S-365
Bashashati, M.; Ho, W.; Mackie, K.; Hollenberg, M.D.; Sharkey, K.A. 2014: Sa2055 Alpha/Beta Hydrolase Domain 6 (Abhd6), A Novel Endocannabinoid Hydrolytic Enzyme, Regulates Contractility in the Mouse Intestine. Gastroenterology 146(5): S-365
Corsetti, M.; Tack, J.F. 2014: Sa2056 Comparison of the Effect of Prucalopride, Sodium Picosulfate and Placebo on Rectal Motor and Sensory Response to Distension Assessed by Electronic Barostat in Healthy Subjects. Gastroenterology 146(5): S-365
Boylan, M.O.; Shah, B.D.; Tatalovic, M.; Dennis, A.T.; Wolfe, M.M. 2014: Sa2058 Gip/Fc-IgG Fusions With Receptor Antagonist Activity. Gastroenterology 146(5): S-366
Broadhead, A.; Reed, D.E.; Peiris, M.; Bulmer, D.C.; Blackshaw, A. 2014: Sa2059 Afferent Activation in the Proximal Colon by Enteroendocrine Mediators and Nutrients. Gastroenterology 146(5): S-366
Suzuki, K.; Yokoyama, J.; Kawauchi, Y.; Honda, Y.; Asakura, H.; Okazaki, K.; Suzuki, Y.; Sameshima, Y.; Fukushima, T.; Fujii, M.; Hashiguchi, T.; Mizumoto, S.; Sugahara, K.; Yoneyama, H. 2014: Su1078 Endoscopic Submucosal Injection of a Synthesized Anti-Chst15 dsRna for Sulfated Glycosaminoglycan Is a Safe and Beneficial Treatment for Patients With Crohn's Disease Who Do Not Respond Sufficiently to the Conventional Treatment. Gastroenterology 146(5): S-366
Nikolaus, S.; Schreiber, S.; Siegmund, B.; Bokemeyer, B.; Baestlein, E.; Bachmann, O.; Kruis, W. 2014: Su1080 Patient Education in a 14 Month Randomized Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-Adherence. Gastroenterology 146(5): S-367
Brown, S.W.; Bly, M.J.; Baker, J.; May, K.; Fioritto, A.F.; Hasler, W.L.; Sun, D. 2014: Su1081 A Novel Method to Investigate Local Concentrations of Mesalamine in the Gastrointestinal Tract of Healthy Volunteers. Gastroenterology 146(5): S-367
Kim, Y.; Mulberg, A.E.; Lee, J.J.; Gottlieb, K.; Cooner, F.; Lee, S.C.H.; Zhang, L.; Kim, I. 2014: Su1083 Can Crohn's Disease Activity Index Differentiate Clinical Remission Induced by Placebo Versus Biologics Treatment? Analyses of Six Clinical Trials for Crohn's Disease. Gastroenterology 146(5): S-368
D'Haens, G.R.; Sandborn, W.; Colombel, J.-F.; Mimrod, D.; Spiegelstein, O.; Brown, K.; Feagan, B.G. 2014: Su1084 Pharmacokinetics of Laquinimod in Patients With Active Moderate to Severe Crohn's Disease. Gastroenterology 146(5): S-368
D, G.; Bressler, B.; Danese, S.; Gibson, P.R.; Hanauer, S.B.; Sandborn, W. 2014: Su1086 Identified Areas of Need to Enhance Evidence-Based Inflammatory Bowel Disease Management and Patient Care. Gastroenterology 146(5): S-369
Lichtenstein, G.R.; He, A.; Hanauer, S.B.; Keshav, S.; Onken, J.E. 2014: Su1087 Ferric Carboxymaltose: Efficacy and Safety in Patients With Gastrointestinal-Related Iron Deficiency Anemia: A Pooled Analysis. Gastroenterology 146(5): S-369
Kruis, W.; Mross, M.; Kahl, M.; Toermer, H.-J.; Deuster, U.H.; Reimers, B. 2014: Su1088 Participation in Decision Making Increases Patients' Adherence to Therapy in Ulcerative Colitis. Gastroenterology 146(5): S-370
Bownik, H.; Taft, T.; Dowjotas, K.; Keefer, L. 2014: Su1089 The Effects of Ibd Patient Self Management Practices on Ibd Flares and Patient Outcomes. Gastroenterology 146(5): S-370
Kasper, A.; Keefer, L.; Gawron, A.J.; Gossett, D.R.; Hahn, E.A.; Gawron, L.M. 2014: Su1090 Fertility-Related Knowledge in Women With Inflammatory Bowel Diseases. Gastroenterology 146(5): S-370
Bewtra, M.; Ha, C.Y.; Ananthakrishnan, A.N.; Rieder, F.; Cohen, B.L. 2014: Su1091 State of Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. Gastroenterology 146(5): S-371
Rossen, N.; Bart, A.; Verhaar, N.; Van Nood, E.; Kootte, R.; de Groot, P.; D'Haens, G.R.; Nieuwdorp, M.; Ponsioen, C.; Van Gool, T. 2014: Su1092 Low Prevalence of Blastocystis Sp in Active Ulcerative Colitis Patients. Gastroenterology 146(5): S-371
Lian, L.; Stocchi, L.; Shen, B.; Hammel, J.; Remzi, F.H. 2014: Su1094 Endoscopic Balloon Dilation Delays the Need for Subsequent Surgery in Patients With Ileocolonic Anastomotic (Ica) Stricture of Crohn's Disease (Cd) A Historical Cohort Study. Gastroenterology 146(5): S-372
Greveson, K.; Shepherd, T.C.; Hamilton, M.I.; Murray, C. 2014: Su1095 A Recent Flare of Disease Does Not Prohibit Travel: Early Results of a Single Centre Study in Inflammatory Bowel Disease and Travel. Gastroenterology 146(5): S-372
Tan, M.C.; Hou, J. 2014: Su1097 Determinants of Healthcare Utilization Among Veterans With Inflammatory Bowel Disease. Gastroenterology 146(5): S-373
Bennett, A.; Wichmann, M.; Andrews, J.M.; Bampton, P.A. 2014: Su1098 Rural and Remote Care for Patients With Inflammatory Bowel Disease -Perceived Barriers Despite Good Non-Expert Practitioner Knowledge. Gastroenterology 146(5): S-373
Hofmekler, T.; Bertha, M.; McCracken, C.; McKinnon, E.; Kugathasan, S.; Sauer, C. 2014: Su1100 Determinants of Immunogenicity in Children With Inflammatory Bowel Disease Receiving Infliximab. Gastroenterology 146(5): S-374
Nasr, I.; Goel, R.M.; Ward, M.G.; Fong, S.C.; Patel, K.V.; Ray, S.; Sastrillo, M.; Anderson, S.H.; Sanderson, J.D.; Irving, P.M. 2014: Su1101 Indeterminate and Inconclusive Results Are Common When Using Interferon Gamma Release Assay As Screening for Tb in Patients With Ibd. Gastroenterology 146(5): S-374
Feuerstein, J.D.; Martínez-Vazquez, M.; Belkin, E.; Singla, A.; Cheifetz, A.S. 2014: Su1103 30 Day Readmissions Rate and Predictors of Readmission in Hospitalized Patients With Ulcerative Colitis. Gastroenterology 146(5): S-375
Van Deen, W.K.; Choi, J.M.; Inserra, E.K.; Eimers, L.; Kane, E.; Ovsiowitz, M.; Centeno, A.; Van Oijen, M.G.; Roth, B.E.; Hollander, D.; Ho, W.; Cole, D.; Getzug, T.; Connolly, L.S.; Ho, A.D. 2014: Su1105 The Development and Evaluation of Coordinated Care Pathways for Inflammatory Bowel Diseases. Gastroenterology 146(5): S-376
Kaufman, L.C.; Doamekpor, F.; Youk, A.; Elliott, W.; Hashash, J.G.; Regueiro, M.; Szigethy, E. 2014: Su1107 Impact of Integrated Behavioral Health Model on Clinical Outcomes and Medical Utilization in Adults With Inflammatory Bowel Disease. Gastroenterology 146(5): S-377
Trevatt, A.; Zafar, S.; Joshi, A.; Besherdas, K. 2014: Su1108 Correlation of Endoscopy and Histology in Ileitis: Are Routine Biopsies Required?. Gastroenterology 146(5): S-377
Cesarini, M.; Collins, G.; Wang, L.M.; Fernandopulle, N.; Corte, C.J.; Brooks, J.A.; Keshav, S.; Travi, S. 2014: Su1109 Predicting the Individal Risk of Acute Severe Colitis At Diagnosis. Gastroenterology 146(5): S-377
Wengrower, D.; Shaul, C.; Peleg, U.; Leore, C.; Menahem, G.; Koslowsky, B. 2014: Su1111 Hearing Loss in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-378
Koslowsky, B.; Gupta, A.; Livovsky, D.M.; Adar, T.; Turner, D.; Hartnell, F.; Pratico', C.; Travis, S. 2014: Su1112 The Use of the Pediatric Ulcerative Colitis Activity Index (Pucai) in Adults With Acute Severe Ulcerative Colitis (Asc). Gastroenterology 146(5): S-378
Mathers, B.; Williams, E.; Bedi, G.; Tinsley, A. 2014: Su1113 An Electronic Alert System Is Associated With a Significant Increase in Pharmacologic Venous Thromboembolism Prophylaxis Rates in Hospitalized Inflammatory Bowel Disease Patients. Gastroenterology 146(5): S-378
Zafar, S.; Trevatt, A.; Joshi, A.; Besherdas, K. 2014: Su1115 Terminal Ileitis At Endoscopy in Clinical Practice: Is It Always Crohn's Disease?. Gastroenterology 146(5): S-379
Gu, J.; Lian, L.; Liu, X.; Remzi, F.H.; Shen, B. 2014: Su1117 Practice Pattern and Detection of Neoplasia by Surveillance Pouch Endoscopy After Ipaa for Ibd Colitis in Academic Centers in the Us. Gastroenterology 146(5): S-380
Scriven, M.; Hewes, P.D.; Knapp, P.; McDonnell, M.E.; Alexanian, S.; Sentovich, S.; Farraye, F.A.; McAneny, D. 2014: Su1118 The Development of a Standardized Peri-Operative Steroid Management Protocol for Ibd Patients. Gastroenterology 146(5): S-380
Limketkai, B.N.; He, D.; Hutfless, S. 2014: Su1119 Hospital Readmissions of Inflammatory Bowel Disease: Developing a High-Dimensional Predictive Model Using Administrative Claims Data. Gastroenterology 146(5): S-380
Maillard, M.H.; Vader, J.-P.; Mottet, C.; Schoepfer, A.; Gonvers, J.-J.; Burnand, B.; Froehlich, F.; Michetti, P.F.; Pittet, V. 2014: Su1120 Appropriateness and Long-Term Discontinuation Rate of Biological Therapies in Ulcerative Colitis. Gastroenterology 146(5): S-381
Yanai, H.; Lichtenstein, L.; Assa, A.; Mazor, Y.; Weiss, B.; Levine, A.; Ron, Y.; Kopylov, U.; Bujanover, Y.; Rosenbach, Y.; Ungar, B.; Eliakim, A.R.; Chowers, Y.; Shamir, R.; Fraser, G. 2014: Su1121 Anti-Tnf and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab. Gastroenterology 146(5): S-381
Suzuki, Y.; Iwasa, R.; Yamada, A. 2014: Su1122 Monitoring C-Reactive Protein in Biologic Naive Patients With Ulcerative Colitis Undergoing Infliximab Remission Induction Therapy. Gastroenterology 146(5): S-381
Stibbe, J.A.; Hoekman, D.R.; Baert, F.J.; Caenepeel, P.; Vergauwe, P.L.; DeVos, M.; Vermeire, S.; D'Haens, G.R. 2014: Su1123 Top-Down Versus Step-Up Treatment in Newly Diagnosed Crohn's Disease: No Difference in Long-Term Outcome. Gastroenterology 146(5): S-381
Yoshimura, N.; Kawaguchi, T.; Sako, M.; Saniabadi, A.; Takazoe, M. 2014: Su1125 Long-Term Efficacy of a pH-Dependent Release Mesalamine Formulation, Asacol in Patients With Ulcerative Colitis Who Showed Inadequate Response to a Time-Dependent Release Mesalamine Formulation, Pentasa: A Prospective Study. Gastroenterology 146(5): S-381-S-382
Yoshimura, N.; Kawaguchi, T.; Sako, M.; Saniabadi, A.; Takazoe, M. 2014: Su1126 In Patients With Crohn's Disease, Concomitant Enteral Nutrition Reduces the Loss of Response to Adalimumab Maintenance Therapy. Gastroenterology 146(5): S-382
Takeuchi, K.; Yamada, A.; Suzuki, Y. 2014: Su1127 In Patients With Crohn's Disease, Timing of Switching From Infliximab Maintenance Therapy to Adalimumab Affects Patients' Prognosis. Gastroenterology 146(5): S-382
Pedersen, N.; Andersen, N.N.; Vegh, Z.; Jensen, L.; Ankersen, D.V.; Felding, M.; Simonsen, M.H.; Burisch, J.; Munkholm, P. 2014: Su1128 e-Health: Web-Based Treatment Solution in Irritable Bowel Syndrome: Low Fodmap vs. Lactobacillus rhamnosus Gg. Gastroenterology 146(5): S-382
Diaz-Gonzalez, A.; Rodríguez, S.; de Miguel, C.R.; Ordás, I.; Jauregui, A.; Ricart, E.; Ramirez, A.; Gallego, M.; Rimola, J.; Pellise, M.; Fernandez-Esparrach, G.; Gines, A.; Sendino, O.; Llach, J.; Panes, J. 2014: Su1130 Capsule Endoscopy (Ce) Is Superior to Magnetic Resonance Enterography (Mre) for the Assessment of Small Bowel Lesions in Crohn's Disease Patients (Cd): A Comparative Trial. Gastroenterology 146(5): S-383
Kjær, M.D.; Laursen, S.B.; Poornorooz, P.H. 2014: Su1131 Sexual Function and Body Image Is Similar After Laparoscopic and Open Ileal Pouch-Anal Anastomosis. Gastroenterology 146(5): S-383
Sood, R.; Ansari, S.; Clark, T.; Hamlin, P.J.; Ford, A.C. 2014: Su1132 Earlier Use of Azathioprine in Ulcerative Colitis Does Not Alter Subsequent Need for Hospitalisation, Biologic Therapy, or Colectomy. Gastroenterology 146(5): S-383
Singh, S.; Garg, S.K.; Wang, Z.; Murad, M.H.; Loftus, E.V. 2014: Su1134 Comparative Efficacy of Biologic Therapy in the Management of Biologic-Naive Patients With Ulcerative Colitis: An Indirect Treatment Comparison Meta-Analysis. Gastroenterology 146(5): S-384
Wani, S.; Rastogi, A.; Early, D.S.; Mullady, D.; Collins, B.T.; Wang, J.F.; Yen, R.D.; Sams, S.B.; Marshall, C.; Gaddam, S.; Brauer, B.C.; Amateau, S.K.; Kushnir, V.M.; Rizeq, M.; Hollander, T.G. 2014: Su1136 Cost Minimization Analysis of Onsite Cytopathologist (CyP) Evaluation During Eus-Fna of Solid Pancreatic Lesions: Results From a Multicenter Prospective Randomized Controlled Trial. Gastroenterology 146(5): S-385
Sofuni, A.; Moriyasu, F.; Sano, T.; Itokawa, F.; Tsuchiya, T.; Kurihara, T.; Tsuji, S.; Ishii, K.; Ikeuchi, N.; Umeda, J.; Tanaka, R.; Tonozuka, R.; Honjo, M.; Mukai, S.; Itoi, T. 2014: Su1139 New Technology Therapy Using High-Intensity Focused Ultrasound (Hifu) for Pancreatic Cancer. Gastroenterology 146(5): S-386
Sikkens, E.C.M.; Cahen, D.L.; de Wit, J.; Looman, C.W.; Kubben, F.J.; Bruno, M.J. 2014: Su1140 Exocrine Insufficiency in Chronic Pancreatitis; Flexible Dosing of Pancreatic Enzymes Improves Treatment Outcome. Gastroenterology 146(5): S-387
Shimasaki, T.; Ueda, N.; Kawada, N.; Nomura, T.; Yamada, K.; Yamada, H.; Hayashi, R.; Matsunaga, K.; Fukuyama, T.; Otsuka, T.; Nakamura, M.; Toshikuni, N.; Shiroeda, H.; Kosaka, T.; Tomosugi, N. 2014: Su1141 Phase I Clinical Trial of the Combination Therapy Using Gemcitabine and Gsk3beta Inhibiting Drugs for Gemcitabine-Resistant Advanced Pancreatic Cancer Patients. Gastroenterology 146(5): S-387
Patel, V.D.; Stobaugh, D.J.; Meiselman, M.; Ehrenpreis, E.D. 2014: Su1142 Analysis of Hospital Charges and Clinical Outcomes in Patients Receiving Inpatient Intervention for Choledocholithiasis. Gastroenterology 146(5): S-387
Jang, S.I.; Choi, H.K.; Kim, H.W.; Kim, Y.H.; Yu, J.-S.; Hwang, J.; Lee, D. 2014: Su1144 Conventional Y Stent Versus Niti-S Large Cell D-Type (Lcd) Stent in Bilateral Stent Placement for Advanced Hilar Malignancy. Gastroenterology 146(5): S-388
Chibbar, R.; D'Souza, P.; Sandha, G.; Zepeda-Gomez, S.; Van Zanten, S.V.; Teshima, C.W.; Sultanian, R.A. 2014: Su1145 The Impact of Endoscopist Case Volume on Ercp Outcomes: Experience At a Canadian Tertiary Centre. Gastroenterology 146(5): S-388
Lee, J.-Y.; Lee, I.S.; Lim, C.-H.; Kim, J.S.; Park, J.M.; Kim, S.W.; Choi, M.-G. 2014: Su1146 Comparative Analysis Between Early and Delayed Laparoscopic Cholecystectomy After Percutaneous Transhepatic Gallbladder Drainage. Gastroenterology 146(5): S-388
Vaishnavi, C.; Kapoor, P.; Kochhar, R. 2014: Su1148 Bacterial Biofilms Produced in Stents Retrieved From Patients With Biliary and Pancreatic Diseases. Gastroenterology 146(5): S-389
Imler, T.D.; Sagi, S.; Teal, E.; Sherman, S.; Cote, G.A. 2014: Su1149 Coding Position of Acute Pancreatitis Significantly Impacts Length of Hospitalization: Implications for Database Studies of Acute Pancreatitis Using the International Classification of Diseases. Gastroenterology 146(5): S-389
Kim, Y.H.; Jang, S.I.; Choi, H.K.; Kim, H.W.; Yu, J.-S.; Hwang, J.; Lee, D. 2014: Su1150 Radiological Characteristics When Percutaneous T-Stenting Could Be Considered As the First Drainage Option for Advanced Hilar Malignancy. Gastroenterology 146(5): S-390
Das, K.; Fitton, C.; Jackson, B.K.; Ismail, M.K.; Tombazzi, C.R. 2014: Su1151 Long Term Outcomes of Incidentally Diagnosed Dilated Common Bile Duct (Cbd) and/or Main Pancreatic Duct (Mpd) With Normal Liver Enzymes in Elderly Population: The Big Dilemma!. Gastroenterology 146(5): S-390
Lee, F.; Rheem, J.; Ohanian, E.; Allen, A.G.; Puri, N.; Basseri, R.J.; Walter, M.H. 2014: Su1152 Does Method of Sedation Affect Post-Endoscopic Retrograde Cholangiopanctreatography Pancreatitis?. Gastroenterology 146(5): S-390
Eisig, J.N.; Navarro-Rodriguez, T.; Teixeira, A.C.; Silva, F.M.; Mattar, R.; Chinzon, D.; Moraes-Filho, J.P.; Haro, C.; Barbuti, R.C. 2014: Su1153 Standard Triple Therapy for Helicobacter pylori Is Still the Best First Line Treatment in Brazil, Compared With Sequential Therapy: A Randomized, Prospective, Double-Blind, Placebo-Controlled Study. Gastroenterology 146(5): S-390
Shiotani, A.; Kamada, T.; Fujita, M.; Nakato, R.; Murao, T.; Ishii, M.; Kimura, T.; Nishibayashi, H.; Haruma, K. 2014: Su1154 Molecular Detection of H. pylori Using Adherent Gastric Mucous to Biopsy Forceps. Gastroenterology 146(5): S-390
Lee, S.-Y.; Kim, J.H.; Sung, I.K.; Park, H.S.; Shim, C.S.; Jin, C.J. 2014: Su1155 Benefit of Helicobacter pylori Eradication Therapy to Symptomatology Is Greater in Patients Without Metaplastic Gastritis. Gastroenterology 146(5): S-391
Kim, S.E.; Park, M.I.; Park, S.J.; Moon, W.; Choi, Y.J.; Kwon, H.J.; Kim, J.H. 2014: Su1156 The Trend in Helicobacter pylori Eradication Rates by First-Line Triple Therapy and Related Factors in Eradication Therapy. Gastroenterology 146(5): S-391
Hauser, G.; Salkic, N.N.; Vukelic, K.; Kuzmic, V.; Stimac, D. 2014: Su1157 The Efficacy of Probiotics As Adjuvant Treatment in Eradicating H. pylori by Standard Triple Therapy: A Prospective, Randomized, Double Blind and Placebo Controlled Trial. Gastroenterology 146(5): S-391
Kim, S.Y.; Han, J.S.; Hyun, J.J.; Jung, S.W.; Koo, J.S.; Park, J.-J.; Chun, H.J.; Lee, S.W. 2014: Su1158 Comparative Study of Helicobacter pylori Eradication Rates With 10-Day Quadruple Concomitant Therapy and 10-Day Sequential Therapy. Gastroenterology 146(5): S-391
Srinarong, C.; Mahachai, V.; Vilaichone, R. 2014: Su1159 High Efficacy of 14-Day Standard Triple Therapy Plus Bismuth With Probiotic Supplement for H. pylori Eradication in Low Clarithromycin Resistance Areas. Gastroenterology 146(5): S-391
Demirci, H.; Uygun, A.; Ozel, A.M.; Sakin, Y.S.; Polat, Z.; Kantarcioglu, M.; Gulsen, M.; Bagci, S. 2014: Su1160 Do Probiotics Improve Eradication Response Rate of Modified First-Line Treatment for Helicobacter pylori?. Gastroenterology 146(5): S-392
Furuta, T.; Sugimoto, M.; Yamade, M.; Uotani, T.; Sahara, S.; Ichikawa, H.; Kagami, T.; Iwaizumi, M.; Yamada, T.; Osawa, S.; Sugimoto, K. 2014: Su1161 Eradication of H. pylori Infection in Patients Allergic to Penicillin. Gastroenterology 146(5): S-392
Song, Z.; Zhou, L.; He, L.; Zhang, J.; Chen, M.; Hou, X.; Li, Z. 2014: Su1162 Prospective Multi-Region Study on Primary Antibiotic Resistance of Helicobacter pylori Strains Isolated From Chinese Dyspeptic Patients. Gastroenterology 146(5): S-392
Gisbert, J.P.; Romano, M.; Molina-Infante, J.; Lucendo, A.J.; Chulia, E.M.; Modolell, I.; Rodriguez, B.J.G.ómez; Barrio, J.; Perona, M.; Ortuno, J.A.; Ariño, I.; Domínguez-Muñoz, J.E.; Aisa, A.P.; Domínguez, J.L.; Almela, P. 2014: Su1164 Second-Line Rescue Therapy With Moxifloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection. Gastroenterology 146(5): S-393
Nyssen, O.P.; McNicholl, A.G.; Megraud, F.; Savarino, V.; Oderda, G.; Fallone, C.A.; Fischbach, L.A.; Bazzoli, F.; Gisbert, J.P. 2014: Su1165 Meta-Analysis of Sequential vs. Standard Triple Therapy for Helicobacter pylori Eradication: Final Results of a Cochrane Systematic Review. Gastroenterology 146(5): S-393
Gisbert, J.P.; Barrio, J.; Modolell, I.; Molina-Infante, J.; Aisa, A.P.; Gisbert, J.; Bermejo, M.F.; Marcos, S. 2014: Su1166 Helicobacter pylori First-Line Treatment With Bismuth-Containing Quadruple Therapy, and Second-Line Levofloxacin-Based Rescue Option, in Patients Allergic to Penicillin. Gastroenterology 146(5): S-393
Caldas, M.; McNicholl, A.G.; Molina-Infante, J.; Huerta, A.; Aisa, A.P.; Castro-Fernandez, M.; Barrio, J.; Montoro, M.A.; Cajal, M.D.; Lucendo, A.J.; Lanas, A.; Ducons, J.; Modolell, I.; Salazar, L.F.; Rodriguez, B.J.G.ómez 2014: Su1167 European Registry on H. pylori Management (Hp-EuReg): Spanish Detailed Results (Interim Analysis). Gastroenterology 146(5): S-393
Burgos-Santamaria, D.; McNicholl, A.G.; Gisbert, J.; Marcos, E.S.; Bermejo, M.F.; Molina-Infante, J.; Gisbert, J.P. 2014: Su1169 Empirical Rescue Therapy After H. pylori Treatment Failure. A 15-Year Single Center Study of 1,000 Patients. Gastroenterology 146(5): S-394
Gisbert, J.P.; Aisa, A.P.; Bermejo, F.; Castro-Fernandez, M.; Almela, P.; Barrio, J.; Cosme, A.; Modolell, I.; Bory, F.; Bermejo, M.F.; Rodrigo, L.; Ortuno, J.A.; Sanchez-Pobre, P.; Khorrami, S.; Franco, A. 2014: Su1170 Second-Line Rescue Therapy With Levofloxacin After Failure of Treatment to Eradicate Helicobacter pylori Infection: Time Trends in a Spanish Multicenter Study of 1,400 Patients. Gastroenterology 146(5): S-394
Gisbert, J.P.; Molina-Infante, J.; Marin, A.C.; Rodriguez, G.V.; Barrio, J.; McNicholl, A.G. 2014: Su1171 Second-Line Rescue Triple Therapy With Levofloxacin After Failure of Non-Bismuth Quadruple Sequential or Concomitant Treatment to Eradicate H. pylori Infection. Gastroenterology 146(5): S-394
McNicholl, A.G.; Tepes, B.; Gasbarrini, A.; Boyanova, L.; Leja, M.; Lerang, F.; Rokkas, T.; Kupcinskas, L.; Przytulski, K.; Katicic, M.; Machado, J.C.; Bordin, D.S.; Bytzer, P.; Beglinger, C.; Shvets, O. 2014: Su1173 Pan-European Registry on H. pylori Management: Interim Analysis. Gastroenterology 146(5): S-395
McNicholl, A.G.; Nyssen, O.P.; Gisbert, J.P. 2014: Su1174 Sequential and Concomitant Treatments in H. pylori Eradication: A Network Meta-Analysis. Gastroenterology 146(5): S-395
Gisbert, J.P.; Castro-Fernandez, M.; Aisa, A.P.; Cosme, A.; Molina-Infante, J.; Rodrigo, L.; Modolell, I.; Nuño, J.L.C.; Gisbert, J.; Lamas, E.; Marcos, S.; Calvet, X. 2014: Su1175 Fourth-Line Rescue Therapy With Rifabutin in Patients With Three H. pylori Eradication Failures. Gastroenterology 146(5): S-395
Park, C.K. 2014: Su1176 The Efficacy of Rapid Urease Test Using Mucosal Scratch Rather Than Biopsy for Diagnosis of H. pylori Infection. Gastroenterology 146(5): S-395
Kim, N.; Lee, J.W.; Nam, R.H.; Lee, D. 2014: Su1178 Antibiotic Activity of Finafloxacin on Helicobacter pylori Isolates Depending on pH Value Comparing With Other Fluoroquinolone in Korea. Gastroenterology 146(5): S-396
Zhou, L.; Zhang, J.; Chen, M.; Hou, X.; Li, Z.; Song, Z.; He, L.; Lin, S. 2014: Su1179 A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial. Gastroenterology 146(5): S-396
Treiber, G. 2014: Su1180 Review -What Constitutes Helicobacter (H.) Pylori Eradication Failure?. Gastroenterology 146(5): S-396
Kamada, T.; Inoue, K.; Manabe, N.; Fujita, M.; Matsumoto, H.; Imamura, H.; Tarumi, K.; Yamashita, N.; Kusunoki, H.; Honda, K.; Watanabe, T.; Shiotani, A.; Hata, J.; Haruma, K. 2014: Su1181 Combination Therapy With Eradication Agents Is Useful for Successful Eradication of Helicobacter pylori in Japan. Gastroenterology 146(5): S-397
Kamada, T.; Haruma, K.; Watanabe, T.; Tsukamoto, M.; Murao, T.; Ishii, M.; Fujita, M.; Matsumoto, H.; Imamura, H.; Manabe, N.; Tarumi, K.; Yamashita, N.; Kusunoki, H.; Honda, K.; Inoue, K. 2014: Su1182 Usefulness of the Non-Invasive Rapid Urease Test Using Gastric Mucus for the Diagnosis of Helicobacter pylori Infection. Gastroenterology 146(5): S-397
Kamada, T.; Sato, M.; Tokutomi, T.; Hara, M.; Watanabe, T.; Murao, T.; Matsumoto, H.; Manabe, N.; Ito, M.; Inoue, K.; Shiotani, A.; Akiyama, T.; Hata, J.; Haruma, K. 2014: Su1183 Rebamipide, Mucosal-Protective and Ulcer-Healing Drug, Improves Chronic Inflammation of the Corpus After H. pylori Eradication: A Multicenter Study in Japan. Gastroenterology 146(5): S-397
Georgopoulos, S.D.; Xirouchakis, E.; Zampeli, E.; Martinez-Gonzalez, B.; Grivas, E.; Spiliadi, C.C.; Sotiropoulou, M.; Petraki, K.; Laoudi, F.; Zografos, K.; Sgouras, D.N.; Kasapidis, P.; Mentis, A.; Michopoulos, S. 2014: Su1184 A Randomised Study Comparing 10 Days Concomitant and Sequential Treatments for the Eradication of Helicobacter pylori, in a High Clarithromycin Resistance Area. Gastroenterology 146(5): S-397
Michopoulos, S.; Zampeli, E.; Argyriou, K.; Xourafas, V.; Kourkoutas, H.; Kissouras, I.; Kalatzis, G.; Martinez-Gonzalez, B.; Sgouras, D.N.; Mentis, A. 2014: Su1186 Standard Triple Regimen Eradication Rates for Helicobacter pylori Are Closely Related to Clarithromycin Resistance Levels. Gastroenterology 146(5): S-398
Heo, J.; Jeon, S.; Cho, C.-M.; Jung, M.K.; Jung, J.T.; Kwon, J.G.; Lee, D.W.; Ha, C.Y.; Kim, E.S.; Park, K.S.; Lee, S.H.; Jang, B.I. 2014: Su1187 Randomised, Multicenter Clinical Trial: Comparison of 10-Day Standard Triple Therapy and Non-Bismuth-Containing Concomitant Therapy for Helicobacter pylori Infection in Korea (Interim Result). Gastroenterology 146(5): S-398
Molakatalla, P.K.; Kumar, A.R.; Gulati, A.; Nathan, R.; Katz, P.O. 2014: Su1189 H. pylori in Peptic Ulcer Bleed: Diagnostic Tests Are Under-Utilized. Gastroenterology 146(5): S-398
Zhang, X.; Yang, Y.; Gang, S.; Yang, C.; Lu, M.; Zhi, J. 2014: Su1190 Berberine-,Allicin-or Clarithromycin-Based Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection: an Open-Label, Randomized Trial. Gastroenterology 146(5): S-398
Shin, C.M.; Kim, N.; Chang, H.; Kim, J.S.; Lee, D.H.; Jung, H.C. 2014: Su1192 A Follow-Up of Cdx1 and Cdx2 mRna Expressions in Noncancerous Gastric Mucosae After Helicobacter pylori Eradication. Gastroenterology 146(5): S-399
Sablin, O.A.; Yurin, M.; Zakharova, N.; Simanenkov, V. 2014: Su1193 Efficiency of Eradication Therapy in Patients With Autoimmune Gastritis Associated With Helicobacter pylori: A Prospective Study. Gastroenterology 146(5): S-399
Coss, E.; Genta, R.M.; Dunbar, K.B.; Park, C.; Rogers, N.S.; Cryer, B.L. 2014: Su1194 Sequential Therapy Is Not Better At Eradication of Primary Helicobacter pylori Infection When Compared to Standard Triple Therapy in the United States-a Prospective, Randomized Evaluation in a United States Population. Gastroenterology 146(5): S-399
Van Zanten, S.V.; Aplin, L.; Chang, H.-J.; Morse, A.L.; Lazarescu, A.; Girgis, S.; Keelan, M.M.; Goodman, K.J. 2014: Su1198 Community H. pylori Project Treatment Trial Results From the Canadian Arctic. Gastroenterology 146(5): S-400
Kim, J.G.; Lee, S.W.; Kim, B.J. 2014: Su1199 Treatment of Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-400
Lee, S.W.; Shin, W.G.; Lee, S.W.; Baik, G.H.; Huh, K.C.; Lee, S.I.; Chung, J.; Jung, W.T.; Park, M.I.; Jung, H.-K.; Kim, H.U.; Kim, J.H.; Seol, S.Y.; Yoon, S.M.; Jeon, S.W. 2014: Su1200 Eradication Rates of Helicobacter pylori in Korea Over the Last 10 Years: Nation-Wide Survey. Gastroenterology 146(5): S-400
Tomtitchong, P.; Crabtree, J.E. 2014: Su1201 The Expression of the 67 kDa Laminin Receptor (Lr) or Green Tea Catechin Epigallocatechin-3-Gallate (Egcg) Receptor May Explain the Different Responses to Egcg in the Cell Lines Infected With H. pylori. Gastroenterology 146(5): S-400
Bai, P.; Zhou, L. 2014: Su1202 Antibiotic Susceptibility Profile of Helicobacter pylori Isolated From Chinese Patients. Gastroenterology 146(5): S-400
den Hollander, W.J.; Holster, I.L.; Van Vuuren, A.; Jaddoe, V.W.; Perez-Perez, G.I.; Blaser, M.J.; Moll, H.A.; Kuipers, E.J. 2014: Su1203 Risk Factors for Helicobacter pylori Acquisition in a Multi-Ethnic Urban Population. Gastroenterology 146(5): S-401
Lee, S.P.; Lee, S.-Y.; Kim, J.H.; Sung, I.K.; Park, H.S.; Shim, C.S.; Jin, C.J.; Moon, H.-W. 2014: Su1204 Absence of Correlation Between IgE Hypersensitivity and Helicobacter pylori Infection in Korean Adults. Gastroenterology 146(5): S-401
Malieckal, A.; Izzy, M.J.; Changela, K.; Bhalani, K.; Lane, D.; Kargoli, F.; Buddhavarapu, V.S.; Malieckal, G.; Momeni, M.; Anand, S. 2014: Su1205 Prevalence of Helicobacter pylori and Intestinal Metaplasia in a Minority Population Registry of Outcomes of Upper Endoscopy in Minorities (Roum): A Hospital-Based Registry. Gastroenterology 146(5): S-401
Shah, M.; Rajan, D.; Shen, H.; Lipka, S.; Rashid, S.; Tan, C.B.; Mustacchia, P. 2014: Su1206 Relationship of Helicobacter pylori and Cigarette Smoking; A Retrospective Analysis. Gastroenterology 146(5): S-401
Vannarath, S.; Vilaichone, R.; Rasachak, B.; Mahachai, V.; Mairiang, P.; Yamaoka, Y. 2014: Su1207 Molecular Epidemiology and Outcome of Helicobacter pylori Infection in Laos. Gastroenterology 146(5): S-402
Furnari, M.; Moscatelli, A.; Brunacci, M.; Savarino, E.; Mazza, F.; Del Nero, L.; Gemignani, L.; Giacchino, M.; Mastracci, L.; Savarino, V. 2014: Su1208 Prevalence of Active H. pylori Infection and Clarithromycin-Containing Triple Therapy Efficacy in Patients With Dyspepsia -Experience of a Tertiary Centre in North of Italy. Gastroenterology 146(5): S-402
Rajan, D.; Cohen, I.; Shah, M.; Shen, H.; Raghavan, P.; Lipka, S.; Tan, C.B.; Rashid, S.; Garg, V.; Mustacchia, P. 2014: Su1209 Association Between Helicobacter pylori Infection and Diabetes Mellitus: A Five-Year Retrospective Analysis. Gastroenterology 146(5): S-402
Halpern, Z.; Ishaq, S.; Neumann, H.; Dobosz, M.; Viale, E.; Hoffman, A.; Hendel, J.; Senturk, H.; Kiesslich, R. 2014: Su1210 G-Eye Colonoscopy Significantly Improves Adenoma Detection Rates -Initial Results of a Multicenter Prospective Cohort Study. Gastroenterology 146(5): S-402
Kapidzic, A.; Grobbee, E.J.; Hol, L.; Van Roon, A.H.; Van Vuuren, A.; Spijker, W.; Izelaar, K.; Van Ballegooijen, M.; Kuipers, E.J.; Van Leerdam, M.E. 2014: Su1212 Increase in Participation Rate With Successive Rounds of Fit Screening. Gastroenterology 146(5): S-403
Redwood, D.; Asay, E.D.; Sacco, P.; Hamlin, C.E.; Otto, E.; Christensen, C.; Davis, P.W.; Tiesinga, J.J.; Sacco, F.D.; Devens, M.E.; Alberts, S.R.; Mahoney, D.W.; Fiero, M.H.; Yab, T.C.; Lidgard, G.P. 2014: Su1213 Stool Dna Testing for Screen-Detection of Colorectal Neoplasia in Alaska Native People. Gastroenterology 146(5): S-403
Launois, R.; Uzzan, B.; LeMoine, J.-G.; Navarrete, L.F.; Benamouzi, R. 2014: Su1215 Systematic Review and Bivariate/Hsroc Meta-Analysis of Immunochemical and Guaiac Fecal Occult Blood Tests for Colorectal Cancer Screening. Gastroenterology 146(5): S-404
Catomeris, P.; Baxter, N.N.; Boss, S.; Paszat, L.; Rabeneck, L.; Randell, E.; Serenity, M.; Sutradhar, R.; Tinmouth, J.M. 2014: Su1216 Effect of Temperature, Time and Freeze/Thaw Cycles on the Stability of Fecal Hemoglobin Using Five Commercial Fecal Immunochemical Test (Fit) Methods and One Guaiac Method. Gastroenterology 146(5): S-404
Tau, J.A.; Cano, J.J.; Shaib, Y.H.; Pan, M.M. 2014: Su1218 Surgical vs. Endoscopic Management of Colorectal Adenomas With High Grade Dysplasia. Gastroenterology 146(5): S-405
Qumseya, B.J.; Kyanam, K.R.; Baig, K.; Bhurwal, A.; Bouras, E.P.; Raimondo, M.; Wallace, M.B.; Woodward, T.A. 2014: Su1219 Braf Mutation Distinguishes Serrated Polyps from Tubular Adenomas: A Case Control Study. Gastroenterology 146(5): S-405
Gluck, N.; Fishman, S.; Melhem, A.; Goldfarb, S.; Halpern, Z.; Santo, E. 2014: Su1221 Aer-O-Scope, a Self-Propelled Pneumatic Colonoscope, Is Superior to Conventional Colonoscopy in Polyp Detection. Gastroenterology 146(5): S-406
Digby, J.; McDonald, P.J.; Strachan, J.A.; Libby, G.; Steele, R.J.; Fraser, C.G. 2014: Su1222 Fecal Hemoglobin Concentration Is Related to Advanced Colorectal Neoplasia Detection in the Subsequent Screening Round. Gastroenterology 146(5): S-406
Digby, J.; McDonald, P.J.; Strachan, J.A.; Libby, G.; Steele, R.J.; Fraser, C.G. 2014: Su1223 Fecal Hemoglobin Concetration Is Related to Degree of Deprivation. Gastroenterology 146(5): S-406
Denis, B.; Gendre, I.; Perrin, P. 2014: Su1224 Participation in the First Four Rounds of the Colorectal Cancer Screening Program With Guaiac Fecal Occult Blood Test Conducted in the Haut-Rhin (Alsace, France). Gastroenterology 146(5): S-407
Leshno, A.; Liberman, E.; Shapira, S.; Kraus, S.; Arber, N.; Moshkowitz, M. 2014: Su1225 The Association Between the Apc I1307K Allele and Colorectal and Non-Colorectal Cancer Risk. Gastroenterology 146(5): S-407
Moshkowitz, M.; Toledano, O.; Galazan, L.; Santo, E.; Hallak, A.; Arber, N. 2014: Su1226 Incidence of Colorectal Neoplasms Among Male Pilots. Gastroenterology 146(5): S-407
Ghouri, Y.A.; Batra, S.; Thosani, N.C.; Guha, S. 2014: Su1228 Increased Risk of Colorectal Cancer in Patients With Prior Ovarian Cancer Diagnosis: A Population Based Us Study. Gastroenterology 146(5): S-408
Hilsden, R.J.; McGregor, S.E.; Bridges, R.; Heitman, S.J.; Rostom, A.; Dube, C. 2014: Su1229 Interval Cancers After Screening Colonoscopy Performed in the Setting of a Continuous Quality Improvement Program With Monitoring of Endoscopist Performance Are Associated With Low Endoscopist Adenoma Detection Rate. Gastroenterology 146(5): S-408
de Ganzo, Z.A.; Alarcón, O.; Gimeno-García, A.Z.; Ramos, L.; Alonso-Abreu, I.; Carrillo-Palau, M.; Quintero, E. 2014: Su1230 Colon Capsule Endoscopy Versus Colonoscopy in Familial Colorectal Cancer Screening: a Randomized Controlled Trial. Gastroenterology 146(5): S-408
Abdeljawad, K.H.; Vemulapalli, K.C.; Kahi, C.J.; Cummings, O.W.; Snover, D.; Rex, D.K. 2014: Su1232 Sessile Serrated Polyp Prevalence Determined by a High Level Detector and an Expert Pathologist. Gastroenterology 146(5): S-409
Yen, R.D.; Wani, S.; Hosford, L.; Brauer, B.C.; Ahnen, D.J.; Austin, G.L. 2014: Su1233 Increased Efficiency in Adenoma Detection With Screening and Surveillance Colonoscopies Over the Course of Scheduled Block. Gastroenterology 146(5): S-409
Patrick, J.L.; Kim, D.H.; Pickhardt, P.J. 2014: Su1235 Characteristics of Serrated Adenomas At Ct Colonography-Based Screening. Gastroenterology 146(5): S-410
Bessa, X.; Hernandez, C.; Alvarez, C.; Augé, J.M.; Grau, J.; Buron, A.; Macià, F.; Castells, A.; Andreu, M. 2014: Su1236 Lower Risk of Advanced Adenoma (Aa) and Colorectal Cancer (Crc) Among Patients With a Previous Negative Result From a Fecal Immunochemical Test (Fit) for Crc. Preliminary Data on Second Round Screening. Gastroenterology 146(5): S-410
Shah, A.S.; Kelli, H.M.; Shea, L.M.; Goebel, S.U.; Qayed, E.S. 2014: Su1237 Effect of Fellow Participation in Screening Colonoscopy on Adenoma and Advanced Adenoma Detection Rates. Gastroenterology 146(5): S-410
Senore, C.; Bonelli, L.A.; Sciallero, S.; Zanetti, R.; Casella, C.; Segnan, N. 2014: Su1239 Can We Apply to the General Population the Results of Sigmoidoscopy Screening Trials? The Case of the Score Trial. Gastroenterology 146(5): S-411
Kumar, A.; Bernheim, O.; Lin, L.; Itzkowitz, S.H.; Jandorf, L.; Shah, B. 2014: Su1240 The Effect of Functional Status on Quality of Bowel Preparation in Elderly Patients Undergoing Colonoscopy. Gastroenterology 146(5): S-411
Kim, K.O.; Chung, H.H.; Kim, S.B.; Kim, K.H.; Lee, S.H.; Jang, B.I.; Kim, T.N. 2014: Su1242 Clinical Significance of Colonoscopic Examination in Patients With Early Gastric Cancer. Gastroenterology 146(5): S-412
Panigadi, G.N.; Pereyra, L.; González, R.; Gómez, E.J.; Omodeo, M.; Fischer, C.; Mella, J.M.; Manazzoni, D.; Pizzala, J.E.; Lasa, J.S.; DePaula, J.A.; Soifer, L.O.; Cimmino, D.G.; Pedreira, S.C.; Boerr, L.A. 2014: Su1243 Risk of Colonic Neoplasia in Patients With Sporadic Duodenal Adenomas: A Multicenter Case-Control Study. Gastroenterology 146(5): S-412
Parava, P.; Azizi, S.; Cheru, L.; Feustel, P.J.; Zhu, X. 2014: Su1245 Post Cholecystectomy, Choleretic Diarrhea Has a Negative Statistical Association With Distal Adenomatous Colorectal Polyps. Gastroenterology 146(5): S-413
Benes, M.; Drastich, P.; Hucl, T.; Wohl, P.; Stirand, P.; Spicak, J. 2014: Su1246 The Histologically Complete Polypectomy Rate (Hcpr) Is an Ideal Indicator of Quality of Colonoscopy. Gastroenterology 146(5): S-413
Marcolongo, M.; Gonzalez, M.L.; Rossi, G.; Beder, D.; Gomez, C.A.M.ías; DePaula, J.A. 2014: Su1247 Postcolonoscopy Colorectal Cancer (Pccrc) in a Population of a Closed System of Health Care Provision. Gastroenterology 146(5): S-413
Igarashi, K.; Hotta, K.; Sugimoto, S.; Imai, K.; Yamaguchi, Y.; Kakushima, N.; Takizawa, K.; Tanaka, M.; Matsubayashi, H.; Ono, H. 2014: Su1249 Could Positron Emission Tomography Detect Colorectal Adenomas and Cancers?. Gastroenterology 146(5): S-414
Sherman, C.B.; Cheng, J.; Terdiman, J.P. 2014: Su1250 Gender Differences in Colon Polyps Identified During Screening Colonoscopy. Gastroenterology 146(5): S-414
van der Pol, R.J.; Smits, M.J.; Dekker, T.; de Waart, D.R.; Ravanetti, L.; Lutter, R.; Benninga, M.A.; Van Wijk, M.P. 2014: Su1252 Gastric Juice Composition and Acid Suppression in Pediatric Gastroesophageal Reflux Disease. Gastroenterology 146(5): S-415
Hayashi, K.; Ro, S.; Ochiai, M.; Hosomi, E.; Ohno, S.; Harada, Y.; Hattori, T.; Yakabi, K. 2014: Su1253 Abnormal Dynamics of Endogenous Acylated Ghrelin Mediates Decreases in Gastric Phase Iii-Like Contraction, Leading to Delayed Gastric Emptying in Urocortin1-Induced Stress Rats. Gastroenterology 146(5): S-415
Singendonk, M.; Kritas, S.; Cock, C.; Ferris, L.; McCall, L.; Rommel, N.; Van Wijk, M.P.; Benninga, M.A.; Moore, D.; Omari, T. 2014: Su1255 Pressure-Flow Signatures Associated With Normal and Disordered Esophageal Motor Patterns: A Pediatric Study. Gastroenterology 146(5): S-416
Singendonk, M.; Smits, M.J.; Heijting, I.; Van Wijk, M.P.; Nurko, S.; Rosen, R.L.; Weijenborg, P.W.; Abu-Assi, R.; Hoekman, D.R.; Seiboth, G.; Benninga, M.A.; Omari, T.; Kritas, S. 2014: Su1256 Inter-and Intrarater Reliability of the Chicago Classification in Pediatric High-Resolution Esophageal Manometry Recordings. Gastroenterology 146(5): S-416
Zar-Kessler, C.; Kuo, B.; Cole, E.; Grosslein, A.; Belkind-Gerson, J. 2014: Su1258 Benefit of Pelvic Floor Physical Therapy With Biofeedback in Pediatric Patients With Dyssynergic Defecation. Gastroenterology 146(5): S-417
Srinath, A.I.; Youk, A.; Bielefeldt, K. 2014: Su1259 Biliary Dyskinesia and Symptomatic Gallstone Disease in Children: Two Sides of the Same Coin?. Gastroenterology 146(5): S-417
Saps, M.; Nichols-Vinueza, D.; Moreno, J.E.; Vinasco, L.G.; Velasco, C.A. 2014: Su1260 Prevalence of Functional Gastrointestinal Disorders A Large Multisite Study in Colombian School Children. Gastroenterology 146(5): S-418
Lavigne, J.; Youssef, N.; Miranda, A.; Nurko, S.; Hyman, P.E.; Cocjin, J.; DiLorenzo, C.; Saps, M. 2014: Su1261 Pain Response At the End of First Week of Treatment Predicts Outcome in Children With Functional Abdominal Pain (Fap). Gastroenterology 146(5): S-418
Ganesh, M.; Rosen, R.L.; Milliren, C.; Nurko, S. 2014: Su1262 Defining Normal Impedance Parameters in Children. Gastroenterology 146(5): S-418
Trauernicht, S.; Pinillos, S.; Rodriguez, L.; Rosen, R.L.; Siddiqui, A.; Nurko, S. 2014: Su1263 Bacterial Overgrowth in Patients With Antro-Duodenal Motility Disorders. Gastroenterology 146(5): S-418
Rommel, N.; Selleslagh, M.; Haesendonck, N.; Hellemans, M.; Van Herck, K.; Omari, T.; Kritas, S.; Hoffman, I.; Tack, J.F. 2014: Su1265 Clinical Challenges of Esophageal High Resolution Manometry in Pediatrics: Acquisition and Analysis. Gastroenterology 146(5): S-419
Van Tilburg, M.A.; Hyman, P.E.; Walker, L.S.; Rouster, A.; Palsson, O.S.; Kim, S.M.; Tack, J.F.; Spiller, R.C.; Spiegel, B.M.; Yang, Y.; Whitehead, W.E. 2014: Su1267 Prevalence of Infant/Toddler Functional Gastrointestinal Disorders in the U.S.: Results of a National Community Survey of Mothers. Gastroenterology 146(5): S-420
de Meij, T.; Benninga, M.A.; de Groot, E.; Budding, A.E.; Kneepkens, C.M.; Van Bodegraven, A.A.; Savelkoul, P. 2014: Su1268 Microbiota Profiling in Children With Functional Constipation. Gastroenterology 146(5): S-420
Tereshchenko, S.; Vityutneva, A.; Gorbacheva, N. 2014: Su1270 School-Based Study of Recurrent Abdominal Pain (Rap) in Siberian Adolescents: Prevalence Structure According Questionnaire on Pediatric Gastrointestinal Symptoms Rome Iii Version (Qpgs-Riii) and Association With Psychologic Problems According Strengths and Difficulties Questionnaire (Sdq). Gastroenterology 146(5): S-421
Kumar, N.; Ryou, M.; Thompson, C.C. 2014: Su1271 Eus-Guided Percutaneous Gastric Remnant Access for Single-Session Ercp in the Gastric Bypass Patient. Gastroenterology 146(5): S-421
Liu, T.-C.; Gao, F.; McGovern, D.P.; Stappenbeck, T.S. 2014: Su1273 Spatial and Temporal Stability of Paneth Cell Phenotypes in Crohn's Disease: Implications for Prognostic Cellular Biomarker Development. Gastroenterology 146(5): S-422
Viennois, E.; Baker, M.; Xiao, B.; Ayyadurai, S.; Laroui, H.; Merlin, D. 2014: Su1274 Longitudinal Study of Circulating miRna Biomarkers in Inflammatory Bowel Disease. Gastroenterology 146(5): S-422
Viennois, E.; Baker, M.; Xiao, B.; Ayyadurai, S.; Laroui, H.; Merlin, D. 2014: Su1275 Circulating Protein Signatures As Biomarkers for Inflammatory Bowel Disease Management. Gastroenterology 146(5): S-422
Keir, M.E.; Tew, G.W.; Luca, D.; Eastham-Anderson, J.; Diehl, L.; Egen, J.G.; Vermeire, S.; Mansfield, J.C.; Lamb, C.A.; Feagan, B.G.; Panes, J.; Baumgart, D.C.; Schreiber, S.; Dotan, I.; Sandborn, W. 2014: Su1276 E Integrin Expression As a Predictive Biomarker for Induction of Clinical Remission by Etrolizumab: Analysis of a Phase Ii Trial in Moderate-to-Severely Active Ulcerative Colitis. Gastroenterology 146(5): S-422
Tew, G.W.; Hackney, J.; Gibbons, D.L.; Lamb, C.A.; Luca, D.; Egen, J.G.; Vermeire, S.; Mansfield, J.C.; Feagan, B.G.; Panes, J.; Baumgart, D.C.; Schreiber, S.; Dotan, I.; Sandborn, W.; Kirby, J.A. 2014: Su1277 Increased Expression of T Cell Associated Genes in Baseline Biopsies From Tnf Antagonist Naive Patients That Achieve Remission With Etrolizumab Treatment in a Phase Ii Trial in Moderate to Severely Active Ulcerative Colitis. Gastroenterology 146(5): S-423
Rosenfeld, G.; Round, A.M.; Takach, O.; Halparin, L.S.; Saadeddin, A.; Ho, J.K.; Enns, R.A.; Bressler, B. 2014: Su1278 Focus: the Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Ibd. Gastroenterology 146(5): S-423
Nikolaus, S.; Schreiber, S.; Nurwakagari, P.; Rath, S.; Wittig, B.M.; Schwarz, M. 2014: Su1279 Clinical Epidemiology of Fecal Calprotectin: Population Data From the Fire Study, a Prospective Longitudinal Study in Germany to Evaluate Fecal Calprotectin in Routine Monitoring of Crohn's Disease. Gastroenterology 146(5): S-423
Ortega, T.L.; Bessissow, T.; DeHertogh, G.; Van Assche, G.A.; Vermeire, S.; Rutgeerts, P.J.; Bisschops, R.; Bitton, A.; Afif, W.; Ferrante, M. 2014: Su1280 The Modified Mayo Endoscopic Score (Mmes): A New Score for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis (Uc) Patients. Gastroenterology 146(5): S-424
Moussata, D.; Boschetti, G.; Chauvenet, M.; Stroeymeyt, K.; Nancey, S.; Berger, F.; Flouri, B. 2014: Su1281 Serrated Polyps in Patients With Inflammatory Bowel Disease: Endoscopic Characteristics Different From Serrated Polyps in the General Population. Gastroenterology 146(5): S-424
Voigt, R.M.; Jedel, S.; Taylor-Clift, A.; Forsyth, C.B.; Raeisi, S.; Shaikh, M.; Gorenz, A.; Swanson, G.B.; Mutlu, E.; Keshavarzian, A. 2014: Su1283 Biopsychological Markers Predict Ulcerative Colitis Disease Flare-Up. Gastroenterology 146(5): S-425
Rieder, F.; Franke, A.; Lopez, R.; Lang, S.; Roggenbuck, D.; Rogler, G.; Klebl, F. 2014: Su1284 Serologic Anti-Gp2 Antibodies Are Linked to Crohn's Disease and Are Associated With but Not Predictive of Strictures and Need for Surgical Resection. Gastroenterology 146(5): S-425
Stidham, R.W.; Lo, A.; Rogler, G.; Lubman, D.M.; Higgins, P.D. 2014: Su1285 Glycoproteomic Profiling of Serum Markers of Fibrosis in Fibrostenotic Crohn's Disease -An Objective Measure of Intestinal Damage?. Gastroenterology 146(5): S-425
Iqbal, T.; Vel, S. 2014: Su1286 Clinical Significance of C-Reactive Protein Levels in Predicting Responsiveness to Iron Therapy in Patients With Inflammatory Bowel Disease and Iron Deficiency Anaemia. Gastroenterology 146(5): S-426
Mortensen, J.H.; Godskesen, L.; Jensen, M.D.; Klinge, L.; Kjeldsen, J.; Karsdal, M.A.; Bay-Jensen, A.-C.; Krag, A. 2014: Su1287 Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in Uc and Cd. Gastroenterology 146(5): S-426
Ho, S.; Cheng, M.; Shih, D.Q.; Vu, M.; Hing, T.; Kubota, Y.; Ichikawa, R.; Tran, D.H.; Gallo, R.; Targan, S.; Pothoulakis, C.; Koon, H.W. 2014: Su1288 Intestinal Cathelicidin Level Indicates Inflammatory Bowel Disease Activity and Mediates Anti-Inflammatory Effects in Colitis. Gastroenterology 146(5): S-426
Seril, D.N.; Lashner, B.; Shen, B. 2014: Su1290 Overlap Between Immune-Mediated Pouchitis and Chronic Antibiotic-Refractory Pouchitis. Gastroenterology 146(5): S-427
de Bruyn, M.; Bessissow, T.; Billiet, T.; Cleynen, I.; Kirkland, R.; Liu, X.; Hauenstein, S.; Drake, K.; Singh, S.; Ferrante, M.; Rutgeerts, P.J.; Van Assche, G.A.; Arijs, I.; Opdenakker, G.; Vermeire, S. 2014: Su1292 Biomarker Panel for Prediction of Mucosal Healing in Patients With Crohn's Disease Under Infliximab Therapy. Gastroenterology 146(5): S-428
Abitbol, V.; Esch, A.; Borderie, D.; Polin, V.; Tabouret, T.; Dhooge, M.; Perkins, G.; Maksimovic, F.; Chaussade, S. 2014: Su1293 Diagnosis of Iron Deficiency in Inflammatory Bowel Diseases by Transferrin Receptor-Ferritin Index. Gastroenterology 146(5): S-428
Dharmasiri, S.; Boud, R.K.; Dower, A.; Hennessy, N.; Standing, L.; Richard-Taylor, A.; Hollingworth, T.; Johnson, H.E.; Weaver, S.; McLaughlin, S.D. 2014: Su1296 Diagnostic Benefit of Mre Following Ct. Gastroenterology 146(5): S-429
Macor, D.; Marino, M.; Macor, C.; di Prampero, S.F.V.'; Berretti, D.; Bulajic, M.M.; Zilli, M. 2014: Su1297 Direct Comparision of Bowel Ultrasonography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Gastroenterology 146(5): S-429
Phua, L.C.; Tan, Y.M.; Wong, R.K.; Li, X.; Wilder-Smith, C.H.; Chan, E.C.Y. 2014: Su1298 Noninvasive Urinary Metabonomic Diagnosis of Inflammatory Bowel Disease Using Gas Chromatography/Mass Spectrometry. Gastroenterology 146(5): S-429
Russo, E.; Dikaios, N.; Makanyanga, J.C.; Bishop, C.A.; Newbould, R.; Matthews, P.M.; Taylor, S.A.; Orchard, T.R. 2014: Su1300 The Use of Maria Score and Dynamic Contrast Enhancement Mri Endpoints in Patients With Endoscopic Evidence of Active Crohn's Disease. Gastroenterology 146(5): S-430
Tontini, G.E.; Mudter, J.; Vieth, M.; Atreya, R.; Günther, C.; Vecchi, M.; Neurath, M.F.; Neumann, H. 2014: Su1301 Prediction of Clinical Outcome in Crohn's Disease by Using Confocal Laser Endomicroscopy: A Prospective, Observational, Follow-Up Study. Gastroenterology 146(5): S-430
Klein, A.; Karban, A.; Mazor, Y.; Ben-Izhak, O.; Chowers, Y.; Sabo, E. 2014: Su1303 Early Histological Findings May Predict the Clinical Phenotype in Crohn's Colitis. Gastroenterology 146(5): S-431
McDonald, E.K.; Chua, T.; Chehl, N.S.; Yeboah-Korang, A.; Kastl, A.; Abraham, R.R.; Swanson, G. 2014: Su1304 Is Fecal Calprotectin Really Useful for Diagnostic Decision Making in the Inpatient Setting?. Gastroenterology 146(5): S-431
Bivin, W.W.; Clarke, K.; Falco, C.; Finkelstein, S.D.; Silverman, J.F. 2014: Su1306 Protease Activity Analysis and Pathologic Examination on the Same Endoscopic Biopsy Specimen in Inflammatory Bowel Disease. Gastroenterology 146(5): S-432
Trivella, J.P.; Yarur, A.; Wong, J.; Sussman, D.A. 2014: Su1307 The Value of Cross-Sectional Imaging to Detect Crohn's Disease Recurrence After Ileo-Colonic Anastomosis. Gastroenterology 146(5): S-432
Bagi, P.; Sandborn, W. 2014: Su1309 Terminal Ileum Intubation Is Essential for Adequate Management of Inflammatory Bowel Disease. Gastroenterology 146(5): S-433
Abramowitz, M.; Golla, V.; Ramachandran, R.; Koczka, C.P.; McFarlane, S.; Lawlor, G. 2014: Su1310 Constipation Is the Primary Clinical Predictor of Urgent Findings on Abdominopelvic Ct in Afro-Caribbean Patients With Crohns Disease Attending the Emergency Department. Gastroenterology 146(5): S-433
Shaw, S.Y.; Nugent, Z.; Targownik, L.; Singh, H.; Bernstein, C.N. 2014: Su1311 A Population-Based Comparison of Influenza Vaccination Use Among Individuals With and Without Ibd. Gastroenterology 146(5): S-433
Dudekula, A.; Schwartz, M.; Binion, D.G. 2014: Su1313 Crohn's Disease Hotspotting: Analysis of Regional Patterns of Admission and Readmission to Identify Clinical Factors Associated With Superutilizer Patient Behavior. Gastroenterology 146(5): S-434
Jauregui-Amezaga, A.; Rimola, J.; Ordás, I.; Rodríguez, S.; Ramírez, A.M.; Gallego, M.; Pinó-Donnay, S.; Masamunt, M.C.; Suarez, B.G.; Ricart, E.; Panes, J. 2014: Su1314 Presence of Stenosing and Penetrating Lesions At Mri but Not Deep Ulcers At Endoscopy Predicts Surgery Requirements in Crohn's Disease in the Era of Biologics. Gastroenterology 146(5): S-434
Corcos, O.; Cazals-Hatem, D.; Ispas, M.; Treton, X.; Maggiori, L.; Stefanescu, C.; Nuzzo, A.; Bondjemah, V.; Guedj, N.; Zappa, M.; Joly, F.; Panis, Y.; Bouhnik, Y. 2014: Su1315 Mesenteric Vascular Occlusion Is Associated With the Penetrating Phenotype and the Postoperative Course of Ileal Crohn's Disease. Gastroenterology 146(5): S-434
Sorrentino, D.; Avellini, C.; Geraci, M.; Zarifi, D.; Benevento, G.; di Prampero, S.F.V.' 2014: Su1317 Tissue Studies in Screened First Degree Relatives Reveal a Distinct Crohn's Disease Phenotype. Gastroenterology 146(5): S-435
Wright, E.K.; DeCruz, P.; Kamm, M.A.; Hamilton, A.L.; Ritchie, K.J.; Krejany, S.; Gorelik, A.; Liew, D.; Prideaux, L.; Lawrance, I.C.; Andrews, J.M.; Bampton, P.A.; Jakobovits, S.; Florin, T.H.; Gibson, P.R. 2014: Su1318 Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the Pocer Study. Gastroenterology 146(5): S-435
Nguyen, G.C.; Bollegala, N.; Chong, C.A. 2014: Su1319 Predictors of Readmissions and Outcomes Among Patients Hospitalized for Inflammatory Bowel Disease. Gastroenterology 146(5): S-435
Nannegari, V.; Colwell, J.; Christensen, B.; Rubin, D.T. 2014: Su1321 Risk Factors of Disease Recurrence After Total Proctocolectomy With End Ileostomy in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-436
Badamas, J.; Limketkai, B.N.; Lazarev, M. 2014: Su1323 Risk of Dysplasia According to Severity of Pseudopolyposis in Inflammatory Bowel Disease. Gastroenterology 146(5): S-436
Leung, Y.; Kaplan, G.; Coward, S.; Tanyingoh, D.; Kaplan, B.J.; Johnston, D.W.; Barkema, H.; Ghosh, S.; Panaccione, R.; Seow, C.H. 2014: Su1325 Women With Inflammatory Bowel Disease Are At Higher Risk of Gestational Diabetes: A Novel Finding. Gastroenterology 146(5): S-437
Have, M.V.; Fidder, H.; Leenders, M.; Kaptein, A.A.; van der Valk, M.E.; van Bodegraven, A.A.; Dijkstra, G.; DeJong, D.J.; Pierik, M.J.; Ponsioen, C.; van der Meulen –de Jong, A.E.; van der Woude, C.J.; van de Meeberg, P.; Romberg-Camps, M.; Clemens, C. 2014: Su1326 Self-Reported Disability Index in Inflammatory Bowel Disease: Results From a Large Dutch Prospective Cohort. Gastroenterology 146(5): S-437
van der Valk, M.E.; Mangen, M.-J.J.; Leenders, M.; Dijkstra, G.; Van Bodegraven, A.A.; Fidder, H.; DeJong, D.J.; Pierik, M.J.; van der Woude, C.J.; Romberg-Camps, M.; Clemens, C.; Jansen, J.M.; Mahmmod, N.; van de Meeberg, P.; van der Meulen –de Jong, A.E. 2014: Su1327 Healthcare Costs and Their Predictors in Inflammatory Bowel Disease: Two Year Results From the Coin study. Gastroenterology 146(5): S-438
Khan, M.A.; Newman, W.; Hill, J. 2014: Su1329 Differences in Luminal Distribution and Clinical Characteristics of Ulcerative Colitis in South Asians and Caucasians in the North of England. Gastroenterology 146(5): S-438
Chun, J.; Hwang, S.W.; Kim, J.H.; Im, J.P.; Cheon, J.H.; Ye, B.D.; Kim, J.W.; Kim, Y.S.; Kim, J.S. 2014: Su1330 Clinical Features and Prognosis of Fistulizing Perianal Crohn's Disease in Korea. Gastroenterology 146(5): S-438
Golovics, P.A.; Balint, A.; Mandel, M.D.; Vegh, Z.; Mohas, A.; Szilagyi, B.; Szabo, A.; Kurti, Z.; Kiss, L.S.; Lovasz, B.D.; Farkas, K.; Molnar, T.; Lakatos, P.L. 2014: Su1332 Hospitalization Rate Before and After Anti-Tnf Therapy, Results From Two Referral Centers. Gastroenterology 146(5): S-438
Ferreiro, R.; Acosta, M.B.; Lorenzo, A.; Dominguez-Munoz, E. 2014: Su1333 Influence of Coping Strategies on the Clinical Course of Inflammatory Bowel Disease: A Prospective, Observational Cohort Study. Gastroenterology 146(5): S-439
Hamid, F.; Gachpaz, B.; Campbell, D.R. 2014: Su1334 Metronidazole Treatment of Clostridium difficile Infection in Inflammatory Bowel Disease Is Associated With a High Risk of Treatment Failure and Recurrence. Gastroenterology 146(5): S-439
Park, S.H.; Yang, S.-K.; Kim, J.-B.; Lee, H.J.; Lee, H.; Yang, D.-H.; Kim, K.-J.; Ye, B.D.; Byeon, J.-S.; Myung, S.-J.; Kim, J.-H. 2014: Su1335 The Influence of Appendectomy on the Clinical Course of Ulcerative Colitis: A Hospital-Based Cohort Study From Korea. Gastroenterology 146(5): S-439
Shitrit, A.B.; Shuali, C.C.; Adar, T.; Koslowsky, B.; Shteingart, S.; Goldin, E. 2014: Su1337 Sleep Disorders in Inflammatory Bowel Disease: Incidence and Use of Ambulatory Polysomnography. Gastroenterology 146(5): S-440
Shitrit, A.B.; Shaubi, M.; Adar, T.; Koslowsky, B.; Goldin, E.; Grisaru-Granovsky, S. 2014: Su1338 The Association Between Inflammatory Bowel Disease (Ibd) and Parity. Gastroenterology 146(5): S-440
Walter, F.; Viola, A.; Manetti, N.; Coppola, M.; Francovic, I.; Monterubbianesi, R.; Cantoro, L.; Pugliese, D.; Aratari, A.; Cappello, M.; Saibeni, S.; Principi, M.; Naccarato, P.; Mocci, G.; Castiglione, F. 2014: Su1339 Ulcerative Colitis (Uc) Diagnosed over Age 65 Years -An Ig-Ibd Study. Gastroenterology 146(5): S-440
Safroneeva, E.; Vavricka, S.R.; Fournier, N.; Seibold, F.; Mottet, C.; Straumann, A.; Rogler, G.; Schoepfer, A. 2014: Su1341 Systematic Analysis of Factors Associated With Progression and Regression of Ulcerative Colitis in the Swiss Ibd Cohort Study. Gastroenterology 146(5): S-441
Leung, Y.K.; Huan, Y. 2014: Su1342 Early Lesions in Small Intestinal Crohn's Disease (Cd): An Endoscopic and Confocal Laser Endomicroscopic (Cle) Appraisal. Gastroenterology 146(5): S-441
de Bruyn, J.R.; Meijer, S.L.; Wildenberg, M.E.; van den Brink, G.R.; D'Haen, G.R. 2014: Su1344 Failure of Infliximab Treatment in Crohn's Disease Is Associated With the Presence of Fibrosis. Gastroenterology 146(5): S-442
Hashash, J.G.; Rivers, C.M.R.; Regueiro, M.; Barrie, A.; Schwartz, M.; Baidoo, L.; Swoger, J.M.; Dunn, M.A.; Binion, D.G. 2014: Su1345 Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4 Year Prospective Study. Gastroenterology 146(5): S-442
Fitzmorris, P.S.; Smith, I.B.; Juneau, J.; Perez, E.G.T.; Blackburn, B.; Kakati, D.D.; Malik, T.A. 2014: Su1346 Impact of Metabolic Syndrome on Hospitalization Rate of Crohn's Disease Patients Seen At a Tertiary Care Center. Gastroenterology 146(5): S-442
Bernstein, C.N.; Targownik, L.; Singh, H.; Israeli, E. 2014: Su1348 The Non Use of Ibd-Specific Prescription Medications in Patients With Ibd. Gastroenterology 146(5): S-443
Eun, C.S.; Han, D.S.; Lee, A.R.; Kim, S.M.; Ro, Y.; Yoo, K.-S. 2014: Su1350 Alterations in Composition and Diversity of the Intestinal Microbiota in Korean Inflammatory Bowel Diseases Patients. Gastroenterology 146(5): S-444
de Lima, A.; Zelinkova, Z.; van der Ent, C.; van der Woude, C.J. 2014: Su1351 Preconception Care in Ibd Women Leads to Less Disease Relapses During Pregnancy. Gastroenterology 146(5): S-444
Eluri, S.; Parian, A.M.; Limketkai, B.N.; Ha, C.Y.; Montgomery, E.A.; Lazarev, M. 2014: Su1352 Prevalence and Characteristics of Previously Undetected (Surprise) Colorectal Cancer in Colectomy Specimens Among Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-444
Ho, N.; Kamal, N.; Alimchandani, M.; Khangura, S.; Marciano, B.E.; Gallin, J.; Malech, H.L.; Holland, S.M.; Quezado, M.; Heller, T. 2014: Su1353 Longstanding Chronic Granulomatous Disease Colitis Does Not Increase the Risk of Colorectal Cancer. Gastroenterology 146(5): S-445
Jones, J.; Perampaladas, K.; Williamson, M.; Kanters, S.; Thorlund, K. 2014: Su1354 Factors Associated With Large Increases in Self-Reported Health Status in Infliximab-Treated Ibd Patients. Gastroenterology 146(5): S-445
Fasanya-Uptagraft, H.; Basile, J.; Lane, A.; Boutte, H.J.; Onken, J.E. 2014: Su1355 Outcomes of Inflammatory Bowel Disease After Organ Transplantation (Solid Organ or Hematopoietic Stem Cell Transplantation). Gastroenterology 146(5): S-445
Arora, Z.; Wu, X.; Navaneethan, U.; Shen, B. 2014: Su1357 Non-Surgical Porto-Mesenteric Vein Thrombosis Is Associated With Worse Outcomes in Inflammatory Bowel Diseases. Gastroenterology 146(5): S-446
Tofani, C.; Valentin, T.; Tierney, A.; Lichtenstein, G.R. 2014: Su1358 Ibd Is an Independent Risk Factor for Major Infectious Complications in Elderly Patients. Gastroenterology 146(5): S-446
Johnson, D.H.; Aboelsoud, M.M.; Yab, T.C.; Cao, X.; Smyrk, T.C.; Loftus, E.V.; Mahoney, D.W.; Ahlquist, D.A.; Kisiel, J.B. 2014: Su1359 Aberrant Dna Methylation of Colonic Serrated Lesions and Subsequent Colorectal Neoplasia in Ulcerative Colitis and Crohn's Colitis. Gastroenterology 146(5): S-446
Patel, A.V.; Fleshner, P.; Melmed, G.Y.; Vasiliauskas, E.A. 2014: Su1361 Systemic Therapy May Mask the Presence of Disease in Colitis Patients Undergoing Preoperative Small Bowel Evaluations. Gastroenterology 146(5): S-447
Cohen, C.; Tuskey, A.G.; Sheehan, J.; Behm, B.W. 2014: Su1362 Elevated Body Mass Index and Clinical Outcomes in Crohn's Disease. Gastroenterology 146(5): S-447
Yang, D.-H.; Yang, S.-K.; Song, K.; Hong, M.; Park, S.H.; Lee, H.; Kim, J.-B.; Lee, H.J.; Park, S.; Jung, K.W.; Kim, K.-J.; Ye, B.D.; Byeon, J.-S.; Myung, S.-J.; Kim, J.-H. 2014: Su1363 Tnfsf15 Is an Independent Predictor for the Development of Crohn's Disease-Related Complications in Koreans. Gastroenterology 146(5): S-447
Yamamoto-Furusho, J.K.; Jacintez-Cazares, M.; Fonseca-Camarillo, G. 2014: Su1364 Peroxisome Proliferator-Activated Receptors Alpha and Gamma Are Associated With Favorable Response to 5 Aminosalycilates and Mild Clinical Course of Ulcerative Colitis. Gastroenterology 146(5): S-447
van den Nieuwendijk, D.; Baeten, C.I.; Veenendaal, R.; Hardwick, J.C.; Vahrmeijer, A.; Bonsing, B.A.; van der Meulen –de Jong, A.E. 2014: Su1365 Yield of Colon Surveillance and Clinical Outcome After Faecal Diversion in Patients With Crohn's Disease. Gastroenterology 146(5): S-448
Biancone, L.; Petruzziello, C.; Armuzzi, A.; Scribano, M.L.; Orlando, A.; Castiglione, F.; Papi, C.; D'Inca, R.; Calabrese, E.; Condino, G.; Onali, S.; Kohn, A.; Mocciaro, F.; Frankovic, I.; Monterubbianesi, R. 2014: Su1366 Characterization of Incident Cases of Cancer in Inflammatory Bowel Disease: A Prospective Multicenter Matched-Pair Ig-Ibd Study. Gastroenterology 146(5): S-448
Jonefjäll, B.; Strid, H.; Ohman, L.; Svedlund, J.; Bergstedt, A.; Simren, M. 2014: Su1367 The Severity of Abdominal Pain At Onset of Ulcerative Colitis Is Associated With Ibs-Like Symptoms During Clinical Remission. Gastroenterology 146(5): S-448
Hoekstra, J.; Baars, J.; van Roon, A.H.; Kimmel, M.; Zwijnenburg, M.; Bekkering, F.C.; van Tilburg, A.J.P.; West, R. 2014: Su1369 Decision-Making, Counselling and Course of Pregnancy in Female Inflammatory Bowel Disease Patients. Gastroenterology 146(5): S-449
Lowenberg, M.; Brandse, J.F.; Vos, L.M.; Ponsioen, C.; van den Brink, G.R.; D'Haens, G.R. 2014: Su1371 High Infliximab Trough Levels Are Associated With Impaired Quality of Life in Ibd Patients in Clinical and Biochemical Remission on Maintenance Ifx Therapy. Gastroenterology 146(5): S-450
Fischer, M.; Campbell, S.C.; Johnson, C.S.; Helper, D.J.; Chiorean, M.V. 2014: Su1373 Risk Factors for Rescue Therapy in Crohn's Patients on Combination Therapy After Discontinuation of the Immunomodulator. Gastroenterology 146(5): S-450
Kotze, P.G.; Suzuki, Y.; Yamamoto, T.; Danese, S.; Saad-Hossne, R.; Albuquerque, I.C.; Teixeira, F.V.; Silva, R.N.; Barcelos, I.F.; Olandoski, M.; Kotze, L.M.; Yamada, A.; Spinelli, A. 2014: Su1375 Direct Retrospective Comparison of Adalimumab and Infliximab in Preventing Early Postoperative Endoscopic Recurrence After Ileocecal Resection for Crohn's Disease: Results From the Multiper Database. Gastroenterology 146(5): S-451
Suzuki, Y.; Kotze, P.G.; Spinelli, A.; Saad-Hossne, R.; Yamada, A.; Sacchi, M.; Teixeira, F.V.; Albuquerque, I.C.; Barcelos, I.F.; Silva, R.N.; Kotze, L.M.; Olandoski, M.; Danese, S.; Yamamoto, T. 2014: Su1376 Retrospective Comparison of the Efficacy of Anti-Tnf Agents in Isolation or Combined With Azathioprine in Prevention of Early Postoperative Endoscopic Recurrence in Crohn's Disease From the Multiper Database. Gastroenterology 146(5): S-451
Leung, Y.K.; Huang, Y. 2014: Su1378 Clinical Efficacy and Mechanism of Action of Thalidomide in Pediatric Patients With Refractory Crohn's Disease. Gastroenterology 146(5): S-452
Nuij, V.J.; somasundaram, R.; Diederen, K.; Vellekoop, L.; Peppelenbosch, M.P.; van der Woude, C.J.; Fuhler, G. 2014: Su1379 Ncf4 Risk Allele Affects Steroid Exposure and Dependency in Crohn's Disease Patients, Preliminary Results. Gastroenterology 146(5): S-452
Bonaz, B.L.; Pellissier, S.; Mathieu, N.; Hoffmann, D.; Trocme, C.; Baudrant-Boga, M.; Sinniger, V.; Picq, C.; David, O.; Vercueil, L.; Dantzer, C.; Cracowski, J.-L.; Clarençon, D. 2014: Su1381 Vagus Nerve Stimulation in Active Crohn's Disease. Gastroenterology 146(5): S-453
Bokemeyer, B.; Helwig, U.; Teich, N.; Schmidt, C.; Krummenerl, T.; Rupf, A.-K.; Hartmann, H.; Bläker, M.; Krummenerl, A.; Düffelmeyer, M.; Hinrichs, R.; Hartmann, P.; Nikolaus, S.; Hüppe, D.; Schreiber, S. 2014: Su1382 Adalimumab and Infliximab As Induction Therapy for Crohn's Disease -A Prospective Observational Study in Germany. Gastroenterology 146(5): S-453
Boden, E.K.; Canavan, J.B.; Moran, C.J.; McCann, K.; Farraye, F.A.; Ananthakrishnan, A.N.; Yajnik, V.; Nguyen, D.D.; Korzenik, J.R.; Snapper, S.B. 2014: Su1383 Pilot Study of Oral Delivery of Monoclonal Anti-Cd3 Antibody (Okt3) in Moderate to Severe Ulcerative Colitis. Gastroenterology 146(5): S-453
Zaghiyan, K.N.; Melmed, G.Y.; Dubinsky, M.; Vasiliauskas, E.A.; McGovern, D.P.; Ippoliti, A.; Shih, D.Q.; Khanna, P.; Targan, S.; Fleshner, P. 2014: Su1384 Medical Prophylaxis After Ileocolic Resection for Crohn's Disease No Need to Rush. Gastroenterology 146(5): S-454
Mathur, J.; Mills, P.; Naing, S.; Limsui, D. 2014: Su1385 Supplementation of Vitamin D3 (Cholecalciferol) in Patients With Ulcerative Colitis and Hypovitaminosis D: A Prospective Randomized Trial. Gastroenterology 146(5): S-454
Franchi, L.; Hlavaty, K.A.; Monteleone, I.; Morgan, R.; Porzondek, K.; Sanchez, B.; Lesch, C.; Spahr, M.A.; Hepburn, C.; Opipari, A.W.; Monteleone, G.; Glick, G.; Carter, L.; Higgins, P.D. 2014: Su1387 F1F0-Atpase Modulation Is Efficacious in Models in Ibd and Induces Apoptosis of Human Ccr9+ Gut-Tropic T-cells. Gastroenterology 146(5): S-455
Turner, D.; Levine, A.; Kaija-Leena, K.; Shaoul, R.; Lev-Tzion, R.; Rachman, Y.; Ledder, O. 2014: Su1388 Oral Antibiotic Cocktail (Madov) for Treatment of Refractory Severe Colitis. Gastroenterology 146(5): S-455
Rivers, C.M.R.; Binion, D.G.; Youk, A.; Regueiro, M.; Dunn, M.A.; Hashash, J.G.; Schwartz, M.; Baidoo, L.; Barrie, A.; Swoger, J.M.; Szigethy, E. 2014: Su1390 The Longitudinal Impact of Serotonin Reuptake Inhibitors on Quality of Life and Disease Activity in Adults With Inflammatory Bowel Disease (Ibd). Gastroenterology 146(5): S-456
Dubinsky, M.; Cucchiara, S.; Escher, J.C.; Faubion, W.A.; Fell, J.; Gold, B.D.; Griffiths, A.M.; Hyams, J.S.; Koletzko, S.; Kugathasan, S.; Veereman, G.; Winter, H.; Colletti, R.B.; Baldassano, R.; Ruemmele, F. 2014: Su1391 Infliximab Therapy in Pediatric Crohn's Disease: Results From Develop, A Multicenter Prospective Inflammatory Bowel Disease Registry. Gastroenterology 146(5): S-456
Papamichael, K.; Gazouli, M.; Tsirogianni, A.; Archavlis, E.J.; Christidou, A.; Kyriakos, N.; Karatzas, P.; Papasteriadi, C.; Mantzaris, G.J. 2014: Su1393 Primary Non Response to Infliximab in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-457
Papamichail, K.; Casteele, N.V.; Hauenstein, S.; Princen, F.; Singh, S.; Ferrante, M.; Van Assche, G.A.; Rutgeerts, P.J.; Gils, A.; Vermeire, S. 2014: Su1394 Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease. Gastroenterology 146(5): S-457
Pavlidis, P.; Ansari, A.R.; Duley, J.; Oancea, I.; Florin, T. 2014: Su1395 Splitting the Normal Daily Dose of Thioguanine May Be Efficacious Treatment for Ibd and Avoid Hepatic Toxicity. Gastroenterology 146(5): S-457
Ma, C.; Huang, V.; Fedorak, D.K.; Kroeker, K.I.; Dieleman, L.A.; Fedorak, R.N. 2014: Su1396 Crohn's Disease Outpatients Treated With Adalimumab Have an Earlier Loss of Response and Requirement for Dose Intensification Compared to Infliximab. Gastroenterology 146(5): S-457-S-458
Huang, V.; Ma, C.; Fedorak, D.K.; Kroeker, K.I.; Dieleman, L.A.; Fedorak, R.N. 2014: Su1397 Outpatients With Ulcerative Colitis Being Treated With Adalimumab and Infliximab Have Similar Rates of Loss of Response. Gastroenterology 146(5): S-458
Kopylov, U.; Afif, W.; Cohen, A.; Bitton, A.; Wild, G.; Bessissow, T.; Wyse, J.; Al-Taweel, T.; Szilagy, A.; Seidman, E.G. 2014: Su1399 Subcutaneous Ustekinumab for the Treatment of Anti-Tnf Resistant Crohn's Disease -The McGill Experience. Gastroenterology 146(5): S-459
Al-Taweel, T.; Kopylov, U.; Strohl, M.; Paradis-Surprenant, L.; Almaimani, M.K.; Martel, M.; Bitton, A.; Afif, W.; Bessissow, T.; Seidman, E.G. 2014: Su1400 Impact of Patient Weight on Adalimumab Efficacy in Crohn's Disease -A Pilot Study. Gastroenterology 146(5): S-459
Minami, N.; Yoshino, T.; Matsuura, M.; Nakase, H. 2014: Su1402 Short and Long Term Outcomes of Severe Ulcerative Colitis Patients Treated With Tacrolimus and Infliximab. Gastroenterology 146(5): S-460
Damman, C.; Brittnacher, M.; Hayden, H.; Radey, M.; Hager, K.; Miller, S.; Zisman, T.L. 2014: Su1403 Single Colonoscopically Administered Fecal Microbiota Transplant for Ulcerative Colitis-A Pilot Study to Determine Therapeutic Benefit and Graft Stability. Gastroenterology 146(5): S-460
Kelly, O.B.; Hartery, K.; Boland, K.; Keegan, D.; Forry, M.; Cullen, G.; Mulcahy, H.; Patchett, S.; Doherty, G. 2014: Su1405 The Safety of Biologic Use in the Pregnant Ibd Patient: Analysis of Patient Characteristics, Pregnancy and Neonatal Outcomes. Gastroenterology 146(5): S-461
Ogata, H.; Watanabe, M.; Matsui, T.; Abe, S.; Haruna, S.; Hibi, T. 2014: Su1406 Efficacy, Safety, and Demographics Factor of Adalimumab Therapy in 1693 Japanese Crohn's Disease Patients. Gastroenterology 146(5): S-461
Inoue, T.; Yorifuji, N.; Fujiwara, K.; Sakanaka, T.; Iguchi, M.; Narabayashi, K.; Okada, T.; Nouda, S.; Kakimoto, K.; Ishida, K.; Kawakami, K.; Abe, Y.; Takeuchi, T.; Umegaki, E.; Higuchi, K. 2014: Su1407 Tacrolimus Decreases the Incidence and Clinical Activity of Cytomegalovirus Infection in Patients With Exacerbated Ulcerative Colitis Compared With Steroids. Gastroenterology 146(5): S-461
Jambaulikar, G.D.; Armbruster, S.; Ally, M.R.; Deising, A.; Cross, R. 2014: Su1409 Factors Associated With Repeat Endoscopic Balloon Dilation and Surgery After Endoscopic Balloon Dilation for the Treatment of Stricturing Crohn's Disease. Gastroenterology 146(5): S-462
Barthel, C.; Wiegand, S.; Scharl, S.; Scharl, M.; Frei, P.; Fried, M.; Vavricka, S.R.; Wiegand, N.; Rogler, G.; Biedermann, L. 2014: Su1410 Patient Perceptions on the Impact of Coffee Consumption in Inflammatory Bowel Disease: Friend or Foe?. Gastroenterology 146(5): S-462
Fujii, T.; Saito, E.; Nagahori, M.; Ohtsuka, K.; Watanabe, M. 2014: Su1411 The Consecutive Salvage Therapy of Tacrolimus and Infliximab Is Effective in Patients With Refractory Ulcerative Colitis Accompanied by Acceptable Adverse Operative Outcomes. Gastroenterology 146(5): S-462
Bressler, B.; Sutcliffe, S.; Bethel, K.P.; Gunn, H. 2014: Su1413 Site-Specific Immunomodulation -A Novel Therapeutic Approach for the Management of Crohn's Disease. Gastroenterology 146(5): S-463
Protic, M.; Seibold, F.; Schoepfer, A.; Radojicic, Z.A.; Juillerat, P.; Bojic, D.; Mwinyi, J.; Mottet, C.; Jojic, N.; Beglinger, C.; Vavricka, S.R.; Rogler, G.; Frei, P. 2014: Su1414 Efficacy and Safety of Sequential Rescue Treatments in Steroid Refractory Ulcerative Colitis Experience. Gastroenterology 146(5): S-463
Indriolo, A.; Ravell, P. 2014: Su1415 Impact of Medical Therapies on the Natural History in Ulcerative Colitis. an 8-Year Follow-Up of a Cohort Study From a Tertiary Center. Gastroenterology 146(5): S-463
Lie, M.R.; Fuhler, G.; de Lima, A.; van der Ent, C.; van der Woude, C.J. 2014: Su1417 Low Dose Naltrexone in Therapy Resistant Ibd, a Case Series. Gastroenterology 146(5): S-464
Govani, S.M.; Waljee, A.K.; Stidham, R.W.; Higgins, P.D. 2014: Su1418 Infliximab Reduces 90 Day Colectomy Rate Versus Cyclosporine for Acute Severe Ulcerative Colitis. Gastroenterology 146(5): S-464
Honzawa, Y.; Matsuura, M.; Yoshino, T.; Nakase, H. 2014: Su1419 Effect of Prior Use of Immunomodulatory Drugs on Endoscopic Balloon Dilation Procedure for Intestinal Stricture in Patients With Crohn's Disease. Gastroenterology 146(5): S-464
Guerra, I.; Algaba, A.; Serrano, .; Aulló, C.; Alcalde, D.; de Lucas, M.; Bonillo, D.; Zapatero, A.; Bermejo, F. 2014: Su1421 Effectiveness and Adverse Events of Azathioprine in Inflammatory Bowel Disease: 9-Year Follow-Up Study. Gastroenterology 146(5): S-465
Kahn, A.; Franco, D.L.; Disbrow, M.; Koepke, L.; Umar, S.B.; Harris, L.A.; Harrison, M.E.; Pasha, S.F.; Leighton, J.A.; Crowell, M.D.; Foxx-Orenstein, A.E.; Ramirez, F.C. 2014: Su1422 The Effects of Bowel Cleansing on the Yield of Duodenal Aspirates for Small Intestinal Bacterial Overgrowth (Sibo). Gastroenterology 146(5): S-465
Gatta, L.; Scarpignato, C. 2014: Su1423 Eradication of Small Intestine Bacterial Overgrowth With Rifaximin: A Doseand Time-Dependent Effect. Gastroenterology 146(5): S-465
Lin, E.C.; Massey, B.T. 2014: Su1425 For Glucose Breath Testing to Identify Small Bowel Bacterial Overgrowth, Addition of Methane Detection Has a Low Yield. Gastroenterology 146(5): S-466
Sunny, J.; Garcia, C.J.; McCallum, R.W. 2014: Su1426 Re-Evaluation of the Interpretation of the Lactulose Breath Test in the Diagnosis of Small Intestinal Bacterial Overgrowth -Guideline to Enhance Specificity. Gastroenterology 146(5): S-466
Newberry, C.; Shulik, O.; Tierney, A.; Pickett-Blakely, O.E. 2014: Su1427 Demographic and Clinical Factors Associated With Small Intestinal Bacterial Overgrowth (Sibo). Gastroenterology 146(5): S-466
Perets, T.T.; Hamouda, D.; Shporn, E.; Niv, Y.; Dickman, R. 2014: Su1428 The Effect of Small Intestinal Bacterial Overgrowth on Lactose Intolerance Breath Test in Subjects With Non-Irritable Bowel Syndrome. Gastroenterology 146(5): S-466
Dhalwani, N.N.; West, J.; Sultan, A.A.; Ban, L.; Tat, L.J. 2014: Su1429 Do Women With Coeliac Disease Clinically Present With Fertiliy Problems More Often Than Women in the General Population?. Gastroenterology 146(5): S-467
Ban, L.; West, J.; Sultan, A.A.; Dhalwani, N.N.; Tata, L.J. 2014: Su1430 Risk of Congenital Anomaly in Children Born to Women With Coeliac Disease: A United Kingdom Population-Based Cohort Study. Gastroenterology 146(5): S-467
Humm, K.C.; Hung, A.; Vanga, R.R.; Theethira, T.G.; Kelly, C.P.; Leffler, D. 2014: Su1432 Prevalence of Celiac Disease Is Higher Among Women With Infertility. Gastroenterology 146(5): S-468
Namatovu, F.; Ivarsson, A.; Lindkvist, M.; Olsson, C.; Myléus, A.; Högberg, U.; Sandström, O. 2014: Su1433 Elective Caesarean Delivery Is Associated With Increased Celiac Disease Risk in Boys, but Not in Girls. Gastroenterology 146(5): S-468
Remes-Troche, J.M.; Vargas, L.A.S.; Meixueiro, A.; Dela Cruz Patiño, E.; Gonzalez-Sicilia, E.; Abreu, J.A.; Medellin-Urquiaga, M. 2014: Su1434 Celiac Disease Screening in Patients Previously Diagnosed With Infertility. A Prospective Study in Mexican Population. Gastroenterology 146(5): S-468
Zubarik, R.; Nathan, M.; Vahora, H.; Ganguly, E.K.; Vecchio, J. 2014: Su1435 Hypothyroid Patients Requiring Elevated Doses of Levothyroxine to Maintain a Euthyroid State Should Be Tested for Celiac Disease (Cd). Gastroenterology 146(5): S-468
Marthey, L.; Cadiot, G.; Seksik, P.; Pouderoux, P.; Lacroute, J.; Skinazi, F.; Mesnard, B.; Chayvialle, J.A.; Lerebours, E.; Druez, A.; Parlier, D.; Abitbol, V.; Gompel, M.; Eoche, M.; Poncin, E. 2014: Su1436 Olmesartan-Associated Sprue: A French National Study. Gastroenterology 146(5): S-469
Lebwohl, B.; Emilsson, L.; Fröbert, O.; Einstein, A.J.; Green, P.H.; Ludvigsson, J. 2014: Su1437 Mucosal Healing and Risk of Ischemic Heart Disease in Celiac Disease: A Population-Based Cohort Study. Gastroenterology 146(5): S-469
Lebwohl, B.; Eriksson, H.; Hansson, J.; Green, P.H.; Ludvigsson, J. 2014: Su1438 Risk of Cutaneous Malignant Melanoma in Celiac Disease: A Population-Based Study. Gastroenterology 146(5): S-469
Zanchetta, M.B.; Costa, A.F.; Longobardi, V.; Longarini, G.I.; de la Paz Temprano, M..; Vázquez, H.; Niveloni, S.I.; Smecuol, E.; Moreno, M.L.; Jer, H.H.; Mazure, R.M.; Gonzalez, A.F.; Mauriño, E.; Bai, J.C. 2014: Su1439 Impaired Bone Microstructure Improves After One-Year on Gluten-Free Diet. A Prospective Longitudinal Study in Women With Active Celiac Disease. Gastroenterology 146(5): S-469
Longarini, G.I.; Richly, P.; de la Paz Temprano, M..; Costa, A.F.; Vázquez, H.; Moreno, M.L.; Niveloni, S.I.; Jer, H.H.; López, P.L.; Smecuol, E.; Mazure, R.M.; Gonzalez, A.F.; Mauriño, E.; Bai, J.C. 2014: Su1441 Cognitive Performance in Patients With Active Celiac Disease. Preliminary Results of a Prospective Study. Gastroenterology 146(5): S-470
Medarapalem, J.B.; Appasani, S.; Khaliq, A.; Prasad, K.K.; Sinha, S.K.; Vaiphei, K.; Varma, S.; Varma, N.; Kochhar, R. 2014: Su1442 Anemia in Celiac Disease is Multifactorial in Etiology: a Prospective Study From India. Gastroenterology 146(5): S-470
Wong, S.-Y.; Kelly, C.; Shah, A.; DiMarino, A.J.; Moleski, S.M. 2014: Su1443 Obesity and Marsh Score in Patients With Celiac Disease. Gastroenterology 146(5): S-470
Moeller, S.; Canetta, P.A.; Arguelles-Grande, C.; Snyder, H.; Green, P.H.; Kiryluk, K.; Alaedini, A. 2014: Su1445 Lack of Serologic Evidence for an Association Between Gluten Sensitivity and IgA Nephropathy. Gastroenterology 146(5): S-471
Ditah, I.C.; Marietta, E.; Nadeau, A.; Brantner, T.L.; Rubio-Tapia, A.; Murray, J.A. 2014: Su1446 Despite an Increased Use of a Gluten Free Diet, Most Celiac Disease Remains Undiagnosed in the Usa. Gastroenterology 146(5): S-471
Vanga, R.R.; Kelly, C.P.; Chen, X.; Xu, H.; Schuppan, D.; Theethira, T.G.; Pallav, K.; Najarian, R.M.; Kabbani, T.A.; Dennis, M.; Leffler, D.A. 2014: Su1447 Ex Vivo Gluten Challenge Differentiates Patients With Celiac Disease on a Gluten Free Diet From Healthy Individuals. Gastroenterology 146(5): S-471
Mooney, P.D.; Finegan, M.J.; Khan, F.; Keld, R.; Naylor, G.; Sander, D.S. 2014: Su1449 Adherence to Duodenal Biopsy Guidelines Increases the Detection of Coeliac Disease: A Multicentre Uk Study. Gastroenterology 146(5): S-472
Mooney, P.D.; Kurien, M.; Johnston, A.J.; Wong, S.H.; Avgerinos, A.; Hadjivassiliou, M.; Sanders, D.S. 2014: Su1450 Point of Care Testing for Adult Celiac Disease: A Novel Role in Endoscopy. Gastroenterology 146(5): S-472
Singh, P.; Wadhwa, N.; Chaturvedi, M.K.; Bhatia, V.; Tandon, N.; Makharia, G.K.; Mäki, M.; Not, T.; Phillips, A.; Bhatnagar, S. 2014: Su1451 Validation of Point of Care Testing for Celiac Disease in Children in a Tertiary Hospital in North India. Gastroenterology 146(5): S-472
Efthymakis, K.; Milano, A.; Laterza, F.; Serio, M.; Neri, M. 2014: Su1452 Iron Deficiency Anemia Despite Effective Gluten-Free Diet in Celiac Disease: Diagnostic Role of Video-Capsule Endoscopy. Gastroenterology 146(5): S-472
Sugai, E.; Jer, H.H.; Nachman, F.; Cabanne, A.M.; Vázquez, H.; Moreno, M.L.; Costa, A.F.; Longarini, G.I.; Pinto-Sanchez, M.I.; Niveloni, S.I.; Smecuol, E.; Mazure, R.M.; Mauriño, E.; Bai, J.C. 2014: Su1454 How Does Specific Serology Match With Esphgan Serologic Guidelines for Diagnosis of Celiac Disease in a Prospective Cohort of Adults With High Pretest Probability?. Gastroenterology 146(5): S-473
Pitman, M.; Green, P.H.; Lebwohl, B. 2014: Sul455 Predictors of Duodenal Biopsy During Endoscopy At One Institution: Wide Variation Between Providers. Gastroenterology 146(5): S-473
Bhandari, A.; Crowe, S.E. 2014: Su1457 Prevalence of Co-Morbid Diseases, Symptoms and Nutritional Deficiencies in Gluten Sensitive Patients Seen At a West Coast Celiac Disease Center. Gastroenterology 146(5): S-474
Coimbra, Joao Carlos; Pinto, Iraja Damiani; Wurdig, Norma Luiza; Do Carmo, Dermeval Aparecido 2014: Su1458 An Assessment of the Diagnostic Utility of Coeliac Serology in an Australian Referral Centre. Gastroenterology 146(5): S-474
Moeller, S.; Tanaka, C.; Green, P.H.; Zone, J.J.; Kasarda, D.D.; Vensel, W.; Briani, C.; Altenbach, S.; Alaedini, A. 2014: Su1459 Characterization of Celiac Disease Antibody Response Reveals Wheat Non-Gluten Proteins As Novel Target Antigens. Gastroenterology 146(5): S-474
Turner, K.; Genta, R.M. 2014: Su1460 Low Prevalence of Microscopic Colitis and Inflammatory Bowel in Americans of East Asian Ancestry. Gastroenterology 146(5): S-475
Barmeyer, C.; Troeger, H.; Bojarski, C.; Siegmund, B.; Fromm, M.; Schulzke, J.D. 2014: Su1461 Lymphocytic Colitis-Related Diarrhea Is Caused by Both, Erk1/2-Dependent Inhibition of the Epithelial Sodium Channel (Enac) and a Claudin-Induced Barrier Defect. Gastroenterology 146(5): S-475
Wells, M.M.; Chande, N.; MacDonald, J.K.; Mrkobrada, M.; Feagan, S.; Feagan, B.G. 2014: Su1462 Oral Corticosteroids for Induction of Remission in Ulcerative Colitis: A Cochrane Review and Meta-Analysis. Gastroenterology 146(5): S-475
Aggarwal, N.; Baker, K.; Rivers, C.M.R.; Hashash, J.G.; Regueiro, M.; Dunn, M.A.; Binion, D.G. 2014: Su1463 Impact of Benign Joint Hypermobility Syndrome on Inflammatory Bowel Disease. Gastroenterology 146(5): S-476
Nguyen, M.; Correia, C.; Manolopoulou, M.; LoSavio, A. 2014: Su1464 Are Endoscopic Mucosal Changes Clinically Significant in Patients With Microscopic Colitis? A Retrospective Study on Clinical Characteristics and Outcomes. Gastroenterology 146(5): S-476
Halilbasic, E.; Staufer, K.; Harm, S.; Klepetko, W.; Jaksch, P.; Lichtenberger, C.; Vogelsang, H.; Trauner, M.H.; Kazemi-Shirazi, L. 2014: Su1465 Stool Calprotectin and Serum Asca Levels as Markers of Intestinal Inflammation are Commonly Elevated in Lung-Transplanted Patients With Cystic Fibrosis. Gastroenterology 146(5): S-476
Pallavi, R.; Bautista, J.E.; Sy, A. 2014: Su1466 Association Between Hiv, Hcv Infections and Rates of Adenomatous Polyps: A Case-Control Study. Gastroenterology 146(5): S-476
Katada, K.; Naito, Y.; Takagi, T.; Mizushima, K.; Higashimura, Y.; Okayama, T.; Yoshida, N.; Kamada, K.; Uchiyama, K.; Takeshi, I.; Handa, O.; Konishi, H.; Yagi, N.; Ichikawa, H.; Yasukawa, Z. 2014: Su1467 Partially Hydrolyzed Guar Gum (Phgg) Attenuates Nonalcoholic Steatohepatitis (Nash) in Mice Through the Gut-Liver Axis. Gastroenterology 146(5): S-477
DiRienzo, T.A.; Cesario, V.; Campanale, M.; D'Angelo, G.; Barbaro, F.; D'Aversa, F.; Caracciolo, G.; Annicchiarico, B.E.; Siciliano, M.; Avolio, A.; Agnes, S.; Pompili, M.; Rapaccini, G.L.; Grieco, A.; DeGaetano, A. 2014: Su1468 Downstaging Therapy in Patients With Intermediate Stage Hcc (Bclc B) as Bridge for Transplantation: The Hepatocatt Experience. Gastroenterology 146(5): S-477
Garcia-Compean, D.; Jaquez-Quintana, J.O.; Lavalle-Gonzalez, F.J.; Gonzalez, J.A.; Munoz-Espinosa, L.E.; Maldonado, H.J.; Villarreal-Perez, J.Z. 2014: Su1469 Subclinical Abnormal Glucose Tolerance Is Associated With Reduced Survival of Patients With Compensated Cirrhosis and Normal Fasting Plasma Glucose. A Prospective Study. Gastroenterology 146(5): S-477
Peng, S.; Kuang, M.; Chen, M. 2014: Su1470 Sorafenib Treatment Efficacy is Modulated by Autocrine Vegf Signaling in the Human Hepatocellular Carcinoma. Gastroenterology 146(5): S-477
Kawamura, T.; Shiraishi, A.; Hiraoka, A.; Kawasaki, H.; Hirooka, M.; Matsuura, B.; Hiasa, Y.; Michitaka, K. 2014: Su1472 Prognosis and Therapy for Ruptured Hepatocellular Carcinoma (Hcc): Should Naive Hcc Rupture Be Included in T4?. Gastroenterology 146(5): S-478
Harki, J.; Plompen, E.P.; van Noord, D.; Hoekstra, J.; Kuipers, E.J.; Janssen, H.; Tjwa, E.T. 2014: Su1473 Gastrointestinal Ischemia in Patients With Acute and Chronic Portal Vein Thrombosis: A Prospective Study. Gastroenterology 146(5): S-478
Braticevici, C.F.; Chirila, R.; Tribus, L.; Usvat, R.; Moldoveanu, A.C.; Baicus, C. 2014: Su1474 Can Splenic Stiffness Measurement Predict the Presence of Esophageal Varices in Patients With Liver Cirrhosis?. Gastroenterology 146(5): S-478
Sato, W.; Goto, T.; Kamada, K.; Ohshima, S.; Miura, K.; Dohmen, T.; Kanata, R.; Sakai, T.; Chiba, M.; Sugimoto, Y.; Minami, S.; Ohnishi, H. 2014: Su1476 Efficacy of Combined Balloon-Occluded Retrograde Transvenous Obliteration With Ethanol and Endoscopic Injection Sclerotherapy for Gastric Varices. Gastroenterology 146(5): S-479
Shaker, M.; Alkhouri, N.; Mansour, N.; Alsabbagh, M.E.Y.; Zein, N.N. 2014: Su1477 The Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Obscure Gastrointestinal Bleeding in Patients With Portal Hypertension. Gastroenterology 146(5): S-479
Tsai, C.-J.; Sanaka, M.R.; Menon, K.N.; Vargo, J.J. 2014: Su1478 Balloon-Assisted Enteroscopy in Portal Hypertensive Enteropathy. Gastroenterology 146(5): S-479
Goel, A.; Patel, N.; Blackwell, R.; Crompton, S.; Moriarty, K.J. 2014: Su1479 Rifaximin Treatment in Hepatic Encephalopathy (He) -Marked Reduction in Hospital Admissions and Hospital Bed Day Occupancy in a Uk District General Hospital. Gastroenterology 146(5): S-479
Sia, R.; Scanzi, J.; Pereira, B.; Sombie, R.A.; Serme, A.K.; Ilboudo, D.P.; Godonou, S.M.M.; Poincloux, L.; Lamblin, G.; Dapoigny, M.; Bommelaer, G.; Abergel, A. 2014: Su1480 Is Tips Indicated in Cirrhotic Patients With Child-Pugh B Score and Active Variceal Bleeding?. Gastroenterology 146(5): S-480
Krishnamurthy, V.; Zhang, P.; Ethiraj, S.kumarsanthanam; Enchakalody, B.; Wang, L.; Wang, S.C.; Su, G.L. 2014: Su1481 Utilization of Analytic Morphomics to Predict Cirrhosis. Gastroenterology 146(5): S-480
Aderinto, A.; Darwish, D.; Chen, W.-C.; Boktour, M.; Monsour, H.P. 2014: Su1483 Ast Platelet Ratio (Apri Scores) Correlates with Hepatoportal Pressure Measurements. Gastroenterology 146(5): S-481
Chason, R.D.; Singal, A.G.; Rockey, D.C. 2014: Su1484 Upper Gastrointestinal Bleeding in Patients With Cirrhosis and Hepatocellular Carcinoma is Associated With Rebleeding and Increased Mortality. Gastroenterology 146(5): S-481
Haga, H.; Yan, I.; Takahashi, K.; Wood, J.D.; Patel, T. 2014: Su1485 Exogenous Extracellular Vesicles From Bone Marrow Derived Mesenchymal Stem Cells Reduce Injury and Improve Survival in Experimental Lethal Hepatic Failure. Gastroenterology 146(5): S-481
Leelasinjaroen, P.; Zhou, S.-Y.; Gillilland, M.; Lu, Y.; Zhang, G.; Owyang, C. 2014: Su1487 Bifobacteria Infantis Contributes Significantly to the Beneficial Effects of Oligofructose (Prebiotic) to Prevent Mucosal Inflammation, Metabolic Endotoxemia and Hyperphagia Induced by High Fat Feeding. Gastroenterology 146(5): S-482
Balamurugan, R.; Balachandar, G.M.; Dharmalingam, T.; Mortimer, E.K.; Gopalsamy, G.; Woodman, R.; Alpers, D.H.; Manary, M.; Binder, H.; Brown, I.; Young, G.P.; Ramakrishna, B.S. 2014: Su1488 Effect of Native and Acetylated High Amylose Maize Starch on Fecal pH and Short Chain Fatty Acid Concentrations in a Cohort of Children in Southern India. Gastroenterology 146(5): S-482
Altomare, A.; Guarino, M.P.L.; Pasqualetti, V.; Cocca, S.; Locato, V.; Cimini, S.; Palma, R.; Alloni, R.; Cicala, M.; DeGara, L. 2014: Su1489 Antioxidant Activity of Inulin and Its Ability to Prevent Human Colonic Muscle Cell Impairment Induced by Lipopolysaccharide Mucosal Exposure. Gastroenterology 146(5): S-482
Dorfman, V.; Verna, E.C.; Poneros, J.M.; Sethi, A.; Allendorf, J.; Gress, F.G.; Schrope, B.; Chabot, J.A.; Gonda, T.A. 2014: Su1491 Progression of Incidental Intraductal Papillary Mucinous Neoplasms in Liver Transplant Recipients. Gastroenterology 146(5): S-483
Moris, M.; Wallace, M.B.; Raimondo, M.; Woodward, T.A.; Skinner, V.; Boemo, C.; DeAngelis, C.; Fusaroli, P.; Poley, J.-W.; Lewis, M.D. 2014: Su1492 Risk Factors for Malignant Progression of Intraductal Papillary Mucinous Neoplasms (Ipmn): An International Registry Cohort. Gastroenterology 146(5): S-483
Ngamruengphong, S.; McCrone, L.; Garrison, S.; Keaveny, A.; Raimondo, M. 2014: Su1493 Outcomes of Branch Duct Intraductal Papillary Mucinous Neoplasm (Br-Ipmn) of the Pancreas in Solid Organ Transplant Recipients. Gastroenterology 146(5): S-483
Jabbar, K.S.; Verbeke, C.S.; Lindkvist, B.; Hansson, G.C.; Sadik, R. 2014: Su1495 Proteomic Studies on Aspirates From Cystic Neoplasms of the Pancreas Provide New Clues to Their Molecular Background and Reveal Novel Biomarker Candidates. Gastroenterology 146(5): S-484
Miyabe, K.; Hori, Y.; Nakazawa, T.; Hayashi, K.; Naitoh, I.; Shimizu, S.; Kondo, H.; Yoshida, M.; Yamashita, H.; Umemura, S.; Kato, A.; Ohara, H.; Joh, T.; Inagaki, H. 2014: Su1496 Evaluation of Chromosomal Abnormalities by Fluorescence in Situ Hybridization in Intraductal Papillary Mucinous Neoplasm. Gastroenterology 146(5): S-484
Kaimakliotis, P.Z.; Small, A.J.; Chandrasekhara, V.; Ginsberg, G.G.; Kochman, M.L.; Ahmad, N.A. 2014: Su1497 Do the Updated Sendai Guidelines Improve Diagnosis of Advanced Neoplasia in Intraductal Papillary Mucinous Neoplasms (Ipmn) and Mucinous Cystic Neoplasms (Mcn) of the Pancreas?. Gastroenterology 146(5): S-484
Napoleon, B.; Lemaistre, A.I.; Pujol, B.; Mialhe-Morellon, B.; Caillol, F.; Giovannini, M. 2014: Su1498 In Vivo Characterization of Mucinous Cystadenomas by Needle-Based Confocal Laser Endomicroscopy (nCle). Gastroenterology 146(5): S-485
Gaddam, S.; Keach, J.W.; Ge, P.S.; Mullady, D.; Fukami, N.; Muthusamy, V.R.; Edmundowicz, S.A.; Azar, R.R.; Shah, R.J.; Murad, F.; Kushnir, V.M.; Watson, R.R.; Ghassemi, K.F.; Sedarat, A.; Brauer, B.C. 2014: Su1499 Creation of a Prediction Tool (M-Pact) to Accurately Identify Premalignant and Malignant Cysts in Patients Undergoing Endoscopic Ultrasound (Eus) for Evaluation of Pancreatic Cystic Lesions: Results From a Large Multicenter Cohort. Gastroenterology 146(5): S-485
Kawada, N.; Matsunaga, K.; Otsuka, T.; Nakamura, M.; Shimasaki, T.; Shiroeda, H.; Arisawa, T.; Tomita, Y. 2014: Su1501 Morphological Changes of Intraductal Papillary Mucinous Neoplasm of the Pancreas Are Not Enough for Indicators of the Development of Pancreatic Carcinoma During Follow Up. Gastroenterology 146(5): S-486
DeSimone, V.; Franzè, E.; Ronchetti, G.; Colantoni, A.; Fantini, M.C.; DiFusco, D.; Sica, G.; Sileri, P.; Thomas, M.; Pallone, F.; Monteleone, G.; Stolfi, C. 2014: Su1856 Th17-Related Cytokines and Excessive Activation of Stat3 Sustain Colorectal Cancer Cell Growth. Gastroenterology 146(5): S-487
Rodriguez-Soler, M.; Juarez-Quesada, M.; Egoavil, C.M.; Guarinos, C.; Hernandez-Illan, E.; Castaño-Soler, L.; Pérez-Carbonell, L.; Martínez, J.; Ruiz, F.; Compañy, L.; Aparicio, J.R.; Casellas, J.A.; Alenda, C.; Jove, R. 2014: Su1857 Use of Surveillance Colonoscopy in Non-Selected Population. Gastroenterology 146(5): S-487
Renz, B.W.; Westphalen, C.B.; Chen, X.; Hayakawa, Y.; Worthley, D.L.; Macchini, M.; Asfaha, S.; Kleespies, A.; Remotti, H.; Olive, K.P.; Wang, T.C. 2014: Su1858 Adrenergic Signaling Promotes Pancreatic Cancer Initiation and Progression. Gastroenterology 146(5): S-487
Principe, D.R.; DeCant, B.; Wayne, E.A.; Droske, L.E.; Mascariñas, E.; Bauer, J.; Munshi, H.G.; Grippo, P.; Jung, B.H. 2014: Su1859 Transforming Growth Factor (((((? Facilitates Early Tumorigenesis Despite Potent Tumor Suppressive Effects in Epithelial Tissues. Gastroenterology 146(5): S-487
Voorneveld, P.; de Vos, T.W.; de Wit, S.; Jacobs, R.J.; Hawinkels, L.; Paauwe, M.; van Pelt, G.; Mesker, W.; van den Brink, G.R.; Kodach, L.L.; Hardwick, J.C. 2014: Su1860 Fibroblasts Promote Invasion in Smad4 Negative Colorectal Cancers by Producing Bmp-2. Gastroenterology 146(5): S-488
Naik, R.D.; McDonough, E.; Barrett, C.; Parang, B.; Bradley, A.; Choksi, Y.A.; Ning, W.; Poindexter, S.; Fischer, M.; Chaturvedi, R.; Revetta, F.; Washington, K.; Rosen, M.J.; Wilson, K.T.; Williams, C.S. 2014: Su1861 Loss of Mtg16 Results in a Pro-Tumorigenic Inflammatory Microenvironment. Gastroenterology 146(5): S-488
Sureban, S.M.; May, R.; Qu, D.; Chandrakesan, P.; Weygant, N.; Ali, N.; Houchen, C.W. 2014: Su1862 Rna Binding Protein Musashi-1 Regulates Tumorigenesis and Angiogenesis via MicroRna-Dependent Mechanism. Gastroenterology 146(5): S-488
Yoshitomi, H.; Shimizu, H.; Ohtsuka, M.; Kato, A.; Furukawa, K.; Miyazaki, M. 2014: Su1863 Tenascin C in Cancer Stroma Induces Migration and Invasion of Pancreatic Cancer Cells by Interaction With Fibronectin. Gastroenterology 146(5): S-488
Nighot, P.K.; Guo, S.; Rawat, M.; Hu, C.-A.A.; Ma, T.Y. 2014: Su1865 Mechanism of Autophagy Regulation of Intestinal Epithelial Tj Barrier: Role of Claudin-2 in Tj Barrier Enhancement. Gastroenterology 146(5): S-489
D'Costa, S.; Edwards, L.; Moeser, A.J. 2014: Su1866 Mast Cell Corticotropin Releasing Factor Receptor 2 Regulates IgE-Mediated Mast Cell Degranulation, Anaphylaxis, and Intestinal Permeability. Gastroenterology 146(5): S-489
Troeger, H.; Hering, N.; Rieger, K.; Siegmund, B.; Schulzke, J.D. 2014: Su1867 Characterization of Epithelial Barrier Function in Intestinal Graft-Versus-Host Disease. Gastroenterology 146(5): S-489
Wittkopf, N.; Günther, C.; Martini, E.; He, Y.-W.; Schuchmann, M.; Neurath, M.F.; Becker, C. 2014: Su1868 Constant Stimulation of Epithelial Cell Death in the Steady-State Gut Is Controlled via Cflip. Gastroenterology 146(5): S-489
Liu, Y.; Bialkowska, A.; Yang, V.W. 2014: Su1869 KrPpel-Like Factor 5 Modulates Intestinal Epithelial Barrier Function by Regulating Components of the Tight Junction In Vitro. Gastroenterology 146(5): S-490
Lauffer, A.; Vanuytsel, T.; Fornari, F.; Farré, R. 2014: Su1870 Differential Effects of Acute, Chronic and Combined Stress Paradigms on Small Intestinal and Colonic Permeability in Rats. Gastroenterology 146(5): S-490
Larauche, M.H.; Tolstanova, G.; Biraud, M.; Million, M.; Tache, Y. 2014: Su1871 Repeated Water Avoidance Stress Induces Sex and Regional-Dependent Alterations in Rats Colonic Epithelial Function. Gastroenterology 146(5): S-490
Liu, Y.; McClain, C.J.; Feng, W. 2014: Su1872 Cobalt Chloride Decreases Fibroblast Growth Factor-21 Expression Dependent on Oxidative Stress but Not Hypoxia-Inducible Factor in CaCo-2 Cells. Gastroenterology 146(5): S-490
Resendez, A.; Halim, M.A.; Hellström, P.M.; Singaram, B.; Webb, D.-L. 2014: Su1875 Rapid Small Intestinal Permeability Assay Based on Riboflavin and Lactulose Detected by Bis-Boronic Acid Appended Benzyl Viologens (Bbv). Gastroenterology 146(5): S-491
Tolstanova, G.; Larauche, M.H.; Yuan, P.-Q.; Tache, Y. 2014: Su1876 The Cic-2 Chloride Channel Agonist, Lubiprostone, Prevents Ileal Epithelial Permeability Alterations in a Murine Model of Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology 146(5): S-491
Yu, M.; Yang, S.; Xiao, W.; Qiu, Y.; Chen, G.; Sun, L.; Zhang, C.; Xu, C.; Peng, K.; Yang, H. 2014: Su1877 Par3 Regulates Intestinal Epithelial Barrier Function by Controlling the Membrane Trafficking of Tj Proteins in an Acute Ischemia/Reperfusion Model. Gastroenterology 146(5): S-491
Ma, Y.; Chen, G.; Xiao, W.; Sun, L.; Yang, S.; Yu, M.; Qiu, Y.; Xu, C.; Peng, K.; Sun, L.; Yang, H. 2014: Su1879 Sirt1 Antagonizes Distinct Effects of Tnf- on Intestinal Epithelial Barrier. Gastroenterology 146(5): S-492
Mullin, J.M.; Valenzano, M.C.; DiGuilio, K.; Teter, M.; Mercado, J.; To, J.; Mixson, B.; Ferraro, B.; Manley, I.; Baker, V. 2014: Su1880 Effects on CaCo-2 Gastrointestinal Epithelial Barrier Properties of the Nutraceuticals Zinc, Berberine, Butyrate, Indole and Quercetin. Gastroenterology 146(5): S-492
Doo, E.; Lee, O.Y.; Lee, H.L.; Jun, D.W.; Yoon, B.C.; Choi, H.S.; Lee, K.N.; Hahm, J.S. 2014: Su1881 The Effect of High-Fat Diet, High-Fructose Diet and Soft Drink on Intestinal Integrity and Inflammation. Gastroenterology 146(5): S-492
Peiris, M.; Dogra, H.; Robinow, A.D.; Page, A.J.; Young, R.L.; Blackshaw, A. 2014: Su1882 Amino Acid and Fatty Acid Sensing Mechanisms in the Human Colon. Gastroenterology 146(5): S-492
van der Wulp, M.Y.; van Dijk, T.H.; Bloks, V.; Groen, A.K.; Verkad, H.J. 2014: Su1883 Genetic Inactivation of the Bile Salt Export Pump in Mice Profoundly Increases Fecal Cholesterol Excretion. Gastroenterology 146(5): S-492
Coon, S.D.; Rajendran, V.M.; Singh, S.K. 2014: Su1885 Prolonged High-Fat Feeding Decreases Sglt1 and Glut2 Activity and Blunts Their Upregulation by Glucose-Dependent Insulinotropic Polypeptide (Gip) in Obese Mice. Gastroenterology 146(5): S-493
Nabokina, S.; Inoue, K.; Subramanian, V.S.; Valle, J.E.; Yuasa, H.; Said, H.M. 2014: Su1886 Molecular Identification and Functional Characterization of the Human Colonic Thiamine Pyrophosphate Transporter. Gastroenterology 146(5): S-493
Singh, S.; Arthur, S.; Sundaram, U. 2014: Su1887 Mechanism of Inhibition of Na-Glutamine Co-Transport by Prostaglandin E2 in Intestinal Epithelial Cells. Gastroenterology 146(5): S-493
Lei, N.Y.; Brinkley, G.; Jabaji, Z.; Sears, C.M.; Wang, J.; Posner, C.; Jaroszewicz, A.; Pellegrini, M.; Stelzner, M.G.; Martin, M.G.; Dunn, J. 2014: Su1889 Characterization of Intestinal Subepithelial Myofibroblasts. Gastroenterology 146(5): S-494
Wierdsma, N.; Nijeboer, P.; de van der Schueren, M.A.E.; Bouma, G.; Van Bodegraven, A.A.; Mulder, C.J. 2014: Su1890 Comprehensive Nutritional Status of Patients With (Complicated) Celiac Disease and Eatl At Presentation. Gastroenterology 146(5): S-494
Yuan, J.; Liu, Y.; Tan, T.; Li, L.; Lugea, A.; Pandol, S. 2014: Su1892 Protein Kinase C Epsilon Promotes Necrosis During Experimental Pancreatitis by Upregulation of Expression of Inhibitors of Apoptosis Proteins and Stabilization of Receptor-Interacting Protein Kinase. Gastroenterology 146(5): S-495
Yang, W.; Li, J.; Tang, C. 2014: Su1893 Betaine Alleviates Alcohol-Induced Pancreatic Steatosis in Rats. Gastroenterology 146(5): S-495
Vilarinho, S.; Overton, J.; Carvajal, D.; Rimm, D.L.; Lifton, R.P. 2014: Su1894 Exome Sequencing of Formalin Fixed Paraffin Embedded Pancreatic Ductal Adenocarcinoma Samples Expands Mutational Landscape and Identifies Hypermutator Phenotype. Gastroenterology 146(5): S-495
Jin, S.; Le, T.; Orabi, A.I.; Sah, S.; Husain, S.Z. 2014: Su1895 Ercp Contrast Induces Nf-B Activation Through Calcineurin and Er Stress in a Pancreatic Ar42J Cell Line. Gastroenterology 146(5): S-495
Raphael, K.L.; Chawla, S.; Keith, C.; Propp, D.; Adsay, V.; Woods, K.E.; Keilin, S.; Cai, Q.; Willingham, F.F. 2014: Su1897 Pancreatic Insufficiency Secondary to Tobacco Exposure: A Prospective Controlled Cross-Sectional Study. Gastroenterology 146(5): S-496
Shibata, W.; Kinoshita, H.; Sue, S.; Maeda, S. 2014: Su1898 Overexpression of Her2 Induces Ipmc Through the Activation of Mapk Pathway. Gastroenterology 146(5): S-496
Lewarchik, C.M.; Jin, S.; Wang, D.; Orabi, A.I.; Muili, K.A.; Shah, A.U.; Eisses, J.F.; Jayaraman, T.; Husain, S.Z. 2014: Su1899 The Ryanodine Receptor is Expressed in Mouse and Human Pancreatic Acinar Cells and Contributes to Acinar Cell Injury. Gastroenterology 146(5): S-496
Reed, A.; Kolodecik, T.R.; Gorelick, F.S. 2014: Su1900 Renalase Deficiency Worsens Acute Pancreatitis in Mice. Gastroenterology 146(5): S-496
Imoto, A.; Mitsunaga, S.; Ikeda, M.; Higuchi, K.; Ochiai, A. 2014: Su1901 Severe Neural Invasion Related to Cachexia in Advanced Pancreatic Cancer. Gastroenterology 146(5): S-496
Castiñeira-Alvariño, M.; Luaces-Regueira, M.; Dominguez-Munoz, E. 2014: Su1902 Tobacco Has a Synergistic Effect With Alcohol in Pancreatic Fibrogenesis: An In-vitro Study in Early and Primary Culture of Pancreatic Stellate Cells. Gastroenterology 146(5): S-497
Lee, Y.S.; Hwang, I.K.; Kim, J.; Kang, B.K.; Hwang, J.-H. 2014: Su1903 MicroRna-196a As a Prognostic Marker in Pancreatic Neuroendocrine Tumor. Gastroenterology 146(5): S-497
Waldron, R.T.; Capri, J.R.; Whitelegge, J.; Faull, K.F.; Pandol, S.; Lugea, A. 2014: Su1904 Ethanol Feeding Causes Alterations in Disulfide Bonding in Pancreatic Carboxyl Ester Lipase. Gastroenterology 146(5): S-497
Shenoy, V.K.; Beaver, K.; Fisher, F.M.; Maratos-Flier, E.; Flier, S.N. 2014: Su1905 Serum Fibroblast Growth Factor 21 Is Elevated in Humans With Acute Pancreatitis. Gastroenterology 146(5): S-497
Carapuça, E.; Gemenetzidis, E.; Feig, C.; Tuveson, D.A.; Kocher, H. 2014: Su1907 Developing Drug Combinations to Co-Target Pancreatic Cancer and Its Supporting Stroma. Gastroenterology 146(5): S-498
Liu, W.; Yuan, J.; Karvar, S.; Baker, S.S.; Baker, R.D.; Ji, G.; Xie, J.; Zhu, L. 2014: Su1908 Potassium Channel Kcnj15 Is Required for Histamine Stimulated Gastric Acid Secretion. Gastroenterology 146(5): S-498
Chiang, H.-S.; Zhao, Y.; Song, J.-H.; Liu, S.; Reinecker, H.-C. 2014: Su1909 Microtubule Dependent Recognition of Intracellular Microbial Nucleic Acids. Gastroenterology 146(5): S-498
Hellström, P.M.; Halim, M.A.; Sjöblom, M.; Saudi, S.; Sommansson, A.; Rosenqvist, E.; Gillberg, L.; Feldreich, T.; Sundbom, M.; Karlbom, U.; Naslund, E.; Webb, D.-L. 2014: Su1911 Neuropeptide S: Effects on Motility, Contractility and Inflammation in the Rat and Human Gastrointestinal Tract. Gastroenterology 146(5): S-499
Duraffourd, C.C.; Tsui, J.; Brecha, N.; Sternini, C. 2014: Su1912 Opioid Receptor Activation Protects Against Intestinal Ischemia-Reperfusion Injury in Mice Through Different Pathways During Early and Late Phase of Reperfusion. Gastroenterology 146(5): S-499
Yuan, P.-Q.; Tache, Y. 2014: Su1914 Cross Talk Between Somatostatin Receptor Subtype 2 (Sst2) and Corticotropin Releasing Factor Receptor 1 (Crf1) Signaling Pathways in the Rat Colon: Functional Implications. Gastroenterology 146(5): S-500
Nakamura, T.; Uehara, H.; Moreno, P.; Nuche-Berenguer, B.; Lee, S.H.; Mantey, S.A.; Igarashi, H.; Ito, T.; Jensen, R.T. 2014: Su1915 The Molecular Basis for the High Affinity and Selectivity of the Nonpeptide Agonist, Mk-5046, and the Peptide Antagonist, Bantag, for the Human Bombesin Receptor Subtype-3, hBrs3. Gastroenterology 146(5): S-500
Saqui-Salces, M.; Tsao, A.C.; Merchant, J.L. 2014: Su1917 Chronic Omeprazole Treatment Induces Weight Gain in Mice When Combined to High Energy Diet. Gastroenterology 146(5): S-501
Vange, P.; Beisvag, V.; Flatberg, A.; Afroz, W.; Nordrum, I.S.; Sørdal, .; Qvigstad, G.; Thommesen, L.; Lægreid, A.; Sandvik, A.K.; Bruland, T.; Bakke, I. 2014: Su1918 Molecular Mechanisms of Cellular Stress Responses in Gastric Cancer. Gastroenterology 146(5): S-501
Brondon, P.; Nagda, M.; Tapper, E.B.; Sethi, S.; Falchuk, M.; Robson, S.C. 2014: Su1919 Low Level Light Therapy (Cold Laser) Produced an Inhibitory Growth Response on Colorectal Adenocarcinoma Cells. Gastroenterology 146(5): S-501
Greenfield, L.K.; Smith, M.T.; Galindo-Mata, E.; Blanke, S.R.; Rubinstein, J.L.; Kim, P.K.; Jones, N.L. 2014: Su1929 Delineating the Mechanism for Disruption of Autophagy Maturation by the Helicobacter pylori Vacuolating Cytotoxin a. Gastroenterology 146(5): S-501
Huang, B.L.; Amin, J.; Stewart, M.J.; Yan, X.; Yoon, J.L.; Melmed, G.Y.; Ippoliti, A.; Vasiliauskas, E.A.; Khanna, P.; Dubinsky, M.; Fleshner, P.; Alemayehu, Y.; Targan, S.; McGovern, D.P.; Shih, D.Q. 2014: Su1931 Genetic and Serological Predictors of H. pylori Infection in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-502
Kim, N.; Chang, H.; Park, S.M.; Choi, Y.J.; Lee, D. 2014: Su1932 H. pylori Might Induce Tgf-1-Induced Emt by Way of cagE. Gastroenterology 146(5): S-502
Singh, A.; Blaskovic, D.; Joo, J.; Yan, M.; Coleman, W.G. 2014: Su1933 Investigating the Role of Helicobacter pylori Pria Protein. Gastroenterology 146(5): S-502
Jin, X.; Asano, N.; Imatani, A.; Fushiya, J.; Kondo, Y.; Iijima, K.; Koike, T.; Shimosegawa, T. 2014: Su1934 Loss of Notch1 Function in Helicobacter pylori Contributes to Gastric Mucosal Atrophy and Carcinogenesis. Gastroenterology 146(5): S-502
Hardbower, D.M.; Barry, D.P.; Piazuelo, M.B.; Chaturvedi, R.; Wilson, K.T. 2014: Su1935 Egfr Signaling Is a Critical Component of Macrophage Responses to Helicobacter pylori Infection. Gastroenterology 146(5): S-502-S-503
Muhammad, J.S.; Zaidi, S.F.; Zhou, Y.; Sakurai, H.; Sugiyama, T. 2014: Su1936 Release of Human -Defensin 3 From Gastric Epithelial Cells Infected With Helicobacter pylori by Novel Egfr Phosphorylation via p38/Erk Activation. Gastroenterology 146(5): S-503
Suarez, G.; Romero-Gallo, J.; Piazuelo, M.B.; Williams, J.; Greenfield, L.K.; Jones, N.L.; Peek, R.M. 2014: Su1937 The Helicobacter pylori Peptidoglycan Deacetylase Pgda Mediates Intracellular Bacterial Survival, Autophagy, and Disease. Gastroenterology 146(5): S-503
Nagashima, H.; Iwatani, S.; Cruz, M.; Abreu, J.A.J.; Mahachai, V.; Vilaichone, R.; Uchida, T.; Shiota, S.; Graham, D.Y.; Yamaoka, Y. 2014: Su1938 The Relations of Bacterial and Host Factors of Il-8 Expression in Helicobacter pylori Infected Gastric Mucosa. Gastroenterology 146(5): S-503
Larussa, T.; Leone, I.; Suraci, E.; Nazionale, I.; Procopio, T.; Conforti, F.; Abenavoli, L.; Hribal, M.L.; Imeneo, M.; Luzza, F. 2014: Su1939 Enhanced Expression of Indoleamine 2,3-Dioxygenase (Ido) in Helicobacter pylori-Infected Human Gastric Mucosa Modulates Th1/Th2 Pathway and Interleukin (Il)-17 Production. Gastroenterology 146(5): S-504
Ichikawa, H.; Sugimoto, M.; Uotani, T.; Sahara, S.; Kagami, T.; Iwaizumi, M.; Yamada, T.; Osawa, S.; Sugimoto, K.; Furuta, T. 2014: Su1940 Influence of Prostate Stem Cell Antigen Gene Polymorphisms on Risk of Gastric Cancer and Duodenal Ulcer in Japanese Patients. Gastroenterology 146(5): S-504
Asaoka, D.; Nagahara, A.; Shimada, Y.; Osada, T.; Hojo, M.; Watanabe, S. 2014: Su1941 H.Pylori Infection Is a Risk Factor of Osteoporosis in Japan. Gastroenterology 146(5): S-504
Garai, J.; Piazuelo, M.B.; Delgado, A.G.; Correa, P.; Zabaleta, J. 2014: Su1942 The Homing Receptor Cd44 Is Involved in the Evolution to More Advanced Gastric Lesions Overtime in Subjects Infected With Helicobacter pylori and Development of Mucous Metaplasia in Mice. Gastroenterology 146(5): S-504
Deng, X.; Xiong, X.; Sandor, Z.; Szabo, S. 2014: Su1944 Formation of a Histodilutional Barrier in Gastric Mucosa: Protective Effect of Vegf on Ethanol-Induced Hemorrhagic Gastric Erosions in Rats. Gastroenterology 146(5): S-505
Magierowski, M.; Jasnos, K.; Drozdowicz, D.; Ptak-Belowska, A.; Flannigan, K.L.; Kwiecien, S.; Wallace, J.L.; Brzozowski, T. 2014: Su1945 Hydrogen Sulfide (H2S)-Releasing Derivative of Naproxen Atb-346 Protects the Gastric Mucosa Compromised by Stress. A Comparative Study With Naproxen and Cyclooxygenase (Cox)-2 Inhibitor. Gastroenterology 146(5): S-505
Yang, S.; Xie, R.; Xu, J.; Dong, H. 2014: Su1946 Role of Calcium-Sensing Receptor in the Development and Progression of Human Gastric Cancer. Gastroenterology 146(5): S-505
Tarnawski, A.S.; Ahluwalia, A.; Jones, M.K.; Zhu, E. 2014: Su1948 In Vivo, Real Time Non-Invasive Assessment of Gastric Mucosal Injury Using Confocal Laser Endomicroscopy: Focus on Mucosal Microvessels, Progenitor Cells and Mucosal Protection. Direct Comparison With Quantitative Histology and Electron Microscopy. Gastroenterology 146(5): S-506
Mauritz, F.A.; Rinsma, N.F.; Conchillo, J.M.; van Heurn, E.; Siersema, P.D.; van der Zee, D.C.; van Herwaarden-Lindeboom, M. 2014: Su1949 Esophageal Mucosal Integrity Recovers After Laparoscopic Fundoplication in Children With Gastroesophageal Reflux Disease. Gastroenterology 146(5): S-506
Takeuchi, K.; Amagase, K.; Satoh, H. 2014: Su1950 Effect of Celecoxib, a Selective Cycloxygenase-2 Inhibitor, on Acid-Induced Hco3-and Ulcerogenic Responses in Rat Duodenums; A Comparative Study With Conventional Non-Steroidal Anti-Inflammatory Drugs. Gastroenterology 146(5): S-506
DiMario, F.; Farkas, H.P.; Ferrara, F.; Bo, N.D.; Slongo, T.; Marcello, R.; Rugge, M.; Scarpignato, C. 2014: Su1951 Recovery of Gastric Function After Acetium Administration: A 6 Months Study in Atrophic Gastritis Subjects. Gastroenterology 146(5): S-506
Collins, M.H.; Alexander, E.S.; Martin, L.J.; Grotjan, T.M.; Abonia, J.P.; Mukkada, V.A.; Putnam, P.E.; Rothenberg, M.E. 2014: Su1953 Esophageal Strictures in Children Contain Focal Obliterative Muscularization and Mural Inflammation. Gastroenterology 146(5): S-507
Coron, E.; Dewitte, M.; Aubert, P.; Musquer, N.; Neunlist, M.; des Varannes, S.B. 2014: Su1954 Reversibility of Gastric Mucosal Lesions Induced by Sodium Phosphate Tablets and Characterized by Probe-Based Confocal Laser Endomicroscopy. Gastroenterology 146(5): S-507
Sullivan, C.; Vipperla, K.; Kancherla, D.; Kaufman, L.C.; Slivka, A. 2014: Su1957 Granulomatous Gastritis Sarcoidosis or Idiopathic? A Diagnostic Dilemma. Gastroenterology 146(5): S-508
Amagase, K.; Murakami, T.; Tanaka, R.; Takeuchi, K.; Kato, S. 2014: Su1958 Probiotic Preparation Biofermin Powder Prevents Nsaid-Induced Small Intestinal Lesions in Rats. Gastroenterology 146(5): S-508
Werawatganon, D.; Lakananurak, N.; Sallapant, S.; Prueksapanich, P.; Somanawat, K.; Wisedopas, N.; Rerknimitr, R. 2014: Su1959 Aloe Vera Attenuated Gastric Injury on Indomethacin-Induced Gastropathy in Rats. Gastroenterology 146(5): S-509
Kikuchi, O.; Ohashi, S.; Horibe, T.; Kohno, M.; Muto, M.; Kawakami, K. 2014: Su1961 Pivotal Cytotoxic Activity of Egfr-Lytic Hybrid Peptide Against 5-Fluorouracil-Resistant Esophageal Squamous Cell Carcinoma In Vitro. Gastroenterology 146(5): S-509
Amanuma, Y.; Ohashi, S.; Tsurumaki, M.; Nakai, Y.; Miyamoto, S.; Chiba, T.; Nakagawa, H.; Matsuda, T.; Muto, M. 2014: Su1962 Induction of Aldehyde Dehydrogenase-2 (Aldh2) Expression in Esophageal Epithelial Cells Suppresses the Acetaldehyde-Mediated Dna Damage. Gastroenterology 146(5): S-509
Nakamura, R.; Omori, T.; Kawakubo, H.; Takeuchi, H.; Kitagawa, Y. 2014: Su1963 Salvage Er for Local Failure of Esophageal Cancer After Crt. Gastroenterology 146(5): S-510
Tang, X.; Meltzer, S.J.; Zhi-ning, F.; Huang, S. 2014: Su1964 Klotho Expression in Esophageal Squamous Cell Carcinoma and Its Association With -Catenin and Disease Progression. Gastroenterology 146(5): S-510
Bennett, J.M.; Hategan, M.; Hindmarsh, A.; Gilligan, D.; Qian, W.; Safranek, P.M.; Sujendran, V.; Hardwick, R.H. 2014: Su1965 Trimodality Therapy for Oesophageal Cancer; The Cambridge Experience. Gastroenterology 146(5): S-510
Farag, M.; Jones, D.; Naik, P.; Bowen, R.; Lewis, W.G.; Havard, T.; Escofet, X. 2014: Su1967 Prognostic Value of Preoperative Pet Scan on Predicting Circumferential Resection Margin (Crm) Clearance in Oesphageal Cancer (Ec) Surgery and Survival Outcomes. Gastroenterology 146(5): S-511
Hudson, M.J.; Greenwald, B.D. 2014: Su1968 Role of Endoscopy in Identifying Esophageal Carcinoma After Definitive Chemoradiation. Gastroenterology 146(5): S-511
Lee, H.J.; Kim, G.H.; Lee, B.E.; Baek, D.H.; Song, G.A. 2014: Su1969 Clinicopathologic Factors Predicting Lymph Node Metastasis in Superficial Esophageal Squamous Cell Carcinoma. Gastroenterology 146(5): S-511
Vieth, M.; Manner, H.; May, A.; Ell, C.; Veit, L. 2014: Su1970 Frequency of Lateral Spread in Esophageal Squamous Cell Neoplasia. Gastroenterology 146(5): S-511
Nassri, A.B.; Spechler, S.J.; Ramzan, Z. 2014: Su1972 Differences in Survival Between Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma Are Not Due to Differences in Demographic Factors or Tumor Location. Gastroenterology 146(5): S-512
Piazuelo, E.; Chueca, E.; Hörndler, C.; Torres, A.V.; Lozano, J.J.; Garcia-Gonzalez, M.A.; Strunk, M.; Lanas, A. 2014: Su1973 Dna Methylation Changes in Barrett's Adenocarcinoma. Gastroenterology 146(5): S-512
Reddy, K.; Wu, B.U.; Yu, W.; Bebchuk, J.D. 2014: Su1975 Gastric Intestinal Metaplasia and Risk of Gastric Cancer in a Diverse Integrated Healthcare Setting. Gastroenterology 146(5): S-513
Tahara, T.; Shibata, T.; Okubo, M.; Sumi, K.; Ishizuka, T.; Ichikawa, Y.; Kawamura, T.; Nakamura, M.; Nagasaka, M.; Nakagawa, Y.; Ohmiya, N.; Arisawa, T.; Hirata, I. 2014: Su1976 Endoscopic, Clinic-Pathological and Molecular Features of Epstein-Barr Virus (Eb) Positive Gastric Carcinoma. Gastroenterology 146(5): S-513
Jin, E.H.; Lee, D.H.; Seo, J.Y.; Kim, J.; Park, Y.S.; Shin, C.M.; Yoon, H.; Hwang, J.; Kim, N. 2014: Su1977 Accuracy of Multidetector-Row Computed Tomography (Mdct) for Clinical N Staging in Early Gastric Cancer. Gastroenterology 146(5): S-513
Choi, H.S.; Lee, S.-Y.; Kim, J.H.; Sung, I.K.; Park, H.S.; Shim, C.S.; Jin, C.J. 2014: Su1980 Combining the Serum Pepsinogen Levels and Helicobacter pylori Antibody Test Is Not Useful for Detecting Gastric Neoplasms With Advanced Histology. Gastroenterology 146(5): S-514
Jung, D.H.; Kim, J.-H.; Lee, Y.C.; Lee, S.K.; Park, J.J.; Youn, Y.H.; Park, H. 2014: Su1981 The Role of H. Pylori Eradication for the Prevention of Metachronous Lesions After Endoscopic Resection in Gastric Neoplasms. Gastroenterology 146(5): S-514
Takeda, S.; Tanigawa, T.; Watanabe, T.; Tatsuwaki, H.; Nadatani, Y.; Yamagami, H.; Shiba, M.; Tominaga, K.; Muguruma, K.; Hirakawa, K.; Arakawa, T. 2014: Su1982 Reduced Expression of Prostaglandin Transporter is an Independent Predictor of Poor Prognosis in Gastric Adenocarcinoma Associated With Tumor Angiogenesis. Gastroenterology 146(5): S-514
Arisawa, T.; Otsuka, T.; Tahara, T.; Yamada, K.; Yamada, H.; Nomura, T.; Hayashi, R.; Matsunaga, K.; Kawada, N.; Fukuyama, T.; Nakamura, M.; Shimasaki, T.; Toshikuni, N.; Shiroeda, H.; Shibata, T. 2014: Su1983 Genetic Polymorphisms of Dnmt3A Are Associated With the Aberrant Dna Methylation of Dapk in Japanese Subjects. Gastroenterology 146(5): S-514
Shi, J.; Sun, Q.; Yu, H.; Zhang, Y.; Fang, C.; Yu, C.; Zou, X.; Mashimo, H.; Huang, Q. 2014: Su1985 Unique Clinicopathologic Features of Early Proximal Gastric Cancer Diagnosed With Who Criteria: Implications for Endoscopic Resection. Gastroenterology 146(5): S-515
Arisawa, T.; Shiroeda, H.; Tahara, T.; Yamada, K.; Yamada, H.; Nomura, T.; Hayashi, R.; Matsunaga, K.; Kawada, N.; Fukuyama, T.; Otsuka, T.; Nakamura, M.; Toshikuni, N.; Shiroeda, H.; Shibata, T. 2014: Su1986 A Polymorphism rs7521584 in pre-miR429 and Pre-Mir200s Genes Is Associated With the Aberrant Dna Methylation in Gastric Mucosa. Gastroenterology 146(5): S-515
LeBras, G.F.; Koumangoye, R.B.; Loomans, H.A.; Taylor, C.; Andl, C.D. 2014: Su1987 Inhibition of Tgfbeta Signaling Promotes Collective Invasion of Esophageal Keratinocytes Through an Adamts1-Dependent Release of Egf. Gastroenterology 146(5): S-515
Barrett, R.; Yeager, N.; Rushton, D.; Ornelas, L.; Sareen, D.; Svendsen, C.; Targan, S. 2014: Su1989 Generation of Functional Human Intestinal Organoids From Lymphoblastoid B-Cell Lines: Opportunity for Gene Specific Functional Assessment in Ibd. Gastroenterology 146(5): S-516
Bortner, J.D.; Hartman, K.G.; Crissey, M.A.S.; Falk, G.W.; Yu, J.; Martin, M.G.; Johnson, F.B.; Rustgi, A.K.; Lynch, J.P. 2014: Su1990 Co-Culture With Th1 Polarized Pbmcs Enhances Growth of Human Intestinal Enteroids. Gastroenterology 146(5): S-516
Sarkar, S.; O'Connell, M.R.; Luthra, G.; Singh, P. 2014: Su1991 Progastrin Up-Regulates the Expression of Both Long and Short Isoforms of Cancer Stem Cell Marker, Dclk1, by Transcriptionally Activating Their Respective Promoters: Role of -Catenin and NfB Response Elements. Gastroenterology 146(5): S-516
Ryu, H.; Singh, A.; Bradford, E.; Lee, G.; Goretsky, T.; Gounaris, E.; Barrett, T.A.; Shealy, D. 2014: Su1992 Tnf Mediates -Catenin Activation in Intestinal Stem Cells During Colitis. Gastroenterology 146(5): S-516
Williams, A.M.; Liu, J.; Walker, N.M.; Clarke, L.L. 2014: Su1994 Loss of Cftr Results in Intestinal Stem Cell Hyperproliferation. Gastroenterology 146(5): S-517
El-Nachef, W.N.; Hou, X.; Garcia, S.; Grikschei, T. 2014: Su1995 Enteric Neurospheres Differentiate Into Neurons Within Tissue-Engineered Colon to Form Neurosphere Enriched Tissue-Engineered Colon. Gastroenterology 146(5): S-517
Lopetuso, L.R.; Scaldaferri, F.; Petito, V.; Sala, E.; Puglisi, M.A.; Andrisani, G.; Caristo, M.E.; Arena, V.; Vetrano, S.; Franceschi, F.; Sgambato, A.; Gasbarrini, A. 2014: Su1996 Effect of Mesenchymal Stem Cell Treatment in Colitis-Associated Colon Cancer Risk. Gastroenterology 146(5): S-517
May, R.; Qu, D.; Weygant, N.; Chandrakesan, P.; Ali, N.; Sureban, S.M.; Houchen, C.W. 2014: Su1997 Ablation of Mesenchymal Dclk1 by the Foxl1-Cre Promoter Results in Increased Epithelial Tuft Cells. Gastroenterology 146(5): S-518
Oikonomopoulos, A.; van Deen, W.K.; Hommes, D.W. 2014: Su1998 Effects of Alternative Xeno-Free Media Formulations on the Functional Characteristics of Ifn--Primed Human Bone Marrow and Adipose Derived Mesenchymal Stem Cells. Gastroenterology 146(5): S-518
Cury, D.B.; Oliveira, R.A.; Versollato, C.; Schor, N. 2014: Su1999 Comparative Study Between Topical and Intravenous Treatment of Stem Cells in Tnbs Model. Gastroenterology 146(5): S-518
Xie, M.; He, X.; Yang, Z.; Lan, P.; Lian, L. 2014: Su2000 Comparison of Adipose-Derived and Bone-Marrow Mesenchymal Stem Cells in a Murine Model of Crohn's Disease. Gastroenterology 146(5): S-518
Aoki, R.; Kaestner, K.H. 2014: Su2001 The Role of the Histone Methyltransferase Ezh2 in the Mouse Intestinal Epithelium. Gastroenterology 146(5): S-519
Dave, M.; Mehta, K.; Faubion, W.A. 2014: Su2002 Nonmyeloablative Stem Cell Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review of Safety and Efficacy. Gastroenterology 146(5): S-519
Ahsen, O.O.; Lee, H.-C.; Liang, K.; Giacomelli, M.G.; Tsai, T.-H.; Wang, Z.; Figueiredo, M.; Huang, Q.; Potsaid, B.; Fujimoto, J.G.; Mashimo, H. 2014: Su2003 Ultrahigh Speed Optical Coherence Tomography With Micromotor Imaging Probe Enables Three-Dimensional Visualization of Mucosal Surface Patterns in the Gastrointestinal Tract. Gastroenterology 146(5): S-519
Yang, C.; Hou, V.W.; Nelson, L.Y.; Johnston, R.S.; Melville, C.D.; Seibel, E.J. 2014: Su2005 Nanomolar Detection Sensitivity in Wide-Field Multispectral Fluorescence Endoscopy. Gastroenterology 146(5): S-520
Alsop, B.R.; Gupta, N.; Able, K.L.; Mathur, S.C.; Leggett, C.L.; Tearney, G.J.; Wallace, M.B.; Wang, K.K.; Wolfsen, H.C.; Vennalaganti, P.; Sharma, P. 2014: Su2006 Performance of Novel Criteria for Distinguishing Dysplastic From Non-Dysplastic Barrett's Esophagus (Ndbe) Using Volumetric Laser Endomicroscopy (Vle) Among Experts and Gi Trainees. Gastroenterology 146(5): S-520
Konda, V.J.; Siddiqui, U.D.; Xiao, S.-Y.; Koons, A.; Turner, J.R.; Pabla, B.; Gelrud, A.; Hart, J.; Waxman, I. 2014: Su2008 Potential Role for Volumetric Laser Endomicroscopy in Barrett's Esophagus. Gastroenterology 146(5): S-521
Giacomelli, M.G.; Tsai, T.-H.; Ahsen, O.O.; Lee, H.-C.; Liang, K.; Wang, Z.; Figueiredo, M.; Huang, Q.; Potsaid, B.; Fujimoto, J.G.; Mashimo, H. 2014: Su2009 Ultrahigh Speed Micromotor Optical Coherence Tomography Enables Improved Access, Image Quality, and Maneuverability in Upper and Lower Endoscopy. Gastroenterology 146(5): S-521
Lee, M.H.; Parikh, N.; Polydorides, A.D.; Louie, J.; Protano, M.-A.; Mitcham, J.; Richards-Kortum, R.; Anandasabapathy, S. 2014: Su2011 Diagnostic Yield and Clinical Impact of a Low-Cost Microendoscope in the Early Diagnosis of Barrett's Associated Neoplasia: A Prospective, Single-Center Randomized Controlled Trial. Gastroenterology 146(5): S-522
Lim, L.G.; Wang, W.; Srivastava, S.; So, J.B.; Shabbir, A.; Liu, Q. 2014: Su2013 Roles of Linear and Circular Polarization Properties and Effect of Wavelength Choice on Differentiation Between Ex Vivo Normal and Cancerous Gastric Samples Using Polarimetry Imaging. Gastroenterology 146(5): S-523
Paskaranandavadivel, N.; Li, J.; O'Grady, G.; Cheng, L.K.; Farajidava, A. 2014: Su2014 A Multichannel Wireless Mapping System for Monitoring Gastric Slow Wave Propagation. Gastroenterology 146(5): S-523
Chatrath, H.; Liang, R.; Chen, Z.; Banerjee, B. 2014: Su2015 Polarized Light Imaging for Detection of Aberrant Cryptic Foci (Acf). Gastroenterology 146(5): S-523
Vivian, D.; Cheng, K.; Khurana, S.; Xu, S.; Kriel, E.H.; Dawson, P.; Polli, J.; Raufman, J.-P. 2014: Su2017 In Vivo Performance of a Novel Fluorinated Magnetic Resonance Imaging Agent for Functional Analysis of Bile Acid Transport. Gastroenterology 146(5): S-524
Robles-Medranda, C.; Del Valle, R.S.; ALcívar, M.S.; Velez, G.B.; Rendon, F.A.; Robles-Jara, C.A. 2014: Su2018 Pentax I-Scan With Magnification for the Identification of Underdiagnosis Organic Esophageal Lesions (Barret Esophagus and Esophagitis) in Patients With Functional Dyspepsia: A Prospective Study. Gastroenterology 146(5): S-524
Bonora, E.; Bianco, F.; Bamshad, M.; Dowless, D.; Francescatto, L.; Katsanis, N.; Cooper, G.; Savic, D.; Stanghellini, V.; Mungan, Z.; Cefle, K.; Cogliandro, R.; Boschetti, E.; Graziano, C.; Seri, M. 2014: Su2019 Functional Characterization of a Novel Rad21 Mutation in Familial Chronic Intestinal Pseudo-Obstruction (Cipo). Gastroenterology 146(5): S-524
Rico, A.L.; Ochoa-Cortes, F.; Alhaj, M.A.; Enneking, J.; Bitticker, E.; Needleman, B.J.; Harzman, A.; Grants, I.; Christofi, F.L. 2014: Su2021 Utp Evokes Ca2+ Oscillations in Human Enterochromaffin Cells via Multiple Intracellular Signaling and Ionic Mechanisms. Gastroenterology 146(5): S-525
Mazzone, A.; Gibbons, S.J.; Bernard, C.E.; Nowsheen, S.; Middha, S.; Almada, L.L.; Ordog, T.; Kendrick, M.L.; Lombardo, K.M.R.; Shen, K.R.; Galietta, L.J.; Fernandez-Zapico, M.E.; Farrugia, G. 2014: Su2023 Il-4 via Stat6 Regulates a Promoter for the Human Ano1 Gene. Gastroenterology 146(5): S-526
Akiho, H.; Ohbuchi, K.; Tsuchiya, K.; Ihara, E.; Nakamura, K.; Yamamoto, M. 2014: Su2024 Il-17A and Il-1 Exert IB-Mediated, but Oppositely-Directed, Effects on Contractility and Rgs4 Translocation in Small Intestinal Smooth Muscle Cells, Whose Directions Are Determined by the Balance Between P38mapk and Jnk Activities. Gastroenterology 146(5): S-526
Buehler, D.P.; Prasad, N.; Byers, S.L.; Rosebrock, J.; Levy, S.E.; Clark, T.A.; Southard-Smith, M. 2014: Su2025 Differential Expression of Phox2b Marks Distinct Progenitor Cell Populations That Differ in Developmental Potential and Gene Expression in the Fetal Mouse Enteric Nervous System. Gastroenterology 146(5): S-526
Linden, D.R.; Farrugia, G. 2014: Su2027 Regeneration of Myenteric Neurons Following Low Concentration Benzylkonium Chloride Is Associated With Increased Expression of Sox2. Gastroenterology 146(5): S-527
Eisenman, S.T.; Verhulst, P.-J.; Gibbons, S.J.; Farrugia, G. 2014: Su2029 Medium Conditioned With Conventionally-Activated M1 Macrophages Inhibits Survival of Mouse Interstitial Cells of Cajal in Primary Culture. Gastroenterology 146(5): S-527
Li, Y.-X.; Lin, Y.M.; Fu, Y.; Xie, D.-P.; Sarna, S.K.; Shi, X.-Z.P. 2014: Su2030 Neurotrophins Facilitate Cholinergic Activation in the Colon: Role of Smooth Muscle Neurotrophin Receptors. Gastroenterology 146(5): S-527
Böttner, M.; Hellwig, I.; Barrenschee, M.; Fritscher-Ravens, A.; Ellrichmann, M.; Jarry, H.; Wedel, T. 2014: Su2032 Gene Expression and Localization Study of Estrogen Receptors in Human and Rat Intestine -Impact on Gender Related Gastrointestinal Motility Disorders. Gastroenterology 146(5): S-528
Musser, M.A.; Rosebrock, J.; Southard-Smith, M. 2014: Su2033 Deficits in Neural Crest-Derived Lineages and Gi Motility in the Ganglionated Regions of Murine Hirschsprung Enteric Nervous System. Gastroenterology 146(5): S-528
Somara, S.; Wylie, A.; Kavanagh, K.; Bitar, K.N. 2014: Su2034 Heat Therapy Induced Phosphorylation of Hsp27 to Improve Gastrointestinal Motility. Gastroenterology 146(5): S-528
Neshatian, L.; Strege, P.R.; Bernard, C.E.; Beyder, A.; Farrugia, G. 2014: Su2035 Y1767 Is Important for Block of NaV1.5 Shear Sensitivity by Ranolazine. Gastroenterology 146(5): S-528
Mihara, H.; Suzuki, N.; Yamawaki, H.; Nishizono, H.; Tominaga, M.; Sugiyama, T. 2014: Su2037 Trpv2 Knockout Mice Exhibit Enhanced Gastric Emptying. Gastroenterology 146(5): S-529
Mendes, C.E.; Palombit, K.; Castelucci, P. 2014: Su2038 Effects of Ischemia and Reperfusion on Rat Enteric Glial Cells Expressing the P2X2 and P2X7 Receptors. Gastroenterology 146(5): S-529
Botteselle, L.; Zhao, X.; Göke, B.; Sibaev, A.; Storr, M. 2014: Su2040 Interaction Between Gpr119 and Cb1 Receptors in the Inhibition of Contractile Activity in Mouse and Human Gut. Gastroenterology 146(5): S-530
Furness, J.B.; Rivera, L.; Leung, C.; Pustovit, R.; Angus, P.W. 2014: Su2041 Enteric Neuropathy Caused by High Fat Diet. Gastroenterology 146(5): S-530
Yakabi, S.; Wang, L.; Karasawa, H.; Koike, K.; Yakabi, K.; Tache, Y. 2014: Su2042 Vasoactive Intestinal Peptide (Vip) Is Involved in Intraperitoneal Corticotropin-Releasing Factor (Crf) Induced Diarrhea in Rats. Gastroenterology 146(5): S-530
Koloski, N.A.; Jones, M.P.; Young, M.; Harris, J.; Talley, N.J. 2014: Su2043 Stability of Rome Iii Constipation Symptom Based Classifications. Gastroenterology 146(5): S-530
Mujagic, Z.; Ludidi, S.; Keszthelyi, D.; Hesselink, M.; Kruimel, J.; Lenaerts, K.; Hanssen, N.; Conchillo, J.M.; Jonkers, D.; Masclee, A. 2014: Su2045 Gut Permeability in Ibs is Site Specific, Subtype Dependent and Affected by Confounding Factors. Gastroenterology 146(5): S-531
Hod, K.; Ringel-Kulka, T.; Martin, C.F.; Maharshak, N.; Ringel, Y. 2014: Su2046 High Sensitive C -Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome. Gastroenterology 146(5): S-531
Hod, K.; Ringel-Kulka, T.; Van Tilburg, M.A.; Ringel, Y. 2014: Su2047 Abdominal Bloating in Patients With Irritable Bowel Syndrome: Characterization of Clinical Symptoms, Psychological Factors and Associated Comorbidities. Gastroenterology 146(5): S-532
Ghoshal, U.; Shukla, R.; Agarwal, V.; Dhole, T.N.; Ghoshal, U.C. 2014: Su2048 Fecal Microbiota in Patients With Irritable Bowel Syndrome Compared to Healthy Controls by Real-Time Pcr: An Evidence of Dysbiosis. Gastroenterology 146(5): S-532
Erdogan, A.; Lee, Y.Y.; Badger, C.; Hall, P.; O'Banion, M.E.; Rao, S.S. 2014: Su2049 What Is the Optimal Threshold for an Increase in Hydrogen and Methane Levels With Glucose Breath Test (Gbt) for Detection of Small Intestinal Bacterial Overgrowth (Sibo)?. Gastroenterology 146(5): S-532
Basra, S.S.; Verne, G.N.; Zhou, Q. 2014: Su2051 Targeted Deletion of MicroRna-29 Prevents Intestinal Hyper-Permeability & Visceral Hyperalgesia in Water Avoidance Mice. Gastroenterology 146(5): S-533
Linlawan, S.; Patcharatrakul, T.; Gonlachanvit, S. 2014: Su2052 Effect of Rice vs. Wheat Carbohydrate Ingestion on Intestinal Gas Production and Gastrointestinal Symptoms in Non-Constipation Irritable Bowel Syndrome Patients. Gastroenterology 146(5): S-533
Salameh, H.; Zhang, B.; Zhou, Q.; Verne, G.N. 2014: Su2053 Lentiviral Delivery of miR-199a Reduces Visceral Hypersensitivity Through Translational Down-Regulation of Trpv1. Gastroenterology 146(5): S-533
Ghoshal, U.C.; Srivastava, D.; Ghoshal, U.; Mittal, R.D. 2014: Su2055 Genetic Variants Producing Less Il-1ra Are Commoner in Irritable Bowel Syndrome Than Controls and Patients With Small Intestinal Bacterial Overgrowth Have Higher Intestinal Mucosal Il-1 and Levels Than Those Without: Evidence for Gut Inflammation. Gastroenterology 146(5): S-534
Murray, K.; Marciani, L.; Hoad, C.L.; Cox, E.; Major, G.A.; Silos-Santiago, A.; Kurtz, C.B.; Mehri, K.; Paul, J.A.; Gowland, P.A.; Johnston, J.; Spiller, R.C. 2014: Su2056 Novel Mri Techniques and Parameters for Assessing the Impact of Laxatives on the Human Colon. Gastroenterology 146(5): S-534
Ludidi, S.; Mujagic, Z.; Jonkers, D.; Keszthelyi, D.; Hesselink, M.; Kruimel, J.; Conchillo, J.M.; Masclee, A. 2014: Su2057 Markers for Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome. Gastroenterology 146(5): S-534
Amieva-Balmori, M.; Meixueiro, A.; Canton, P.; Remes-Troche, J.M. 2014: Su2059 Prevalence of Irritable Bowel Syndrome in Mexico. A Nationwide Population Based Study Using the Rome Iii Questionnaire. Gastroenterology 146(5): S-535
Setty, P.; Antonopoulos, D.A.; Mills, N.; Chang, E.B.; Bard, J.; Koval, J.C.; Lin, H.C. 2014: Su2060 Small Intestinal Microbial Composition Is Different in Veterans With Gulf War Illness. Gastroenterology 146(5): S-535
Heitkemper, M.; Jarrett, M.; Raftery, D.; Djukovic, D.; Gu, H.; Cain, K. 2014: Su2062 Serum Tryptophan Metabolite Profiling During Sleep in Patients With and Without Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-536
Wilder-Smith, C.H.; Li, X.; Wong, R.K.; Ho, S.S.; Leong, S.M.; Lee, H.K.; Koay, E.S.; Ferraris, R.P. 2014: Su2063 There Is No Relationship Between the Fructose Transporter, Glut5 and Glut2, Protein or mRna Expression Levels in Irritable Bowel Syndrome With Fructose Malabsorption and Intolerance. Gastroenterology 146(5): S-536
Wilder-Smith, C.H.; Van Oudenhove, L.; Li, X.; Ho, K.-Y.; Wong, R.K. 2014: Su2064 Visceral Pain Perception in Ibs Patients and Controls in the Fmrii Scanner Environment Is Significantly Altered by Psychological Factors. Gastroenterology 146(5): S-536
Rodríguez-Fandiño, O.A.; Mejía-López, L.A.; Hernández-Ruiz, J.; López-Vidal, Y.; Charua-Guindic, L.; Azuceno-García, I.; Escobedo, G.; Schmulson, M.J. 2014: Su2065 Peripheral Blood Monocyte/Macrophage Maturation Phenotype in Ibs After Stimulation With Lps. Gastroenterology 146(5): S-537
Harrington, A.M.; Castro, J.; Young, R.L.; Kurtz, C.B.; Silos-Santiago, I.; Nguyen, N.Q.; Andrews, J.M.; Brierley, S.M. 2014: Su2066 Distinct Alterations in the Guanylate Cyclase-C (Gc-C)/Cyclic Gmp (cGmp) Pathway Are Evident Across Different Subtypes of Irritable Bowel Syndrome (Ibs) Patients. Gastroenterology 146(5): S-537
Yu, S.W.; Attaluri, A.; Lee, Y.Y.; Erdogan, A.; Badger, C.; Fedewa, A.; Rao, S.S. 2014: Su2067 Dietary Fructan Intolerance and Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-537
Lasa, J.S.; Senderovsky, M.T.; Fanjul, I.; Dima, G.; Peralta, A.D.; Prizont, R.; Soifer, L.O. 2014: Su2068 Proton-Pump Inhibitors' Influence on Lactulose Breath Tests and Irritable Bowel Syndrome Symptom Severity. Gastroenterology 146(5): S-537
Bettes, N.; Griffith, J.; Camilleri, M.; Farrugia, G.; Alnahhas, M.F.; Busciglio, I.A.; Smith, K.; Grover, M. 2014: Su2070 Risk and Predictors of Post-Infectious Irritable Bowel Syndrome Among Community-Acquired Cases of Bacterial Enteritis. Gastroenterology 146(5): S-538
Andreasson, A.; Jones, M.P.; Walker, M.M.; Talley, N.J.; Nyhlin, H.; Agreus, L. 2014: Su2071 Prediction Pathways for Innate Immune Pathology, Ibs, Anxiety and Depression in a General Population (The Popcol Study). Gastroenterology 146(5): S-538
Krogsgaard, L.R.; Engsbro, A.L.O.; Bytzer, P. 2014: Su2072 Symptom Stability of the Irritable Bowel Syndrome: A Population-Based Survey Over 3 Years in Denmark. Gastroenterology 146(5): S-538
Li, Q.; Cordner, Z.; Liu, L.; Tamashiro, K.L.; Moran, T.H.; Pasricha, P.J. 2014: Su2073 Neonatal Colonic Irritation Produces Persistent Visceral Hypersensitivity and Altered Affective Behavior in a Mouse Model of Irritable Bowel Syndrome (Ibs). Gastroenterology 146(5): S-539
Ren, T.; Zhou, Y. 2014: Su2074 The Effects of Adenosine A3 Receptor Agonist on Visceral Hypersensitivity of Neonatal Maternally Separated Rat Models. Gastroenterology 146(5): S-539
Farup, P.G.; Hestad, K. 2014: Su2075 Cognitive Functions and Depression in Patients With Irritable Bowel Syndrome (Ibs) -What Is the Connection?. Gastroenterology 146(5): S-539
Kanazawa, M.; Kano, M.; Muratsubaki, T.; Yagihashi, M.; Sasaki, A.; Tanaka, Y.; Morishita, J.; Fukudo, S. 2014: Su2077 Phasic and Tonic Motility Responses in the Colorectum After Peripheral Administration of Corticotropin-Releasing Hormone Are Exaggerated in Patients With Irritable Bowel Syndrome. Gastroenterology 146(5): S-540
Labus, J.S.; Mayer, E.A.; Love, A.D.; Stains, J.; Liu, C.; Ashe-McNalley, C.; Keefer, L.; Lackner, J.M.; Naliboff, B.D.; Tillisch, K. 2014: Su2078 Grey Matter Alterations in Medial Prefrontal Cortex Show Negative Associations With Subjective Reports of Worry in Ibs Patients. Gastroenterology 146(5): S-540
Merwat, S.N.; Verne, G.N.; Zhou, Q. 2014: Su2079 Decreased miR-199a/B Augments Visceral Pain Through Translational Up-Regulation of Trpv1 in Ibs Patients. Gastroenterology 146(5): S-540
Frändemark, .; Ringstrom, G.; Törnblom, H.; Simren, M. 2014: Su2081 Work Productivity and Activity Impairment in Ibs: A Multifaceted Problem. Gastroenterology 146(5): S-541
Grover, M.; Farrugia, G.; Linden, D.R.; MacNaughton, W.K.; Kashyap, P.C.; Smith, K.; Griffith, J.; Sharma, A.N.; Carlson, P.; Szurszewski, J.H.; Bernard, C.E.; Burton, D.D.; Busciglio, I.A.; Camilleri, M. 2014: Su2082 Colonic Barrier Function Is Impaired in Post-Campylobacter jejuni Irritable Bowel Syndrome. Gastroenterology 146(5): S-541
Lackner, J.M.; Gudleski, G.D.; Ma, C.; Dewanwala, A.; Naliboff, B.D. 2014: Su2085 The Impact of Fear of Gi Symptoms on Quality of Life Impairment Due to Irritable Bowel Syndrome. Gastroenterology 146(5): S-542
Tejera, V.C.; Jerlstad, P.; Venge, P.; Simren, M.; Törnblom, H. 2014: Su2086 A Pilot Study of Mesalazine Treatment in Ibs, Evaluating the Tolerance and Usefulness of the Mucosal Patch Technique for Measurement of Rectal Inflammatory Markers. Gastroenterology 146(5): S-542
Gonzalez-Fraga, J.D.; Verne, M.L.; Zhou, Q. 2014: Su2087 Evidence for Central Nociceptive Cross-Talk Between Tmd and Ibs. Gastroenterology 146(5): S-542
Jossan, N.; Backman, A.-S.; Linder, M.; Altman, M.; Simren, M.; Olen, O.; Törnblom, H. 2014: Su2089 Validation of the Use of the Icd-10 Diagnostic Code for Irritable Bowel Syndrome in the Swedish National Patient Register. Gastroenterology 146(5): S-543
Kameyama, K.; Itoh, K.; Fujii, T.; Nishikawa, S.; Kajiura, T.; Nakamura, E. 2014: Su2090 Colonization of a Novel Lachnospiraceae Bacterium, Isolated From Hyperglycemic Obese Mice, Induces Metabolic Syndrome in Gnotobiotic Mice in Association With Escherichia coli. Gastroenterology 146(5): S-543
Chuang, P.; Walsh, E.; Kim, S.; Lee, T.; Hwang, J.I.; Cho, I. 2014: Su2091 Differential Response to Anticoagulation in Germ-Free Swiss Webster Mice Conventionalized With Fecal Transplantation From Human Donors Requiring Varying Doses of Warfarin. Gastroenterology 146(5): S-543
Sigalet, D.L.; Lam, V.; Brindle, M.; Boctor, D.L.; Hartmann, B.; Wallace, L.; Stanger, J.D.; Holst, J.J. 2014: Su2093 Glucagon Like Peptide-2 Production and Sensitivity in Infants Post-Resection or Gastroschisis. Gastroenterology 146(5): S-544
Sigalet, D.L.; Lam, V.; Karnik, V.; Brindle, M.; Hartmann, B.; Boctor, D.L.; Casey, L.; Dicken, B.; Stoffman, S.; de Heuvel, E.; Wrightwilson, G.; Wallace, L.; Holst, J.J. 2014: Su2094 Safety and Dosing Study of Glucagon-Like Peptide 2 (Glp-2) in Children With Intestinal Failure. Gastroenterology 146(5): S-544
Salden, B.; Monserrat, V.; Troost, F.; Bruins, M.; Edens, L.; Bartholomé, R.; Winkens, B.; Koning, F.; Masclee, A. 2014: Su2096 Gluten Degrading Enzyme Effectively Digests Gluten in the Stomach and Small Intestine of Healthy Volunteers. Gastroenterology 146(5): S-545
Obi, K.; Arsenescu, V.; Naem, M.; Arsenescu, R. 2014: Su2097 Impact of Metabolic Syndrome on Inflammatory Bowel Disease Phenotype and Outcome. Gastroenterology 146(5): S-545
Yoshii, S.; Mabe, K.; Keiko, W.; Akakura, N.; Kato, M. 2014: Mo1061 A Comparison of Immunochemical Fecal Occult Blood Test and Total Colonoscopy in an Asymptomatic Population. Gastroenterology 146(5): S-545
Ramos, J.N.; Mehta, S.J.; Lamanna, A.A.; Kochman, M.L.; Guerra, C.E. 2014: Mo1063 Cost-Effectiveness Analysis of the First Year of a Colorectal Cancer (Crc) Screening Patient Navigation Program At an Academic Medical Center. Gastroenterology 146(5): S-546
Mittmann, N.; Hassan, S.; Patel, J.; Tinmouth, J.M. 2014: Mo1065 Cost-Effectiveness of Directly Mailed Fobt Kits in a Hard to Reach Population in Colorectal Cancer Screening. Gastroenterology 146(5): S-547
Straatman, J.; van der Peet, D.L.; Cuesta, M. 2014: Mo1066 The Precious Trial, Prediction of Complications: a Step-Up Approach, Crp First Followed by Ct-Scan Imaging to Ensure Quality Control After Major Abdominal Surgery. Gastroenterology 146(5): S-547
Adar, T.; Tribich, L.; Lieberman, S.; Levy-Lahad, E.; Goldi, E. 2014: Mo1067 High Yield Pro-Active Outreach Program for Identifying Patients At High Risk for Lynch Syndrome After Surgery for Colorectal Cancer -Results of a Pilot Study. Gastroenterology 146(5): S-547
Calderwood, A.H.; Schroy, P.C.; Cabral, H.; Burgess, J.F. 2014: Mo1068 Predictors of Adherence to Post-Polypectomy Surveillance. Gastroenterology 146(5): S-547
May, F.P.; Whitman, C.B.; Varlyguina, K.; Bromley, E.G.; Martinez, B.M.; Spiegel, B.M. 2014: Mo1069 Addressing Low Colorectal Cancer Screening in African Americans: Focus Groups Reveal Insights for Developing an Effective Intervention. Gastroenterology 146(5): S-548
Gandhi, R.; Muriithi, J.G.; Wayde, E.; Wayde, M.; Akram, S. 2014: Mo1070 Colorectal Health Disparities in a Government Healthcare System: a Retrospective Comparative Study Using Data From a A Us Veterans Affairs Population. Gastroenterology 146(5): S-548
Englum, B.R.; Speicher, P.J.; Ganapathi, A.M.; Castleberry, A.; Thacker, J.K.; Mantyh, C.R.; Migaly, J. 2014: Mo1072 Optimizing the Utilization of Adjuvant Chemotherapy Following Surgical Resection of Colon Cancer: A Comparison of Laparoscopic Versus Open Approach. Gastroenterology 146(5): S-549
Hsu, W.-H.; Sun, M.-S.; Lo, H.-W.; Tsai, C.-Y.; Tsai, Y.-J. 2014: Mo1074 Physicians with High-Volume Colonoscopies Are Associated with Better Bowel Preparation. Gastroenterology 146(5): S-550
Assavapongpaiboon, B.; Aniwan, S.; Angsuwatcharakon, P.; Kongkam, P.; Rerknimitr, R.; Kullavanijaya, P. 2014: Mo1075 Factors Predicting Proximal Advanced Adenoma in Colon Cancer Screening. Gastroenterology 146(5): S-550
Padron, M.; Avalos, D.J.; Cantisano, B.G.J.; Ukleja, A.; Castro, F.; Palekar, N.; Charles, R.J.; Parlade, A.; Lara, L.F. 2014: Mo1077 Clinical Efficacy of Same Day Ct Colonography Following Incomplete Colonoscopy. Gastroenterology 146(5): S-551
John, B.K.; Nakshabendi, R.; Mourad, B.; Munoz, J.C. 2014: Mo1078 Choice of Sedation and Its Impact on Adenoma Detection Rate (Adr). Results From a Retrospective Study. Gastroenterology 146(5): S-551
Bjornsson, E.; Onundarson, P.T. 2014: Mo1079 Screening of Warfarin Users With Regular Full Blood Counts Commonly Identifies Malignant and Premalignant Gastrointestinal Lesions: a Prospective Study. Gastroenterology 146(5): S-551
Braschi, C.; Lee, K.; Shah, B.; Montgomery, G.H.; Jandorf, L.; Itzkowitz, S.H. 2014: Mo1080 Underuse of Surveillance Colonoscopy in Ethnic Minorities With a History of Advanced Adenomas: Patient, Provider and System-Level Factors. Gastroenterology 146(5): S-552
Brimhall, B.B.; Hankins, S.C.; Austin, G.L. 2014: Mo1081 Effect of a Low-Volume Compared to a High-Volume Polyethylene Glycol Bowel Preparation Solution on Prep Quality, Procedure Times, and Adenoma Detection Rates. Gastroenterology 146(5): S-552
Gawron, L.M.; Goldberger, A.R.; Gawron, A.J.; Hammond, C.; Keefer, L. 2014: Mo1082 The Effect of Hormonal Contraceptives on Menstrual-Related Inflammatory Bowel Disease Symptoms. Gastroenterology 146(5): S-552
Spizzo, P. 2014: Mo1084 Standard Surveillance Intervals Appear Appropriate for Patients At Increased Risk of Colorectal Cancer Due to Renal Transplantation. Gastroenterology 146(5): S-553
Rieder, B.; Koenigsberger, P.; Hofmann, W.; Pfeiffer, A. 2014: Mo1085 Incidence and Characteristics of Interval Colorectal Carcinoma: A Single Center Experience. Gastroenterology 146(5): S-553
Changela, K.; Malieckal, A.; Izzy, M.J.; Bhalani, K.; Lane, D.; Singhal, S.; Duddempudi, S.; Anand, S. 2014: Mo1086 The Predictors and Outcomes of Poor Bowel Preparation During Colonoscopy: an Analysis From Colonoscopy Outcome in Minority Population (Comp) Registry. Gastroenterology 146(5): S-553
Peeraphatdit, T.; Naksuk, N. 2014: Mo1088 Increased Resource Utilization in Patients With Gastrointestinal Bleeding With Left Ventricular Assist Device Compared to Medical Controls. Gastroenterology 146(5): S-554
Thomas, C.E.; Karran, A.; Davies, L.; Foley, K.; Witherspoon, J.; Joseph, G.; Roberts, A.; Lewis, W.G. 2014: Mo1089 Prognostic Significance of Radiological Staging and Open and Close Laparotomy in Upper Gastrointestinal Cancer Patients. Gastroenterology 146(5): S-554
Theivanayagam, S.; Lopez, K.T.; Asombang, A.W.; Matteson-Kome, M.L.; Bechtold, M.L. 2014: Mo1090 Asa Classification Prior to Endoscopic Procedures: A Retrospective Analysis on Accuracy of Gastroenterologists. Gastroenterology 146(5): S-554
Park, J.M.; Lee, S.-W.; Lim, C.-H.; Kim, J.S.; Kim, S.W.; Choi, M.-G. 2014: Mo1092 C-Reactive Protein as a Predictive Marker for Rebleeding in the Patients With Acute Non-Variceal Upper Gastrointestinal Bleeding. Gastroenterology 146(5): S-555
Mustafa, Z.; Clark, E.; Campbell, N.; Cameron, A.; Stanley, A.J. 2014: Mo1093 Outpatient Management of Low-Risk Patients With Upper Gi Bleeding: Can We Safely Extend the Glasgow Blatchford Score in Clinical Practice?. Gastroenterology 146(5): S-555
Jaboli, M.F.; Grimes, M.; Palmer, H.; Wylie, P.; Planche, K.; Epstein, O. 2014: Mo1094 The Split Clinic A Prescription for Efficiency in the Gastroenterology Outpatient Clinic. Gastroenterology 146(5): S-555
Low, I.W.; Wong, C.C.; Jayanna, M.; Bryant, R.V.; Schoeman, M.; Holloway, R.H.; Nguyen, N.Q. 2014: Mo1095 Which Is the Most Clinically Useful Risk-Scoring System in Predicting Needs of Intervention and Clinical Outcomes of Upper Gastrointestinal Bleeding?. Gastroenterology 146(5): S-555
Nguyen, N.Q.; Lim, A.H.; Schoeman, M. 2014: Mo1097 Long-Term Outcomes of Direct Percutaneous Endoscopic Jejunostomy: A 10-Year Cohort. Gastroenterology 146(5): S-556
Chong, B.; Richmond, B. 2014: Mo1098 Gastric Electrical Stimulation for Refractory Gastroparesis: Defining Predictors of Response and Redefining What Constitutes a Successful Outcome. Gastroenterology 146(5): S-556
Lopez, K.T.; Theivanayagam, S.; Asombang, A.W.; Matteson-Kome, M.L.; Bechtold, M.L. 2014: Mo1099 Do Gastroenterologists Get It Right? a Retrospective Analysis of Airway Assessment of Patients Undergoing Endoscopic Procedures. Gastroenterology 146(5): S-556
Lim, H.C.; Moon, B.S. 2014: Mo1101 Comparison of the Efficacy of 10 Day-Triple Therapy-Based, Bismuth-Containing Quadruple Therapy With Sequential Therapy for First-Line Therapy of Helicobacter pylori. Gastroenterology 146(5): S-557
Choi, M.-G.; Lee, J.-Y.; Lim, C.-H.; Kim, J.S.; Park, J.M.; Lee, I.S.; Kim, S.W. 2014: Mo1102 Helicobacter pylori Eradication According To23s Ribosomal Rna Point Mutations. Gastroenterology 146(5): S-557
Rodriguez, E.A.; Lopez, M.A.; Donath, E.; Sussman, D.A. 2014: Mo1103 Eradication and Adherence Rates Among Helicobacter pylori Regimens -A Network Meta-Analysis. Gastroenterology 146(5): S-557
Mahady, S.E.; Schlub, T.E.; Bero, L.; George, J.; Craig, J. 2014: Mo1105 Side Effects Are Side Issues: Completeness of Reporting of Harms Among Systematic Reviews in Gastroenterology. Gastroenterology 146(5): S-558
Draper, K.; Huang, R.J.; Gerson, L.B. 2014: Mo1106 Gastrointestinal Bleeding in Patients With Continuous-Flow Left-Ventricular Assist Devices: a Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-558
Phoa, K.Y.N.; Rosmolen, W.; Weusten, B.L.; Bisschops, R.; Schoon, E.J.; Ragunath, K.; Fullarton, G.; Pietro, M.di; Ravi, N.; Visser, M.; Offerhaus, J.; Seldenrijk, C.A.; Meijer, S.L.; Ten Kate, F.T.; Tijssen, J. 2014: Mo1108 Cost-Effectiveness Analysis of Radiofrequency Ablation for Barrett's Esophagus With Low-Grade Dysplasia: Results From a Randomized Controlled Trial (Surf). Gastroenterology 146(5): S-559
Yuhara, H.; Nakamura, J.; Nishina, R.; Tsukune, Y.; Uchida, T.; Koike, J.; Igarashi, M.; Suzuki, T.; Mine, T. 2014: Mo1109 Antithrombotic Agents and Bleeding Risk After Endoscopic Submucosal Dissection in Patients With Gastric Neoplasms: A Meta-Analysis. Gastroenterology 146(5): S-559
Saligram, S.; Hall, M.; Vennalaganti, P.; Seewald, S.; Repici, A.; Parasa, S.; Gupta, N.; Sharma, P. 2014: Mo1110 Efficacy of Multimodality Endoscopic Eradication Therapy in the Treatment of Barrett's Esophagus (Be): A Systematic Review and Meta-Analysis. Gastroenterology 146(5): S-559
Shakhatreh, M.H.; Duan, Z.; Kramer, J.R.; Naik, A.; Helm, A.; Hinojosa-Lindsey, M.; Chen, G.; El-Sera, H. 2014: Mo1113 The Risk of Esophageal Adenocarcinoma in Us Veterans With Barrett's Esophagus; A Retrospective National Cohort Study. Gastroenterology 146(5): S-560
Vanga, R.R.; Castillo, N.E.; Bonder, A.; Theethira, T.G.; Villafuerte-Galvez, J.A.; Kabbani, T.A.; Mukherjee, R.; Dennis, M.; Hansen, J.; Kelly, C.P.; Leffler, D. 2014: Mo1114 The Liver in Celiac Disease and Effect of the Gluten Free Diet. Gastroenterology 146(5): S-560
Malmi, H.; Kautiainen, H.; Färkkilä, M.A. 2014: Mo1115 Increasing Incidence of Unspecified Gastrointestinal Bleeding Is Associated With Markedly Increased Long-Term Mortality. Gastroenterology 146(5): S-560
Nguyen, T.; Khalaf, N.; Ramsey, D.J.; El-Serag, H. 2014: Mo1116 Statin Use May Decrease the Risk of Barrett's Esophagus: A Case-Control Study of U.S. Veterans. Gastroenterology 146(5): S-561
Allen, R.L.; Rugge, M.; Genta, R.M. 2014: Mo1117 Atrophic Autoimmune Gastritis: Manifestations and Clinicopathologic Associations in a Large United States Cohort. Gastroenterology 146(5): S-561
Khalaf, N.; Nguyen, T.; Ramsey, D.J.; El-Serag, H. 2014: Mo1118 Non-Steroidal Anti-Inflammatory Drugs and the Risk of Barrett's Esophagus. Gastroenterology 146(5): S-561
Tanaka, Y.; Hidaka, H.; Yamaguchi, D.; Sakata, Y.; Shimoda, R.; Sakata, H.; Iwakiri, R.; Fujimoto, K. 2014: Mo1120 Relatively High Prevalence of Endoscopic Reflux Esophagitis in Young Healthy Japanese Volunteers. Gastroenterology 146(5): S-562
Gubatan, J.; Staller, K.; Kuo, B. 2014: Mo1121 Cannabinoid Use Decreases Ed Utilization in a Gastroenterology Clinic Population. Gastroenterology 146(5): S-562
Gubatan, J.; Staller, K.; Kuo, B. 2014: Mo1122 Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders. Gastroenterology 146(5): S-562
Bjornsson, E.; Gretarsdottir, H.M. 2014: Mo1123 Etiology and Management of Esophageal Food Bolus Impaction: A Population Based Study. Gastroenterology 146(5): S-562
Hidaka, H.; Tanaka, Y.; Yamaguchi, D.; Sakata, Y.; Shimoda, R.; Sakata, H.; Iwakiri, R.; Fujimoto, K. 2014: Mo1124 Retrospective Analysis of Upper Gastrointestinal Bleeding in 11,919 Patients Who Were Prescribed Antithrombotics in Japan. Gastroenterology 146(5): S-563
Thaker, A.M.; Feuerstein, J.; Sengupta, N.; Ketwaroo, G.A.; Leffler, D. 2014: Mo1125 A Prospective Analysis of the Glasgow-Blatchford Score as a Predictor of Length of Hospital Stay for Upper Gastrointestinal Bleeding. Gastroenterology 146(5): S-563
Rendon, R.F.; Avendaño-Reyes, M.J.; Vazquez-Elizondo, G. 2014: Mo1127 Regurgitation in Patients With Gastro-Esophageal Reflux Disease Is Frequently Associated With Dyspepsia Symptoms and Correlates With the Intensity of Heartburn. Gastroenterology 146(5): S-564
Kamada, K.; Tokioka, Y.; Takaaki, J.; Yagi, N.; Naito, Y.; Yoshida, N.; Itoh, Y. 2014: Mo1128 Association Between Barrett's Esophagus, Reflux Esophagitis and Metabolic Syndrome. Gastroenterology 146(5): S-564
Baker, J.; Chey, W.D.; Kao, J.Y.; Saad, R.J. 2014: Mo1129 The Impact of Helicobacter pylori Status Following a Course of Eradication Therapy on Common Gastrointestinal Symptoms. Gastroenterology 146(5): S-564
Rosmolen, W.; Phoa, K.Y.N.; Nieuwkerk, P.; Weusten, B.L.; Bisschops, R.; Schoon, E.J.; Sprangers, M.A.; Bergman, J.J. 2014: Mo1130 Impact of Ablation vs. Surveillance on Quality of Life and Illness Perception in Patients With Barrett's Esophagus Containing Low-Grade Dysplasia: A Multi-Center Randomized Controlled Trial. Gastroenterology 146(5): S-564
Sengupta, N.; Feuerstein, J.D.; Tapper, E.B.; Thaker, A.M.; Ketwaroo, G.A.; Leffler, D. 2014: Mo1132 A Prospective Analysis of the Rates and Predictors of Readmissions Following Hospitalization for Gastrointestinal Bleeding. Gastroenterology 146(5): S-565
Camargo, M.C.; Michel, A.; Kim, K.-M.; Matsuo, K.; Liao, L.M.; Torres, J.; Zabaleta, J.; Gulley, M.L.; Yatabe, Y.; Alvarado-Cabrero, I.; Lissowska, J.; Kim, S.; Pawlita, M.; Rabkin, C.S. 2014: Mo1133 Anti-Viral Antibodies in Epstein-Barr Virus (Ebv) Positive and Negative Gastric Cancer. Gastroenterology 146(5): S-566
Protano, M.-A.; Xu, H.; Wang, G.; Polydorides, A.D.; Dawsey, S.M.; Cui, J.; Xue, L.; Zhang, F.; Quang, T.; Pierce, M.; Shin, D.; Bhutani, M.S.; Lee, M.H.; Parikh, N.; Hur, C. 2014: Mo1134 Accuracy of a High Resolution, Low-Cost Microendoscope for the Early Detection of Esophageal Squamous Cell Neoplasia: a Prospective, International, Multicenter Trial. Gastroenterology 146(5): S-566
Rifkin, S.; Shrubsole, M.J.; Cai, Q.; Smalley, W.E.; Ness, R.; Swift, L.L.; Zheng, W.; Murff, H. 2014: Mo1138 Erythrocyte Membrane Phospholipid Fatty Acid Concentrations and Colorectal Adenomas: A Case Control in Tennessee. Gastroenterology 146(5): S-568
Zheng, X.E. 2014: Mo1139 Do Survival Outcomes Differ Between and Within Left and Right-Sided Colon Cancers? A Population-Based Study. Gastroenterology 146(5): S-568
Blake, P.A.; Thomas, C.E.; Karran, A.; Chan, D.S.; Blackshaw, G.; Clark, G.W.; Havard, T.; Escofet, X.; Roberts, A.; Lewis, W.G. 2014: Mo1140 Prognostic Significance of Deprivation in Upper Gastrointestinal Cancer. Gastroenterology 146(5): S-568
Kohoutova, D.; Smajs, D.; Cihak, M.; Bures, J. 2014: Mo1141 Association of Right-Sided Colorectal Cancer and Ulcerative Colitis With Escherichia coli Strains of Phylogenetic Group B2, Which Harbour Genotoxic Pks Island. Gastroenterology 146(5): S-568
Maruoka, D.; Arai, M.; Okimoto, K.; Minemura, S.; Matsumura, T.; Nakagawa, T.; Katsuno, T.; Yokosuka, O. 2014: Mo1143 Sporadic Non-Ampullary Duodenal Adenoma/Carcinoma Is Associated With Not Only Colon Adenoma/Carcinoma but Also Gastric Cancer. Gastroenterology 146(5): S-569
Fang, C.; Sun, Q.; Shi, J.; Zhang, Y.; Yu, H.; Zou, X.; Huang, Q. 2014: Mo1144 Risk Factors of Proximal Gastric Carcinoma in 340 Chinese Patients. Gastroenterology 146(5): S-569
Malieckal, A.; Izzy, M.J.; Changela, K.; Bhalani, K.; Lane, D.; Kargoli, F.; Buddhavarapu, V.S.; Malieckal, G.; Momeni, M.; Anand, S. 2014: Mo1145 Prevalence of Intestinal Metaplasia and Gastric Cancer in a Minority Population Registry of Outcomes of Upper Endoscopy in Minorities (Roum): A Hospital-Based Registry. Gastroenterology 146(5): S-569
Martínez, M.G.; Dorsey, F.Z.; Labra, A.A.; Carmona, A.; Blanco, C.I. 2014: Mo1146 Clinicopathological Characteristics of Gastric Adenocarcinoma in Mexican Patients: Ten Years Experience in a Tertiary Referral Center. Gastroenterology 146(5): S-569
Cheng, M.; Coope, G.S. 2014: Mo1147 Longitudinal Follow-Up of Proximal Hyperplastic or Serrated Polyps. Gastroenterology 146(5): S-570
Cooper, G.S.; Kou, T.D.; Schluchter, M.D. 2014: Mo1148 Sociodemographic Disparities in Colorectal Cancer Screening Use Among Medicare Beneficiaries. Gastroenterology 146(5): S-570
Kim, N.; Choi, Y.J.; Chang, H.; Shin, C.M.; Park, Y.S.; Lee, D.H. 2014: Mo1149 Influence of (Tgfb1 C-509T) Polymorphism on Gastric Cancer Risk Associated With Tgf-1 Expression in the Gastric Mucosa. Gastroenterology 146(5): S-570
Morgan, D.R.; Dominguez, R.L.; Camargo, M.C.; Martinez-Reina, E.; Rabkin, C.S.; Wilson, K.T. 2014: Mo1150 Gastric Cancer Association With Odc1 Gene Polymorphism in a High Risk Population of Central America, With Potential Implications for Chemoprevention. Gastroenterology 146(5): S-570
Basta, Y.; Tytgat, K.M.; Greuter, H.H.; Klinkenbij, J.H. 2014: Mo1151 Blueprint for a Multidisciplinary Fast Track Oncology Clinic; the Road to Success. Gastroenterology 146(5): S-570
Antaki, F.; Farhana, L.; Miller, L.A.; Anees, M.R.; Yu, Y.; Nangia-Makker, P.; Levi, E.; Majumdar, A.P. 2014: Mo1152 The Role of Cancer Stem Cells in the Increased Risk of Colorectal Cancer in African-Americans. Gastroenterology 146(5): S-571
Ravella, S.; Xicola, R.M.; Pibiri, F.; Carroll, T.; Sandler, R.S.; Kupfer, S.; Ellis, N.A.; Llor, X. 2014: Mo1153 Association of a Variant in Fads2 the Gene Encoding the Polyunsaturated Fatty Acid Metabolizing Enzyme Fads2 With Colorectal Cancer in African Americans. Gastroenterology 146(5): S-571
Nam, S.-J.; Chun, H.J.; Lee, D.; Song, Y.; Kim, S.H.; Lee, J.M.; Lee, J.S.; Choi, H.S.; Kim, E.S.; Keum, B.; Jeen, Y.T.; Lee, H.; Kim, C.D.; Ryu, H.S.; Lee, S.W. 2014: Mo1154 3D Reconstruction of Stomach Using Endoscopy for Endoluminal Bariatric Treatment. Gastroenterology 146(5): S-571
Kumar, N.; Thompson, C.C. 2014: Mo1156 The Pursestring Technique for Endoscopic Transoral Outlet Reduction. Gastroenterology 146(5): S-572
Paolini, B.; Del Ciondolo, I.; Lapini, E.; Ceccarelli, L.; Gennai, K.; Vincenzi, M.; Tirone, A.; Carbone, S.F.; Bellini, C.; Vuolo, G. 2014: Mo1157 Effects of Laparoscopic Sleeve Gastrectomy on Gastric Emptying Time and Residual Antrum Peristalsis Assessed Through Magnetic Resonance. Gastroenterology 146(5): S-572
Breynaert, C.M.; Dresselaers, T.; Peeters, R.; Roebben, I.; Van Steen, K.; Vanuytsel, T.; Ballet, V.; Ferrante, M.; Vermeire, S.; Rutgeerts, P.J.; Himmelreich, U.; Dymarkowski, S.; Vanbeckevoort, D.; Van Assche, G.A. 2014: Mo1158 Mri T2 Relaxometry to Image Fibrosis in Patients With Crohn's Disease. Gastroenterology 146(5): S-572
Lu, C.; Jacob, D.A.; Afshar, E.E.; Kellar, A.; Kaplan, G.; Ghosh, S.; Wilson, A.; Leung, Y.; Panaccione, R.; Novak, K.L. 2014: Mo1160 Accuracy of Gastroenterologist Performed Point of Care Transabdominal Ultrasound in Detection of Crohn's Disease Activity. Gastroenterology 146(5): S-573
Jacob, D.A.; Afshar, E.E.; Lu, C.; Wilson, A.; Panaccione, R.; Kaplan, G.; Novak, K.L. 2014: Mo1161 Accuracy of Point of Care Ultrasound Performed by Gastroenterologists in Patients Investigated for Symptoms of Diarrhea and Abdominal Pain. Gastroenterology 146(5): S-573
Lopes, S.; Baldaque-Silva, F.; Pereira, P.; Vilas-Boas, F.; Ribeiro, A.; Endoscopic, G.M. 2014: Mo1163 Endoprothesis for an Innovative Treatment of Walled-off Pancreatic Necrosis: The Diabolo Experience. Gastroenterology 146(5): S-574
Scheiman, J.; Wilson, R.H.; Chandra, M.; Simeone, D.M.; Taylor, J.; Lee, O.E.; Lloyd, W.R.; Lee, S.Y.; Mycek, M.-A. 2014: Mo1164 Optical Spectroscopy Distinguishes Pancreatic Cancer from Non-Malignant Pancreatic Tissues. Gastroenterology 146(5): S-574
Sheikh, U.A.; Kadir, S.; Iqbal, J. 2014: Mo1166 The Management and Assessment of Incidental Pancreatic Cysts on Computer Tomography in a Non-Pancreatic Centre. Gastroenterology 146(5): S-575
Giovannini, M.; Caillol, F.; Lucidarme, D.; Pujol, B.; Poizat, F.; Monges, G.M.; Filoche, B.; Napoleon, B. 2014: Mo1167 Needle-Based Confocal Laser Endomicroscopy (nCle) for the Diagnosis of Pancreatic Masses: Preliminary Criteria (Contact Study). Gastroenterology 146(5): S-575
Chuang, M.; Zarghom, O.; Mgaieth, S.E.; Mitchell, B.; Fanning, S.B. 2014: Mo1170 Endoscopic Ultrasound-Guided Fine Needle Aspiration (Eus-Fna): Experience of a Regional Centre in Australia. Gastroenterology 146(5): S-576
Li, J.; Xie, Y.; Yuan, F.; Song, B.; Tang, C. 2014: Mo1172 Effect of Long-Term Alcohol Intake on Pancreatic Fat Content in Humans -Characteristics of Alcohol-Induced Pancreatic Steatosis. Gastroenterology 146(5): S-577
Rubin, D.T.; Sandborn, W.; Bosworth, B.P.; Zakko, S.F.; Gordon, G.L.; Rolleri, R.L.; Golden, P.; Barrett, A.; Bortey, E.; Forbes, W.P. 2014: Mo1173 Safety Analysis of Budesonide Foam for Inducing Remission in Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis: Data From Two Randomized, Placebo-Controlled Trials. Gastroenterology 146(5): S-577
Miranda-Bautista, J.; de Gracia, C.; López-Ibáñez, M.; Barrientos, M.; Marin-Jimenez, I.; Díaz-Redondo, A.; Menchen, L. 2014: Mo1174 Lipid Profile in Inflammatory Bowel Disease Patients on Anti-Tnf Therapy. Gastroenterology 146(5): S-577
Jauregui-Amezaga, A.; Rovira, M.; Pinó-Donnay, S.; Marín, P.J.; Feu, F.; Elizalde, J.I.; Fernández-Avilés, F.; Martínez, C.; Rosiñol, L.; Suárez-Lledó, M.; Masamunt, M.C.; Ramírez, A.M.; Gallego, M.; Ordás, I.; Panes, J. 2014: Mo1176 Autologous Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Feasibility and Toxicity. Gastroenterology 146(5): S-578
Soh, J.S.; Won, C.H.; Kim, K.-J.; Yun, W.jin; Park, S.H.; Yang, D.-H.; Ye, B.D.; Byeon, J.-S.; Myung, S.-J.; Yang, S.-K. 2014: Mo1177 Combined Use of Azathioprine/6-Mercaptopurine Are Associated With Decreased Risk of Anti-Tnf Induced Skin Lesions. Gastroenterology 146(5): S-578
Ortega, T.L.; Vermeire, S.; Ballet, V.; Rutgeerts, P.J.; Van Assche, G.A.; Ferrante, M. 2014: Mo1179 Efficacy and Safety of Anti-Tnf Therapy in Elderly Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-579
Cole, E.B.; Abbas, A.; Koleva, Y.N.; Khan, N. 2014: Mo1180 Sustained Leukopenia Not Observed in Patients With Thiopurine-Associated Lymphoma and Ulcerative Colitis. Gastroenterology 146(5): S-579
Hou, J.; Ahmed, N.; Malaty, H.M.; Abraham, B.; Sellin, J.H. 2014: Mo1182 Medications Associated with Complications among Elderly Patients with Inflammatory Bowel Disease. Gastroenterology 146(5): S-580
Bellaguarda, E.; Pekow, J.; Cohen, R.D.; Rubin, D.T.; Sakuraba, A. 2014: Mo1183 Prevalence of Serum Jc Virus Antibody in Refractory Crohn's Disease Patients. Gastroenterology 146(5): S-580
Stein, A.C.; Huo, D.; Rubin, D.T. 2014: Mo1184 Meta-Analysis of Thiopurine Exposure and Risk of Colonic Neoplasia in Inflammatory Bowel Disease. Gastroenterology 146(5): S-580
Kent, A.; Stephens, H.G.; Catuneanu, A.; Siddhanathi, P.; Brooks, J.A.; Travis, S.; Uhlig, H.; Keshav, S. 2014: Mo1186 Intolerance to Treatment for Inflammatory Bowel Disease (Ibd) in Over 1,800 Patients in the Oxford Ibd Cohort. Gastroenterology 146(5): S-581
Kahn, S.A.; Goeppinger, S.R.; Vaughn, B.P.; Moss, A.C.; Rubin, D.T. 2014: Mo1187 Tolerability of Colonoscopic Fecal Microbiota Transplantation in Ibd. Gastroenterology 146(5): S-581
Cheung, M.; Khan, S.; Akerman, M.; Hung, C.K.; Vennard, K.; Sulta, K. 2014: Mo1188 Fistulizing Disease is the Strongest Predictor of Opiate Use in Patients With Crohn's Disease (Cd). Gastroenterology 146(5): S-581
Bahi, M.; Gray, A.; Walmsley, R.S.; Schultz, M. 2014: Mo1189 The Effect of Immunomodulator Therapy on Non-Melanomatous Skin Cancer Incidence in a Cohort of Ibd Patients in New Zealand. Gastroenterology 146(5): S-581
Broekman, M.M.; Roelofs, H.M.; Hoentjen, F.; Peters, W.H.; Wanten, G.; DeJong, D.J. 2014: Mo1190 Co-Administration of 5-Aminosalicylic Acid to 6-Mercaptopurine Reduces In Vitro Hepatoxicity. Gastroenterology 146(5): S-582
Al-Taweel, T.; Pai, M.; Strohl, M.; Bessissow, T.; Bitton, A.; Seidman, E.G.; Afif, W. 2014: Mo1191 A Pilot Study of Optimal Screening for Latent Tuberculosis in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-582
Lolli, E.; Saraceno, R.; Ventura, A.; Condino, G.; Onali, S.; Scarozza, P.; Capanna, A.; Ascolani, M.; Petruzziello, C.; Calabrese, E.; Chimenti, S.; Pallone, F.; Biancone, L. 2014: Mo1192 Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study. Gastroenterology 146(5): S-582
Scaldaferri, F.; Lopetuso, L.R.; Petito, V.; Gerardi, V.; Cufino, V.; Arena, V.; Stigliano, E.; Caristo, M.E.; Poscia, A.; Franceschi, F.; Cammarota, G.; Papa, A.; Sgambato, A.; Gasbarrini, A. 2014: Mo1193 Infliximab Is Not Increasing Colonic Cancer Risk in Experimental Ibd. Gastroenterology 146(5): S-582
Araki, T.; Okita, Y.; Fujikawa, H.; Toiyama, Y.; Tanaka, K.; Inoue, Y.; Uchida, K.; Mohri, Y.; Kusunoki, M. 2014: Mo1195 Impact of Perioperative Serum Infliximab Concentration on Surgical Site Infection in Patients With Inflammatory Bowel Diseases. Gastroenterology 146(5): S-583
Broekman, M.M.; Roelofs, H.M.; Hoentjen, F.; Peters, W.H.; Wanten, G.; DeJong, D.J. 2014: Mo1196 In Vitro Pancreas Toxicity by Azathioprine but Not 6-Mercaptopurine. Gastroenterology 146(5): S-583
Nardelli, A.; Chauhan, U.K.; Marshall, J.K.; Halder, S.L.; Tse, F.; Lima, H.; Pinto-Sanchez, M.I.; Moayyedi, P.; Bercik, P.; Armstrong, D. 2014: Mo1197 Dermatological Complications of Anti-Tnf-a Therapy in Crohn's Disease. Gastroenterology 146(5): S-583
Gadani, A.; George, L.; Jambaulikar, G.D.; Cross, R.; Ghazi, L.J. 2014: Mo1199 Characteristics and Outcome of Psoriasiform Skin Lesions Caused by Anti-Tnf Agents Used for the Treatment of Inflammatory Bowel Disease. Gastroenterology 146(5): S-584
Reingold, L.J.; Rittie, L.; Hurlburt, J.N.; Schmiedlin-Ren, P.; Prax, P.M.; Owens, S.R.; Zimmermann, E. 2014: Mo1200 Effect of Pegylated Murinized Rabbit Anti-Mouse Tnf on Incisional Muscle and Skin After Laparotomy in Experimental Crohn's Disease. Gastroenterology 146(5): S-584
Murdoch, T.B.; Stinton, L.; Panaccione, R.; Kaplan, G.; Ghosh, S.; Anderson, C.A.; Eksteen, B. 2014: Mo1202 Characterization of Anti-Tumor Necrosis Factor Agent-Induced Lupus in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-585
González, R.; Pereyra, L.; Omodeo, M.; Gómez, E.J.; Panigadi, G.N.; Mella, J.M.; Fischer, C.; Vizcaíno, B.; Hadad, A.R.; Bun, M.; Canelas, A.; Rotholtz, N.A.; Cimmino, D.G.; Pedreira, S.C.; Boerr, L.A. 2014: Mo1203 Clinical Risk Factors for Complications After Laparoscopic Ileal-Pouch-Anal Anastomosis in Patients With Ulcerative Colitis. Gastroenterology 146(5): S-585
Zelinkova, Z.; Zakuciova, M.; Gombosova, L.; Veseliny, E.; Horakova, M.; Lietava, P.; Palencikova, K.; Kadleckova, B.; Gregus, M.; Gregusova, K.; Pav, I.; Hlavaty, T.; Koller, T.; Toth, J.; Hlista, M. 2014: Mo1204 Screening for Latent Tuberculosis Is Effective but Does Not Fully Protect Against Tuberculosis Reactivation During antiTnf Treatment in Areas With High Background Incidence of Tuberculosis. Gastroenterology 146(5): S-585
Rutgeerts, P.J.; Reinisch, W.; Sandborn, W.; D'Haens, G.R.; Colombel, J.-F.; Petersson, J.; Zhou, Q.; Thakkar, R. 2014: Mo1205 Evaluation of Site Versus Central Assessment of Endoscopies in Crohn's Disease: Comparison Using Data From Extend. Gastroenterology 146(5): S-585
Reinisch, W. 2014: Mo1206 The Effect of Iron Isomaltoside 1000 on the Association Between Hematopoietic Parameters and Platelets in Subjects With Inflammatory Bowel Disease and Iron Deficiency Anemia. Gastroenterology 146(5): S-586
Reinisch, W.; Panes, J.; Page, K.; Khurana, S.K.; Moorehead, T.M.; Hua, F.; Comer, G.M.; Hinz, M.; Cataldi, F. 2014: Mo1207 Discrepancy Between Fecal Biomarkers and Their Intestinal Gene Expression in Ulcerative Colitis: Results From an Anti-Il-13 Antibody Study. Gastroenterology 146(5): S-586
deBruyn, J.; Fonseca, K.; Van Woudenberg, M.; Ghosh, S.; Gasia, M.F.; Ueno, A.; Panaccione, R.; Kaplan, G.; Seow, C.H.; Wrobel, I.T. 2014: Mo1208 Timing of Influenza Vaccination Relative to Maintenance Infliximab Infusion in Inflammatory Bowel Disease Patients Does Not Impact Immune Response or Safety of Vaccine. Gastroenterology 146(5): S-586
Münch, A.; Bohr, J.; Miehlke, S.; Benoni, C.; Olesen, M.; Ost, A.; Hellström, P.M.; Hertervig, E.; Armerding, P.; Björk, J.A.; Lapidus, A.B.; Bonderup, O.K.; Avnstrom, S.; Rössle, M.; Mueller, R. 2014: Mo1209 Clinical Remisison and Quality of Life in Collagenous Colitis: A One-Year, Randomised, Placebo-Controlled Study With Low-Dose Budesonide (Buc-63/ Coc). Gastroenterology 146(5): S-586
Pedersen, N.; Ankersen, D.V.; Felding, M.; Vegh, Z.; Burisch, J.; Abstract, P.M. 2014: Mo1210 Low Fodmap Diet Reduces Irritable Bowel Symptoms and Improves Quality of Life in Patients With Inflammatory Bowel Disease in a Randomized Controlled Trial. Gastroenterology 146(5): S-587
Israeli, E.; Goldin, E.; Fishman, S.; Konikoff, F.M.; Lavy, A.; Chowers, Y.; Melzer, E.; Lahat, A.; Mahamid, M.; Shirin, H.; Nussinson, E.; Segol, O.; Ya'acov, A.B.; Shabat, Y.; Ilan, Y. 2014: Mo1211 Oral Administration of Non-Absorbable Delayed Release 6-Mercaptopurine is Locally Active in the Gut, Exerts a Systemic Immune Effect and Alleviates Crohn's Disease With Low Rate of Side Effects: Results of Double Blind Phase Ii Clinical Trial. Gastroenterology 146(5): S-587
Gibson, P.R.; Reinisch, W.; Sandborn, W.; Feagan, B.G.; Marano, C.W.; Strauss, R.; Johanns, J.; Zhang, H.; Padgett, L.; Colombel, J.-F.; Collins, J.; Rutgeerts, P.J. 2014: Mo1214 Long-Term Safety and Efficacy of Golimumab in Patients With Moderately to Severely Active Ulcerative Colitis: Results From the Pursuit-Sc Maintenance Study Extension. Gastroenterology 146(5): S-587
Adedokun, O.J.; Xu, Z.; Marano, C.W.; Strauss, R.; Zhang, H.; Johanns, J.; Zhou, H.; Davis, H.M.; Liao, S.; Colombel, J.-F.; Reinisch, W.; Feagan, B.G.; Rutgeerts, P.J.; Gibson, P.R.; Sandborn, W. 2014: Mo1215 Serum Golimumab Exposure and the Incidence of Selected Safety Events in Patients With Ulcerative Colitis Following Treatment With Golimumab: An Exploratory Analysis of the Pursuit Study Data. Gastroenterology 146(5): S-588
Kucharzik, T.; Lemmnitz, G.; Abels, C.; Maaser, C. 2014: Mo1216 Tripeptide Kdpt Accelerates Disease Remission in Patients With Mild to Moderate Active Ulcerative Colitis. Gastroenterology 146(5): S-588
Sandborn, W.J.; Feagan, B.G.; Reinisch, W.; Smyth, M.D.; Xu, J.; Parikh, A.; Fox, I. 2014: Mo1217 Effects of Continued Vedolizumab Therapy for Crohn's Disease in Week 6 Induction Therapy Nonresponders. Gastroenterology 146(5): S-588
Sandborn, W.; Wolf, D.C.; Colombel, J.-F.; Panes, J.; Eichner, S.; Iezzi, A.; Zhou, Q.; Robinson, A.; Castillo, M.; Thakkar, R. 2014: Mo1219 Adalimumab Achieves Efficacy in Mucosal Healing Regardless of Baseline Disease Severity in Patients With Crohn's Disease: Data From Extend. Gastroenterology 146(5): S-589
Colombel, J.-F.; Sandborn, W.; Reinisch, W.; Robinson, A.; Wang, W.; Huang, B.; Lazar, A.; Thakkar, R. 2014: Mo1220 Patient-Reported Symptom Measures Differ in Their Association With Mucosal Healing in Adults With Moderately to Severely Active Ulcerative Colitis: Results From Ultra 1 and 2. Gastroenterology 146(5): S-589
Feagan, B.G.; Sandborn, W.; Smyth, M.D.; Sankoh, S.; Parikh, A.; Fox, I. 2014: Mo1222 Effects of Continued Vedolizumab Therapy for Ulcerative Colitis in Week 6 Induction Therapy Nonresponders. Gastroenterology 146(5): S-590
Feagan, B.G.; Colombel, J.-F.; Rubin, D.T.; Mody, R.; Sankoh, S.; Lasch, K. 2014: Mo1223 Health-Related Quality of Life in Patients With Ulcerative Colitis After Treatment With Vedolizumab: Results From the Gemini 1 Study. Gastroenterology 146(5): S-590
Bosworth, B.; Sandborn, W.; Zakko, S.F.; Gordon, G.L.; Rubin, D.T.; Yu, J.; Barrett, A.; Paterson, C.; Forbes, W.P. 2014: Mo1224 Budesonide Foam for the Treatment of Patients With Mild-to-Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis: Subgroup Analyses of Two Randomized, Placebo-Controlled, Phase 3 Clinical Trials. Gastroenterology 146(5): S-590
Dirks, N.L.; Rosario, M.; Gastonguay, M.R.; Fox, I.; Milton, A. 2014: Mo1225 Population Pharmacokinetic Modeling of Vedolizumab in Patients With Ulcerative Colitis or Crohn's Disease. Gastroenterology 146(5): S-591
Indriolo, A.; Ravelli, P. 2014: Mo1226 Comparison Between Liposomial Iron and Ferrous Sulfate in Patients With Iron Deficiency Anemia and Inflammatory Bowel Disease. A Pilot Controlled Study. Gastroenterology 146(5): S-591
Petersen, A.M.; Mirsepasi, H.; Halkjaer, S.; Mortensen, E.M.; Nordgaard-Lassen, I.; Krogfelt, K.A. 2014: Mo1227 Ciprofloxacin and Probiotic Escherichia coli Nissle As Add-on Treatment in Active Ulcerative Colitis; a Double-Blinded Randomized Placebo Controlled Clinical Trial. Gastroenterology 146(5): S-591
French, J.; Rosario, M.; Dirks, N.L.; Milton, A.; Fox, I.; Gastonguay, M.R. 2014: Mo1229 Exposure-Response Relationship of Vedolizumab Treatment in Adults With Ulcerative Colitis. Gastroenterology 146(5): S-592
Ferrante, M.; Papamichael, K.; Duricova, D..; D'Haens, G.R.; Vermeire, S.; Archavlis, E.J.; Rutgeerts, P.J.; Bortlik, M.; Mantzaris, G.J.; Van Assche, G.A. 2014: Mo1230 Systematic Versus Endoscopy-Driven Treatment With Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence: Interim Results From a Randomized, Multicenter Trial. Gastroenterology 146(5): S-592
French, J.; Rosario, M.; Dirks, N.L.; Milton, A.; Fox, I.; Gastonguay, M.R. 2014: Mo1231 Vedolizumab Exposure-Response Relationship During Induction Therapy in Adults With Crohn's Disease. Gastroenterology 146(5): S-592-S-593
Liu, Y.; Reichmann, W.; Macaulay, D.; Wang, S.; Skup, M.; Mulani, P.; Chao, J. 2014: Mo1232 Indirect Comparison of Adalimumab, Infliximab, and Golimumab in Ulcerative Colitis: Cost Per Remitter Analysis. Gastroenterology 146(5): S-593
Hughes, P.A.; Mikocka-Walus, A.A.; Moretta, M.; Pilichiewicz, A.N.; Bampton, P.A.; Andrews, J.M. 2014: Mo1233 Cognitive Behavioural Therapy (Cbt) Influences Innate and Adaptive Inflammatory Responsiveness in Ibd Patients With Clinical Remission Sustained Over 6 Months: A Randomised Control Trial. Gastroenterology 146(5): S-593
Vanhoutte, F.P.; Namour, F.S.; Dupont, S.; Pizzonero, M.; DeVos, S.; Sanière, L.; van der Aa, A.; Beetens, J.; van 't Klooster, G. 2014: Mo1234 The Ffa2 Antagonist Glpg0974: A Promising Approach to Treat Neutrophil-Driven Inflammation. Gastroenterology 146(5): S-593
Iwasaki, T.; Komoike, N.; Kato, T.; Sawada, R.; Ide, D.; Mitsunaga, M.; Saruta, M.; Arihiro, S.; Matsuoka, M.; Tajiri, H. 2014: Mo1235 Photodynamic Diagnosis of Endoscopically Undetectable Dysplasia in Patients With Ulcerative Colitis by Visualization Following Oral 5-Aminolevulinic Acid Sensitization. Gastroenterology 146(5): S-593
Raffals, L.H.; Bharucha, A.E.; Timmons, L.J.; Pemberton, J.H.; Camilleri, M.; Tremaine, W.J. 2014: Mo1236 Ileal Pouch Anal Anastomosis and Non-Relaxing Pelvic Floor Dysfunction. Gastroenterology 146(5): S-594
Bethge, J.; Ellrichmann, M.; Conrad, C.; Nikolaus, S.; Noth, R.; Schuldt, D.; Zeissig, S.; Schreiber, S. 2014: Mo1237 Pulmonary Involvement in Ibd-Patients and the Effect of Tnf-Alpha-Inhibitors on Pulmonary Function. Gastroenterology 146(5): S-594
Hundal, R.; Gui, X.; Panaccione, R.; Iacucci, M.; Kaplan, G.; Heatherington, J.; Liu, S.; Becker, H.M.; Ueno, A.; Ghosh, S. 2014: Mo1238 Resected Fibrostenotic Intestine From Crohn's Disease Patients Express Significant Tnf in Proliferative Fibroblasts and in Extracellular Matrix. Gastroenterology 146(5): S-594
Hou, J.; Shakhatreh, M.H.; Richardson, P.; Waljee, A.K.; Khan, N.; El-Serag, H. 2014: Mo1239 Dysplasia Detection in Surveillance Colonoscopy in a National Cohort of Veterans With Inflammatory Bowel Disease. Gastroenterology 146(5): S-594
O'Donnell, S.; Borowski, K.; Milgrom, R.; Stempak, J.M.; Eksteen, B.; Kaplan, G.; Silverberg, M.S. 2014: Mo1241 Has the Time to First Abdominal Surgery for Crohn's Disease Reduced With Early Immunosuppressant Therapy?. Gastroenterology 146(5): S-595
Fu, N.; Yan, X.; Haritunians, T.; Targan, S.; Melmed, G.Y.; Vasiliauskas, E.A.; McGovern, D.P. 2014: Mo1242 Genetic, Serological and Clinical Associations in Inflammatory Bowel Disease (Ibd) Patients With Clostridium difficile Infection (Cdi). Gastroenterology 146(5): S-595
Varayil, J.E.; Loftus, E.V.; Prabhu, N.C. 2014: Mo1244 Outcomes of Endoscopic Therapy of Luminal Strictures in Crohn's Disease. Gastroenterology 146(5): S-596
Le, N.H.Q.; Rollet, K.C.; Afif, W.; Bitton, A.; Bessissow, T.; Sebastiani, G. 2014: Mo1245 Impact of Inflammatory Bowel Disease Activity on the Incidence of Non-Alcoholic Fatty Liver Disease: A 7-Year Longitudinal Study. Gastroenterology 146(5): S-596
Yadav, S.; Varayil, J.E.; Kamal, N.; Harmsen, W.S.; Wetter, D.A.; Davis, M.D.P.; Tremaine, W.J.; Colombel, J.-F.; Loftus, E.V. 2014: Mo1246 Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Study. Gastroenterology 146(5): S-596
Fortinsky, K.J.; Kevans, D.; Qiang, J.; Xu, W.; Greenberg, G.R.; Steinhart, A.H.; Cohen, Z.; MacRae, H.M.; Bellolio, F.; Stempak, J.M.; McLeod, R.S.; Silverberg, M.S. 2014: Mo1248 Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease. Gastroenterology 146(5): S-597
Subramaniam, K.; Fallon, K.; Ruut, T.; Mckay, R.; Shadbolt, B.; Ang, S.; Cook, M.; Platten, J.; Pavli, P.; Taupin, D. 2014: Mo1249 The Anti-Tnf Agent Infliximab Reverses Inflammatory Sarcopenia in Crohn's Disease. Gastroenterology 146(5): S-597
Bettenworth, D.; Matthias, R.; Brückner, M.; Martin, J.B.; Lenze, F.; Heinzow, H.; Lügering, A.; Nowacki, T.M. 2014: Mo1250 Cytomegalovirus (Cmv) and Epstein Barr Virus (Ebv) Specific Elispot Assays Detect Frequent Reactivation of Cmv and Ebv in Inflammatory Bowel Disease. Gastroenterology 146(5): S-597
Jimenez, K.; Khare, V.; Evstatiev, R.; Austerlitz, T.; Jambrich, M.; Kulnigg-Dabsch, S.; Strobl, H.; Gasche, C. 2014: Mo1251 Thrombocytosis in an Animal Model of Colitis Is Mediated by Iron Deficiency. Gastroenterology 146(5): S-598
Cheng, A.G.; Oxford, E.; Nguyen, D.D.; Sauk, J.; Yajnik, V.; Friedman, S.; Ananthakrishnan, A.N. 2014: Mo1252 The Impact of Mode of Delivery on Long-Term Outcomes in Patients With Perianal Crohn's Disease. Gastroenterology 146(5): S-598
Drastich, P.; Bajer, L.; Wohl, P.; Benes, M.; Spicak, J. 2014: Mo1253 De Novo Inflammatory Bowel Disease After Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis. Gastroenterology 146(5): S-598
Kamal, N.; Cohen, B.L.; Colombel, J.-F. 2014: Mo1254 Hidradenitis Suppurativa and Inflammatory Bowel Disease: A Challenging Association. Gastroenterology 146(5): S-598
Wiesenthal, M.; Dienethal, A.; Dignass, A.U.; Stein, J. 2014: Mo1255 Diagnostic Accuracy of Zinc Protoporphyrin/Heme Ratio for Screening of Iron Deficiency Anaemia in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-599
Wiesenthal, M.; Hartmann, F.; Iqbal, T.; Dignass, A.U.; Stein, J. 2014: Mo1256 Serum Hepcidin Levels Predict Intestinal Iron Absorption in Ibd Patients. Gastroenterology 146(5): S-599
Fernández-Blanco, I.; Taxonera, C.; Bastida, G.; García-Sánchez, V.; Gómez, R.; Marin-Jimenez, I.; Flores, E.I.; Gisbert, J.P.; Acosta, M.B.; Bermejo, F.; Casanova, M.J.; Saro, C.; Lopez-Serrano, P.; Plaza, R.; Algaba, A. 2014: Mo1257 Outcomes of Surgical Treatment of Entero-Urinary Fistulas in Crohn's Disease. Gastroenterology 146(5): S-599
Iskandar, H.; Vivio, E.; Patel, A.; Sayuk, G.S.; Ciorba, M.A. 2014: Mo1259 Characterization of Sleep Disturbance in Active Crohn's Disease Using Subjective and Objective Measures of Sleep Quality. Gastroenterology 146(5): S-600
Graziani, M.G.; Lukic, I.K.; Cicerone, C. 2014: Mo1260 Long-Term Outcome of Endoscopic Balloon Dilatation in Crohn's Stenosis Is Not Associated to Steroid Intrastricture Injection and to Use of Larger Balloon. Gastroenterology 146(5): S-600
Yanai, H.; Waizbard, A.; Kopylov, U.; Ben-Horin, S.; Lubetsky, A.; Dotan, I. 2014: Mo1261 Thrombosis in Inflammatory Bowel Disease Patients Is Driven by Inflammation Rather Than by Thrombophilia. Gastroenterology 146(5): S-600
Ananthakrishnan, A.N.; Cagan, A.; Gainer, V.S.; Cheng, S.-C.; Cai, T.; Shaw, S.; Szolovits, P.; Karlson, E.W.; Churchill, S.; Murphy, S.N.; Kohane, I.; Liao, K.P. 2014: Mo1263 Higher Plasma Vitamin D is Associated With Reduced Risk of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-601
Kim, Y.S.; Doh, Y.S.; Kim, Y.-H.; Cheon, J.H.; Ye, B.D.; Kim, J.W.; Im, J.P.; Kim, J.S. 2014: Mo1264 The Clinical Characteristics of Crohn's Disease Patients With Free Perforation in Korea. Gastroenterology 146(5): S-601
Have, M.V.; Brakenhoff, L.; Kaptein, A.A.; van der Heijde, D.; Scharloo, M.; van der Meulen –de Jong, A.E.; Veenendaal, R.; Hommes, D.W.; Fidder, H. 2014: Mo1266 Illness Perceptions and Coping Predict Quality of Life and Work Productivity in Ibd Patients With Athropathy: A 12-Month Prospective Study. Gastroenterology 146(5): S-602
Olaisen, M.; Rydning, A.; Martinsen, T.C.; Mjones, P.G.; Nordrum, I.S.; Fossmark, R. 2014: Mo1267 Cytomegalovirus Infection and Postoperative Complications in Patients With Ulcerative Colitis Undergoing Colectomy. Gastroenterology 146(5): S-602
Mizuki, A.; Tatemichi, M.; Nakazawa, A.; Tsukada, N.; Nagata, H.; Kanai, T. 2014: Mo1269 Long-Term Outcome After Conservative and Endoscopic Treatment of Colonic Diverticular Bleeding. Gastroenterology 146(5): S-603
Treeprasertsuk, S.; Phaosawasdi, K.; Thepsuthammarat, K.; Kitsahawong, B.; Chirawatkul, A. 2014: Mo1270 Foodborne Disease-a Significant Burden to Thailand's Universal Health Care System. Gastroenterology 146(5): S-603
Samo, S.; Stobaugh, D.J.; Ehrenpreis, E.D. 2014: Mo1272 Investigation of the Link Between Intestinal Adverse Events and Olmesartan Using the Food and Drug Administration Adverse Event Reporting System. Gastroenterology 146(5): S-604
DeFelice, K.M.; Markovic, S.; Kottschade, L.A.; Finnes, H.D.; Loftus, E.V.; Raffals, L.H. 2014: Mo1273 Ipilimumab-Induced Colitis in Patients With Metastatic Melanoma. Gastroenterology 146(5): S-604
El-Serag, H.; Kanwal, F.; Davila, J.A.; Kramer, J.R.; Richardson, P. 2014: Mo1275 A New Lab Based Algorithm for Hcc Surveillance in Patients With Cirrhosis. Gastroenterology 146(5): S-605
Heinzow, H.; Uphoff, M.-A.; Domagk, D.; Meister, T. 2014: Mo1276 Clinical Predictors to Identify Malignancy in Indeterminate Bile Duct Strictures by Ercp Results of a Cohort Analysis With 1135 Patients. Gastroenterology 146(5): S-605
Gheorghe, L.; Iacob, R.; Vagu, C.D.; Nastase, A.; Iacob, S.; Botea, F.; Herlea, V.; Croitoru, A.E.; Dima, S.; Gheorghe, C.; Popescu, I. 2014: Mo1277 A Predictive Score Using Quantitative Gene Expression of Stem/Liver Progenitor Cells Specific Genes Can Be Used to Identify Patients At Risk for Tumor Recurrence in Curatively Treated Hepatocellular Carcinoma. Gastroenterology 146(5): S-605
Raff, E.; Kakati, D.D.; Shoreibah, M.G.; Bloomer, J.R.; Singal, A.K. 2014: Mo1279 Ct and Mri Scans Are Overused for Hepatocellular Carcinoma Screening in Patients With Cirrhosis. Gastroenterology 146(5): S-606
Gibbons, S.J.; Bernard, C.E.; Zubair, A.S.; Boone, K.L.; Kendrick, M.L.; Shen, K.R.; Sarr, M.G.; Lombardo, K.M.R.; Consortium, G.; Parkman, H.P.; Pasricha, P.J.; Farrugia, G. 2014: Mo1280 Next Generation Sequencing of Gastric Smooth Muscle Rna Identifies Gene Markers for Altered Immune Function and Reduced Cellular Proliferation and Differentiation in Patients With Gastroparesis. Gastroenterology 146(5): S-606
Wang, Y.; Wang, Q.; Lin, L. 2014: Mo1281 Gastric Myopathy Is Involved in Type 2 Diabetic Patients With High Level of Advanced Glycation End Products. Gastroenterology 146(5): S-606
Homko, C.J.; Zamora, L.C.; Duffy, F.N.; Friedenberg, F.K.; Boden, G.H.; Parkman, H.P. 2014: Mo1283 Effect of Dietary Fat and Food Consistency on Gastroparesis Symptoms in Patients With Gastroparesis. Gastroenterology 146(5): S-607
Koch, K.L.; Hasler, W.L.; Parkman, H.P.; Van Natta, M.L.; Abell, T.L.; McCallum, R.W.; Snape, W.J.; Farrugia, G.; Tonascia, J.; Pasricha, P.J.; Hamilton, F.A.; Lee, L.A.; Unalp, A.; Nguyen, L. 2014: Mo1285 Correlations of Liquid Nutrient Meal-Induced Symptpoms With Satiety Test Volumes in Idiopathic Gastroparesis: Relation to Gastric Emptying and Myoelectric Activity. Gastroenterology 146(5): S-608
Barshop, K.; Semler, J.R.; Kuo, B. 2014: Mo1286 Small Bowel Rather Than Gastric Motility Parameters Correlate With Gastroparesis Cardinal Symptoms Index (Gcsi) in Gastroparesis Patients. Gastroenterology 146(5): S-608
Kedar, A.; Abell, T.L.; Bernard, C.E.; Farrugia, G.; Lahr, C.J.; Hasler, W.L.; Koch, K.L.; McCallum, R.W.; Nguyen, L.A.B.; Parkman, H.P.; Pasricha, P.J.; Sarosiek, I.; Snape, W.J.; Unalp, A.; Tonascia, J. 2014: Mo1288 Intra-Operative Electrophysiological and Interstitial Cell of Cajal Findings in Patients With the Symptoms of Gastroparesis. Gastroenterology 146(5): S-609
Revicki, D.A.; Camilleri, M.; Parkman, H.P. 2014: Mo1289 Comparing Gastroparesis Symptom Severity Between Patients With Idiopathic and Diabetic Gastroparesis: The Gcsi-Dd Reliably Assesses Symptoms From Both Diabetic and Idiopathic Gastroparesis. Gastroenterology 146(5): S-609
Roland, B.C.; Ciarleglio, M.; Raja, S.; Semler, J.R.; Pasricha, P.J. 2014: Mo1290 Intrapyloric Pressures (Ipp) Are Elevated in Gastroparesis and Reliably Predict Scintigraphic Meal Emptying. Gastroenterology 146(5): S-609
Hasler, W.L.; Belt, P.; Wilson, L.; McCallum, R.W.; Parkman, H.P.; Koch, K.L.; Abell, T.L.; Pasricha, P.J.; Snape, W.J.; Nguyen, L.A.B.; Sarosiek, I.; Farrugia, G.; Calles-Escandon, J.; Tonascia, J.; Lee, L.A. 2014: Mo1292 Correlation of Fermentable Carbohydrate Consumption With Symptoms and Quality of Life in Patients With Diabetic and Idiopathic Gastroparesis. Gastroenterology 146(5): S-610
Homko, C.J.; Parkman, H.P. 2014: Mo1294 Diabetic Patients' Perceptions Regarding the Impact of Gastroparesis on Diabetes Control. Gastroenterology 146(5): S-611
Hassam, A.; Arasu, S.; Malik, Z.A.; Maurer, A.H.; Parkman, H.P. 2014: Mo1295 Symptoms Following Meal Ingestion During Gastric Emptying Scintigraphy in Patients With Gastroparesis. Gastroenterology 146(5): S-611
Malik, Z.A.; Parkman, H.P. 2014: Mo1297 Symptoms of Nausea and Postprandial Fullness Improve in Gastroparetic Patients Receiving Botulinum Toxin a Injection Into the Pylorus. Gastroenterology 146(5): S-612
Törnblom, H.; Kilincalp, S.; Ringstrom, G.; Simren, M.; Abrahamsson, H. 2014: Mo1298 One-Year Response Rate to Gastric Electrical Stimulation in Patients Selected for Treatment by Temporary Percutaneous Gastric Electrical Stimulation. Gastroenterology 146(5): S-612
Wang, L.; Yakabi, S.; Karasawa, H.; Yakabi, K.; Tache, Y. 2014: Mo1300 Rikkunshito Improves Post-Operative Gastric Ileus and Meal Pattern in Rodents. Gastroenterology 146(5): S-613
Swartz, E.M.; Deiter, G.M.; Holmes, G.M. 2014: Mo1301 Trpv1 Upregulation in Rat Vagal Afferent Neurons Following Experimental Spinal Cord Injury. Gastroenterology 146(5): S-613
Wang, G.; Poscente, M.D.; Filip, D.; Yadid-Pecht, O.; Andrews, C.N.; Mintchev, M.P. 2014: Mo1302 Gastric-Retentive Transcutaneous Intraluminal Impedance Measurement (Tiim): Sham Controlled, Minimally-Invasive Assessment of Gastric Motility in Acute Canine Models. Gastroenterology 146(5): S-613
Bielefeldt, K. 2014: Mo1304 Time Trends in Gastroparesis Treatment. Gastroenterology 146(5): S-614
Saadi, M.; Sunny, J.; Torabi, A.; Davis, B.R.; Sarosiek, I.; McCallum, R.W. 2014: Mo1305 Histological Evidence of Inflammatory Changes in the Myenteric Plexus of Gastric Smooth Muscle in Idiopathic Gastroparesis Patients. Gastroenterology 146(5): S-614
Scott, B.K.; Koch, K.L.; Westcott, C.J. 2014: Mo1307 Pyloroplasty for Patients With Medically-Refractory Functional Obstructive Gastroparesis. Gastroenterology 146(5): S-615
Lynch, K.; Okeke, F.C.; Raja, S.; Hummers, L.; Wigley, F.; Ziessman, H.A.; Clarke, J.O. 2014: Mo1308 Liquid and Solid Gastric Scintigraphy Are Frequently Abnormal in Symptomatic Patients With Systemic Sclerosis. Gastroenterology 146(5): S-615
Muszynski, N.D.; Somarajan, S.; Richards, W.O.; Bradshaw, L.A. 2014: Mo1310 Cholecystokinin Alters Serosal Emg but Not Mgg in Porcine Subjects. Gastroenterology 146(5): S-616
Muszynski, N.D.; Somarajan, S.; Richards, W.O.; Bradsha, L.A. 2014: Mo1311 Noninvasive Measurement of Gastric Slow Wave Dysrhythmia in Porcine. Gastroenterology 146(5): S-616
Calles-Escandon, J.; Hasler, W.L.; Koch, K.L.; Van Natta, M.L.; Vaughn, I.A.; Parkman, H.P.; Abell, T.L.; Pasricha, P.J.; Snape, W.J.; McCallum, R.W.; Sarosiek, I.; Farrugia, G.; Tonascia, J.; Unalp, A.; Lee, L.A. 2014: Mo1312 Continuous Blood Glucose Patterns in Diabetic Patients With Gastroparesis: Baseline Findings From the Gpcrc Glumit-Dg Study. Gastroenterology 146(5): S-616
Hameed, A.; Stroehlein, J.R.; Qureshi, W.A.; Shafi, M.A. 2014: Mo1314 Gastric Electrical Stimulator and Its Impact on Symptom Reduction in Gastroparesis Patients With Prior Cholecystectomy. Gastroenterology 146(5): S-617
Absah, I.; Szarka, L.A. 2014: Mo1316 Two Hour Gastric Emptying Radionuclide Scintigraphy is Associated With False Diagnosis of Gastroparesis in Children. Gastroenterology 146(5): S-618
Yasser, A.M.; Miftahof, R. 2014: Mo1317 Towards the Rationalization of Treatment of Gastroparesis. Gastroenterology 146(5): S-618
Mathew, A.; Beshir, H.; Peiffer, L.; Sharzehi, K.; Davila, R.E.; Dye, C.E.; Moyer, M.T.; Pooran, N.; McGarrity, T.J. 2014: Mo1318 To Evaluate Topical Intraductal Lidocaine in the Pancreatic Duct for Prevention of Post-Ercp Pancreatitis (Pep). Gastroenterology 146(5): S-618
Gluck, M.; Rocha, F.G.; Irani, S.; Gan, S.I.; Larsen, M.C.; Kozarek, R.A.; Ross, A.S. 2014: Mo1319 Similar Outcomes of Sterile Versus Infected Walled off Pancreatic Necrosis Treated With Combined Endoscopic and Percutaneous Drainage. Gastroenterology 146(5): S-618
Click, B.H.; Papachristou, G.I.; Yadav, D. 2014: Mo1321 Is Apheresis Helpful in Reducing the Severity of Hypertriglyceridemia (Htg)-Induced Acute Pancreatitis (Ap): A Systematic Review. Gastroenterology 146(5): S-619
Sharma, V.; Sharma, R.; Rana, S.S.; Chaudhary, V.; Gupta, R.; Bhasin, D.K. 2014: Mo1322 Impact of Naso-Jejunal Fluid Resuscitation in Predicted Severe Acute Pancreatitis on Necrosis, Organ Failure and Intra-Abdominal Pressure; a Randomised Comparative Study With Intravenous Ringer's Lactate. Gastroenterology 146(5): S-619
Sharma, V.; Sharma, R.; Rana, S.S.; Chhabra, P.; Kang, M.; Gupta, R.; Bhasin, D.K. 2014: Mo1323 Extra Pancreatic Inflammation on Computed Tomography and Severity of Acute Pancreatitis: Comparison of Extra Pancreatic Inflammation on Ct (Epic) Score With Bisap, Sirs, Renal Rim, Ctsi, and Mctsi Scoring Systems. Gastroenterology 146(5): S-620
Easler, J.J.; Kilian, S.J.; Kushnir, V.M.; Maxwell, J.; Fowler, K.J.; Murad, F.; Edmundowicz, S.A.; Early, D.S.; Mullady, D. 2014: Mo1324 Idiopathic Recurrent Acute Pancreatitis (Irap) and Diminished Parenchymal Radiodensity on Interval Non-Contrast Ct Scan (Nct). Is Increased Intraparenchymal Pancreatic Fat (Ipf) Content Associated With iRap?. Gastroenterology 146(5): S-620
Easler, J.J.; Nawaz, H.; Yadav, D.; Koutroumpakis, E.; Whitcomb, D.C.; Papachristou, G.I. 2014: Mo1325 Patterns of Alcohol and Tobacco Use in a Prospective Cohort: Alcohol Is Associated With Organ Failure and Necrosis in Sentinel Acute Pancreatitis. Gastroenterology 146(5): S-620
Lipinski, M.; Rydzewska, G. 2014: Mo1326 Bisap-Egfr Could Improve Prediction of Severity and Mortality in Acute Pancreatitis. Egfr -Play the Trump Card. Gastroenterology 146(5): S-621
Karabulut, U.; Koyuncu, M.B.; Sezgin, O.; Ucbilek, E.; Aydin, M.K.; Altintas, E. 2014: Mo1327 Early Oral Feeding and Selection of Initial Diet in Mild Acute Pancreatitis. Gastroenterology 146(5): S-621
Bertilsson, S.; Sward, P.; Kalaitzakis, E. 2014: Mo1329 Urine Albumin: Creatinine Ratio Is Associated With Severity of Acute Pancreatitis: A Pilot Study. Gastroenterology 146(5): S-621
Yang, A.L.; Vege, S.S. 2014: Mo1331 When, Why and How Do Patients With Acute Pancreatitis Die? A Large Experience of 910 Direct (Not Transfer), Consecutive Admissions in Recent Years. Gastroenterology 146(5): S-622
Jayaraman, V.; Luo, R.; Malalur, P.; Stone, C.D. 2014: Mo1332 Temporal and Regional Trends in Acute Pancreatitis: Does Mortality or Severity Vary With Day of Admission?. Gastroenterology 146(5): S-622
Thandassery, R.B.; Manrai, M.; Siddappa, P.K.; Medarapalem, J.B.; Appasani, S.; Sinha, S.K.; Sharma, M.; Yadav, T.D.; Kochhar, R. 2014: Mo1334 Validation and Comparison of the New Severity Classification Systems With Old Atlanta Classification for Severity of Acute Pancreatitis. Gastroenterology 146(5): S-623
Faghih, M.; Afghani, E.; Sinha, A.; Khashab, M.; Law, J.K.; Lennon, A.M.; de-Madaria, E.; Singh, V.K. 2014: Mo1335 Systemic Inflammatory Response Syndrome (Sirs) in Acute Pancreatitis (Ap): Outcome of Early Fluid Therapy. Gastroenterology 146(5): S-623
Faghih, M.; Afghani, E.; Sinha, A.; Law, J.K.; Khashab, M.; Lennon, A.M.; de-Madaria, E.; Singh, V.K. 2014: Mo1336 Early Predictors and Outcomes of Increased Fluid Sequestration in Acute Pancreatitis. Gastroenterology 146(5): S-623
Gardner, T.B.; Gordon, S.R. 2014: Mo1337 Risk Factors for the Development of Intra-Abdominal Fungal Infections in Acute Pancreatitis. Gastroenterology 146(5): S-623
Manrai, M.; Medarapalem, J.B.; Siddappa, P.K.; Appasani, S.; Thandassery, R.B.; Sinha, S.K.; Yadav, T.D.; Gupta, V.; Khandelwal, N.; Kochhar, R. 2014: Mo1340 Does the Site of Fluid Collection Alter the Clinical Course of Acute Pancreatitis? -A Prospective Observational Study. Gastroenterology 146(5): S-624
Appasani, S.; Medarapalem, J.B.; Varma, N.; Ahluwalia, J.; Yadav, T.D.; Gupta, V.; Singh, K.; Kochha, R. 2014: Mo1341 D -Dimer in Acute Pancreatitis -A New Approach for an Early Assessment of Severity, Necrosis, Organ Failure and Mortality in Acute Pancreatitis. Gastroenterology 146(5): S-624
Vipperla, K.; Saul, M.I.; Slivka, A.; Chennat, J.S.; Whitcomb, D.C.; Papachristou, G.I.; Yadav, D. 2014: Mo1343 Clinical Profile and Natural Course in Patients With Hypertriglyceridemia (Htg) and Pancreatitis. Gastroenterology 146(5): S-625
Coffey, M.J.; Nightingale, S.; Ooi, C.Y. 2014: Mo1344 Diagnosing Acute Pancreatitis in Children: What Is the Diagnostic Yield and Concordance for Serum Pancreatic Enzymes and Imaging?. Gastroenterology 146(5): S-625
Stan-Iuga, R.; Bertin, C.; Vullierme, M.-P.; Hammel, P.; Ruszniewski, P.; Levy, P.; Rebours, V. 2014: Mo1345 Pancreas Divisum (Pd), a Protective Factor against Biliary Acute Pancreatitis (Ap)?. Gastroenterology 146(5): S-625
Picard, J.-M.; Baillargeon, J.-D.; Garant, M.-P. 2014: Mo1346 Prediction of Retained Common Bile Duct Stones (Rcbds) in Acute Biliary Pancreatitis: Evaluation of Laboratory Testing According to Time. Gastroenterology 146(5): S-626
Okamoto, K.; Huang, S.; Yu, C.; Sinicrope, F.A. 2014: Mo1645 P62/Sequestosome 1 Is an Effector of Chemotherapy-Induced Apoptosis in Colorectal Cancer Cells With Disabled Autophagy. Gastroenterology 146(5): S-626
Wang, J.; Zeng, Y.; Zhao, J.; Gao, J.; Sung, J.J.Y.; Yu, J. 2014: Mo1646 Rec8, a Novel Ebv-Associated Hypermethylated Gene, Contributes to the Pathogenesis of Ebv-Associated Gastric Cancer. Gastroenterology 146(5): S-626
Katona, B.; Liu, Y.; Ma, A.; Jin, J.; Hua, X. 2014: Mo1647 Inhibition of Ezh2/Ezh1 by Unc1999 Enhances the Potency of the Egfr Inhibitor Gefitinib in Colon Cancer Cells. Gastroenterology 146(5): S-626
Weiswald, L.-B.; Hasan, M.; Yin, Y.; Schaeffer, D.F.; Kennecke, H.; Tai, I.T. 2014: Mo1649 Cdk10, a Potential Predictive Biomarker for Colorectal Cancer, Is Involved in Bcl-2 and Bcl-Xl Mediated-Resistance to Apoptosis. Gastroenterology 146(5): S-627
Chern, Y.-J.; Win-Piazza, H.; Yu, A.; Wong, J.C.; Schaeffer, D.F.; Kennecke, H.; Lim, H.; Tai, I.T. 2014: Mo1650 Sparc and Grp78 Interferes With Er Stress Signaling and Influences Chemotherapeutic Response in Colorectal Cancer Cells. Gastroenterology 146(5): S-627
Soutto, M.; Katsha, A.M.; Peng, D.; Zaika, A.; Belkhiri, A.; El-Rifai, W. 2014: Mo1651 Tff1 Acquires Its Tumor Suppressor Functions Through Regulation of P53. Gastroenterology 146(5): S-627
Hu, S.; Wang, J.-Y.; Chang, E.B.; Raufman, J.-P. 2014: Mo1652 Butyrate Modulates MicroRna 92A and 222 Transcription, P57 Expression and the Cell Cycle in Human Colon Cancer Cells. Gastroenterology 146(5): S-627
Sakitani, K.; Hirata, Y.; Hikiba, Y.; Ihara, S.; Serizawa, T.; Suzuki, N.; Kinoshita, H.; Nakagawa, H.; Ikenoue, T.; Koike, K. 2014: Mo1653 Ck19-Specific Autophagy Knockout Mice Model to Examine the Colon Cancer Progression. Gastroenterology 146(5): S-628
Basson, M.D.; Sirivelu, M.; Downey, C.; Zeng, B. 2014: Mo1654 Extracellular Pressure-Induced Increases in [Ca2+]i via T-Type Cav3.3 Channels Stimulate Cancer Cell Proliferation by Enhancing Activity of a Pkcbeta-Dependent Ikk, Ikb, Nf-kB Pathway. Gastroenterology 146(5): S-628
Guarinos, C.; Hamaya, Y.; Tseng-Rogenski, S.; Jover, R.; Carethers, J.M. 2014: Mo1655 The Transcription Factor E2F4 Is Selectively Frameshift Mutated and Is Non-Functional in Emast Colorectal Cancers. Gastroenterology 146(5): S-628
Kim, Y.B.; Lee, S.-Y.; Kim, J.H.; Sung, I.K.; Park, H.S.; Shim, C.S.; Jin, C.J. 2014: Mo1656 Microsatellite Instability of the Gastric and Colorectal Cancers As a Predictor for Synchronous Gastrointestinal Neoplasms. Gastroenterology 146(5): S-628
Schumacher, Y.; Aparicio, T.; Postic, C.; Guilmeau, S. 2014: Mo1657 Crtc1 Signaling Contribution to Pge2 Driven Colonic Tumorigenesis. Gastroenterology 146(5): S-628
Hong, J.; Li, D.; Cao, W. 2014: Mo1658 Acid-Induced Decrease in Cell Apoptosis Is Mediated by Activation of Nadph Oxidase Nox5-S, Nf-B and Sodd in Barrett's Esophageal Adenocarcinoma Cells. Gastroenterology 146(5): S-629
Riquelme, I.; Tapia, O.; Sandoval, A.M.; Leal, P.; Letelier, P.; Roa, J.C. 2014: Mo1659 The Pi3K/Akt/mTor Pathway in Gastric Cancer and Its Potential Relationship With Mir-125b, Mir-451 and Mir-101. Gastroenterology 146(5): S-629
Yimei, L.; Guifen, M.; Chen, S. 2014: Mo1660 Foxp3 Inhibits Cell Proliferation of Gastric Cancer Cells Through Modulation of the Tgf-/Smad Signaling Pathway. Gastroenterology 146(5): S-629
Kupcinskas, L.; Link, A.; Wex, T.; Kiudelis, G.; Jonaitis, L.; Gyvyte, U.; Leja, M.; Skieceviciene, J.; Malfertheiner, P. 2014: Mo1662 The Role of Snps of Genes Encoding Psca, Muc1 and Plce1 in Gastritis, Gastric Cancer and Colorectal Cancer Development. Gastroenterology 146(5): S-630
Hong, S.N.; Kim, E.R.; Chang, D.K.; Kim, Y.-H.; Kim, J.J.; Rhee, P.-L. 2014: Mo1663 Differential Expression Proteomics Analysis to Evaluate the Progression of Adenoma to Adenocarcinoma in Colorectal Carcinogenesis. Gastroenterology 146(5): S-630
Li, Y.; Li, C.; Chen, J.; Zhu, Y.; Gao, X.; Hu, P.; Cai, Q.; Hu, S. 2014: Mo1664 Chop Expression and Its Correlation With Proliferative/Apoptotic Ratio in Colorectal Adenoma-Carcinoma Sequence Under the Same Genetic Background. Gastroenterology 146(5): S-630
Tacconi, C.; D'Alessio, S.; Correale, C.; Gandelli, A.; Vetrano, S.; Arena, V.; Danese, S. 2014: Mo1665 The Vegfc/Vegfr3 Pathway Controls Colitis Associated Cancer Formation and Progression Through Lymphangiogenesis and Lymphatic Endothelial Vecadherin. Gastroenterology 146(5): S-631
Hayashi, S.; Hamada, T.; Ishii, Y.; Sasahara, M.; Kadowaki, M. 2014: Mo1666 Nicotine Suppresses Colonic Tumorigenesis Associated With Chronic Colitis Through the Inhibition of Il-6/Stat3 Pathway in Mice. Gastroenterology 146(5): S-631
Rizzo, A.; DeMare, V.; Stolfi, C.; Pallone, F.; Monteleone, G.; Fantini, M.C. 2014: Mo1667 Colitis-Associated Colorectal Cancer Induces Phenotype Instability and Effector Functions in Tumor-Infiltrating Regulatory T Cells. Gastroenterology 146(5): S-631
Raisch, J.; Darfeuille-Michaud, A.; Bringer, M.-A. 2014: Mo1668 The Persistence of Colon Cancer-Associated Escherichia coli Within Human Macrophages Induces Cox-2 Expression. Gastroenterology 146(5): S-631
Lang, M.; Dammann, K.W.; Mesteri, I.; Evstatiev, R.; Passecker, K.; Khare, V.; Meisner-Kober, N.; Gasche, C. 2014: Mo1670 Systemic HuR Inhibition Augments Tumorigenesis in the Aom/Dss Mouse. Gastroenterology 146(5): S-632
Mooiweer, E.; van der Meulen -de Jong, A.E.; Ponsioen, C.; van der Woude, C.J.; Jansen, J.M.; Mahmmod, N.; Kremer, W.C.; Siersema, P.D.; Oldenburg, B. 2014: Mo1671 Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Enrolled in a Colonoscopic Surveillance Program. Gastroenterology 146(5): S-632
Dammann, K.W.; Khare, V.; Lang, M.; Mesteri, I.; Evstatiev, R.; Gasche, C. 2014: Mo1672 Pak1 Depletion Promotes Tumor Invasiveness in the Aom/Dss Mouse Model. Gastroenterology 146(5): S-632
Wang, L.; Cao, H.; Acra, S.; Polk, D.B.; Yan, F. 2014: Mo1674 Upregulation of Mucin Production by a Probiotic-Derived Protein Through Activation of Egf Receptor. Gastroenterology 146(5): S-633
Schwertschlag, U.; Kumar, A.; Kochhar, S.; Ings, R.; Ji, Y.; de Hostos, E.L.; Choy, R.; Salam, M.; Khan, W.A.; Lin, P. 2014: Mo1675 Pharmacokinetics and Tolerability of iOwh032, an Inhibitor of the Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) Chloride Channel, in Normal Volunteers and Cholera Patients. Gastroenterology 146(5): S-633
Xu, H.; Li, J.; Ananthanarayanan, M.; Ghishan, F.K. 2014: Mo1676 The Role of Bile Acid Receptor Fxr Activation on Nhe8 Expression Regulation. Gastroenterology 146(5): S-633
Xu, H.; Li, J.; McCoy, A.; Ghishan, F.K. 2014: Mo1677 Modulation of Nhe8 by Butyrate in Human Intestinal Epithelial Cells. Gastroenterology 146(5): S-633
Jain, A.K.; Blomenkamp, K.S.; Rodrigues, J.; Blaufuss, T.A.; Carl, M.A.; Liou, V.D.; Wen, J.X.; Strebeck, F.; Knobeloch, A.C.; Stoll, B.; Burrin, D.; Long, J.P.; Teckman, J. 2014: Mo1679 Development and Validation of a Novel Ultra-Mobile Ambulatory Total Parenteral Nutrition Model. Gastroenterology 146(5): S-634
Noah, T.K.; Shroyer, N.F. 2014: Mo1680 Spdef Is an Essential Mediator of Notch-Atoh1 Effects on Cell Proliferation and Goblet Cell Differentiation but Is Dispensible for Stem Cell Self-Renewal and Maintenance in the Intestine. Gastroenterology 146(5): S-634
Bell, K.N.; Shroyer, N.F. 2014: Mo1682 Krpple-Like Factor 5 Is Required for Normal Intestinal Homeostasis As a Transcription Factor Controlling Proliferation. Gastroenterology 146(5): S-635
Kusek, M.E.; Chu, K.; Liu, L.; Shreffler, W.G.; Tearney, G.J.; Hurley, B. 2014: Mo1683 Imaging Mucosal Surfaces with Micro-Optical Coherence Tomography. Gastroenterology 146(5): S-635
Blosser, E.G.; Weaver, C.T.; Randolph, D.A. 2014: Mo1684 The Role of Commensal Microbes in Mucosal Defense of the Neonatal Gut. Gastroenterology 146(5): S-635
Sturgeon, C.; Lan, J.; Fasano, A. 2014: Mo1686 Hp2 Mice Are More Susceptible to Dss Treatment. Gastroenterology 146(5): S-636
Sapone, A.; Senger, S.; Siniscalco, D.; Johnson, R.; Zielke, H.R.; Cascella, N.G.; Kelly, D.L.; Antonucci, N.; de Magistris, L.; Fasano, A.; Fiorentino, M.R. 2014: Mo1687 The Gut-Brain Axis in Neurobehavioral Disorders: Expression Analysis of Tight Junction Claudins and Mmps in the Brain of Autistic and Schizophrenic Subjects. Gastroenterology 146(5): S-636
Weage, K.; Maier, E.A.; Wu, D.; Hogan, S.P.; Moore, S.R. 2014: Mo1688 Undernutrition and Augmented Levels of Lps in the Colon Additively Impair Small Intestinal Barrier Function in Weanling Mice. Gastroenterology 146(5): S-636
Chen, M.-S.; Donahue, B.; Shroyer, N.F. 2014: Mo1690 Intestinal Stem Cells and Lineage Progenitors Have Distinct Cycle Behaviors Under Homeostasis. Gastroenterology 146(5): S-637
Schuck-Phan, A.; Phan, T.M.; Dawson, P.; Dial, E.; Lichtenberger, L.M. 2014: Mo1691 Enhanced Indomethacin-Induced Gut Injury in Formula-Fed Rat Pups. Gastroenterology 146(5): S-637
Sivignon, A.; Brument, S.; Gouin, S.; Bernard, J.; Bouckaert, J.; Barnich, N.; Darfeuille-Michaud, A. 2014: Mo1692 Synthetic Mannosides As a Promising Anti-Adhesive Strategy to Eradicate Adherent-Invasive E. Coli From the Gastrointestinal Tract of Crohn's Disease Patients. Gastroenterology 146(5): S-637
Levin, A.D.; Wildenberg, M.E.; D'Haens, G.R.; van den Brink, G.R. 2014: Mo1693 FcR-Mediated Effector Function Contributes to the Therapeutic Response of Anti-Tnf Monoclonal Antibodies in a Mouse Model of Ibd. Gastroenterology 146(5): S-637-S-638
Pietropaoli, D.; Del Pinto, R.; Corridoni, D.; Rodriguez-Palacios, A.; DiStefano, G.; Weinberg, A.; Cominelli, F. 2014: Mo1694 Occurrence of Periodontal Disease in Samp1/YitFc Mice With Crohn's Disease-Like Ileitis. Gastroenterology 146(5): S-638
de Kivit, S.; Morgan, M.E.; Koelink, P.J.; Zheng, B.; Knippels, L.; Verspaget, H.W.; Willemsen, L.; Garssen, J.; Kraneveld, A.D. 2014: Mo1695 Specific Non-Digestible Oligosaccharides Combined With B. Breve M-16V Attenuates Experimental Colitis and Suppress Th17 Immunity Potentially via Regulation of Galectin-4 and -9 Expression in the Gut. Gastroenterology 146(5): S-638
Capron, M.; ElNady, M.; Dubuquoy, L.; Rousseaux, C.; Driss, V.; Colombel, J.-F.; Desreumaux, P. 2014: Mo1696 Treatment With P28Gst, a Recombinant Enzyme From Schistosome Helminth Parasite Prevents Hapten-Induced Colitis by Inducing a Regulatory Th2 Response. Gastroenterology 146(5): S-638
Ramos, L.; González-Paredes, F.J.; Abrante-Pérez, B.; Hernández-León, N.; Salido, E.; Camba, A.H.; Quintero, E. 2014: Mo1697 Cromoglycate Disodium Treatment Down-Regulates the Expression of Mmp-9 and Ccl-2 Genes Ameliorating Induced Experimental Colitis. Gastroenterology 146(5): S-638
Minamoto, Y.; Otoni, C.C.; Büyükleblebici, O.; Steiner, J.M.; Jergens, A.; Suchodolski, J.S. 2014: Mo1699 Serum Metabolite and 454 Pyrosequencing Analysis Reveal the Presence of Oxidative Stress, Fecal Dysbiosis, and Dysfunction of the Fecal Microbiota in Spontaneous Canine Idiopathic Inflammatory Bowel Disease. Gastroenterology 146(5): S-639
Lutz, C.; Bollmann, G.; Caj, M.; Fried, M.; Rogler, G.; Hausmann, M. 2014: Mo1700 Novel Murine Heterotopic Transplant Model of Intestinal Fibrosis. Gastroenterology 146(5): S-639
Lutz, C.; Caj, M.; Fried, M.; Rogler, G.; Hausmann, M. 2014: Mo1701 Myd88 Signaling Is Not Essential in Intestinal Fibrosis in Mice. Gastroenterology 146(5): S-639
Holgersen, K.; Kvist, P.H.; Hansen, A.K.; Holm, T.L. 2014: Mo1702 Validation of Piroxicam-Accelerated Colitis in the Interleukin-10 Knock out Mouse -A Preclinical Model Mimicking Human Inflammatory Bowel Disease. Gastroenterology 146(5): S-639
McLean, M.H.; Gold, B.; Golubeva, Y.; Wu, X.; Sun, D.; Anver, M.R.; Hanson, M.L.; Steidler, L.; Durum, S.K. 2014: Mo1704 Intra-Luminal Interleukin (Il)-27 Attenuates Acute Murine 2,4,6-Trinitrobenzene Sulfonic Acid (Tnbs) Colitis and Is Associated With Down-Regulation of Mucosal Humoral Response. Gastroenterology 146(5): S-640
Viennois, E.; Xiao, B.; Ayyadurai, S.; Wang, P.G.; Merlin, D. 2014: Mo1705 Micheliolide, a New Sesquiterpene Lactone Inhibiting Intestinal Inflammation and Colitis-Associated Cancer. Gastroenterology 146(5): S-640
Hirokawa, H.; Koga, Y.; Sasaki, R.; Hara, S.; Meguro, H.; Kainoh, M. 2014: Mo1706 Inhibitory Effects of an Orally Active Small Molecule Alpha4beta1/ Alpha4beta7 Integrin Antagonist, Trk-170, on Spontaneous Colitis in Hlab27 Transgenic Rats. Gastroenterology 146(5): S-640
Grgic, T.; Klicek, R.; Grgic, D.; Suran, J.; Patrlj, L.; Patrlj, M.H.; Seiwerth, S.; Sikiric, P. 2014: Mo1707 The Effect of Pentadecapeptide Bpc 157 on Colovesical Fistula Healing. Gastroenterology 146(5): S-641
Maas, K.J.; Brand, M.W.; Henderson, A.; Detzel, C.J.; Horgan, A.; Hostetter, J.M.; Phillips, G.; Jergens, A.; Wannemuehler, M.J.; Darling, R.; Weaver, E. 2014: Mo1708 Serum-Derived Bovine Immunoglobulin/Protein Isolate Attenuated Dssinduced Colitis in a Defined Floral Model. Gastroenterology 146(5): S-641
Song, Y.; Marin, R.; Morley, S.C.; Williams, D.A.; Nguyen, D.D. 2014: Mo1709 The Actin Network Is Crucial in Regulatory T Cell Development. Gastroenterology 146(5): S-641
Zhao, Y.; Chiang, H.-S.; Song, J.H.; Liu, S.; Wang, N.; Terhorst, C.; Reinecker, H.-C. 2014: Mo1710 Gef-H1 Controls Irf3 Activation by Rig-I Like Receptor Signaling. Gastroenterology 146(5): S-641
Papadakis, K.A.; Krempski, J.; Dave, M.; Svingen, P.A.; Faubion, W.A. 2014: Mo1712 Kruppel-Like Factor Klf10 Regulates Transforming Growth Factor Receptor Signaling in Cd8+ Cytotoxic T Lymphocytes. Gastroenterology 146(5): S-642
Gobbi, R.P.; Sambuelli, A.M.; Rocca, A.; Muglia, C.; Curciarello, R.; Rabinovich, G.A.; Toscano, M.A.; Gil, A.H.; Negreira, S.M.; Huernos, S.P.; Goncalves, S.A.; Bellicoso, M.I.; Pablo, T.; Yantorno, M.; Irigoyen, A. 2014: Mo1713 The Role of the Galectin-1 in the Pathogenesis of Ibd. Gastroenterology 146(5): S-642
Atreya, I.; Diall, A.; Dvorsky, R.; Gruen, M.; Hofmann, U.; Schaeffeler, E.; Henninger, C.; Atreya, R.; Billmeier, U.; Neufert, C.; Zenker, S.; Lopez-Posadas, R.; Daehn, I.; Fritz, G.; Schwab, M. 2014: Mo1714 Designer Thiopurine Analogues for Optimized Immunosuppressive Therapy of Inflammatory Bowel Disease. Gastroenterology 146(5): S-642
Rabizadeh, S.; Wang, H.L.; Shimada, K.; Chen, S.; Crother, T.; Targan, S.; Sears, C.L.; Arditi, M. 2014: Mo1715 Role of Receptor Interacting Protein 2 (Rip-2) in Il17 Production and Stat3 Activation in Etbf Induced Colitis. Gastroenterology 146(5): S-642
Flores, C.; Kanagavelu, S.kumar; Chung, K.D.; Riveron, R.; Romero, L.; Ruiz, J.R.; Singh, G.; Fukata, M. 2014: Mo1716 Dual Regulation of Macrophage Il-1 Production by Trif Signaling: Implication of Host Inflammatory Response to Commensal Bacteria. Gastroenterology 146(5): S-643
Xin, W.W.; Wang, Y.; DiMartino, L.; Cominelli, F.; Xin, W.; Zhou, L. 2014: Mo1717 Nk Regulation of Colon Epithelial Integrity, Colitis and Dysplasia in a Model of Colon Adenocarcinoma in Mice With a Targeted Mutation in the Fx Locus. Gastroenterology 146(5): S-643
Bakke, D.; Paski, S.; Boone, D.L. 2014: Mo1718 A Secreted Gastric Protein Protects Against Nsaid Induced Injury and Colitis. Gastroenterology 146(5): S-643
Vanhove, W.; Staelens, D.; Peeters, P.; van der Goten, J.; DeSchepper, S.; Cleynen, I.; Wouters, E.F.; Van Assche, G.A.; Ferrante, M.; Vermeire, S.; Rutgeerts, P.J.; Nys, K.; Arij, I. 2014: Mo1719 Strong Mucosal Upregulation of Aim2 and Ifi16 Inflammasomes in Patients With Active Inflammatory Bowel Disease. Gastroenterology 146(5): S-643
Larmonier, C.B.; Shehab, K.W.; McFadden, R.-M.T.; Hill, F.M.; Alizadeh, D.; Thurston, R.D.; Kiela, P.R.; Ghishan, F.K. 2014: Mo1720 Relevance of Poly(Adp-ribose) Polymerase 1 (Parp1) in Experimental Colitis. Gastroenterology 146(5): S-644
Bai, A.; Moss, A.C.; Robson, S.C. 2014: Mo1721 Cd39 Is a Surface Marker for Type 1 Cd8+ T-Cells in Patients With Crohn's Disease. Gastroenterology 146(5): S-644
Lennon, E.M.; Edwards, L.; Borst, L.B.; Moeser, A.J. 2014: Mo1722 Mast Cells Play a Protective Role in Spontaneous Colitis. Gastroenterology 146(5): S-644
DeVries, L.C.; Duarte, J.; Hilbers, F.; Ludbrook, V.J.; Woodrow, M.D.; Sims, M.J.; de Winther, M.; Moerland, P.; D'Haens, G.R.; de Jonge, W. 2014: Mo1723 Comparative Efficacies of Novel Jak Inhibitors to Reduce Macrophage Activation. Gastroenterology 146(5): S-644
Song, L.; Xia, B.; Zhou, R.; Xu, S.; Zhang, Y. 2014: Mo1724 Amelioration of Dss-Induced Colitis by Sr1001 Treatment Through Inhibition of Il-23/Th17 Pathway. Gastroenterology 146(5): S-644
Sato, H.; Hokari, R.; Maruta, K.; Yasutake, Y.; Narimatsu, K.; Kurihara, C.; Okada, Y.; Watanabe, C.; Komoto, S.; Tomita, K.; Nagao, S.; Miura, S. 2014: Mo1725 Possible Protective Role of Lymphangiogenesis in the Inflamed Colonic Mucosa of Inflammatory Bowel Diseases. Gastroenterology 146(5): S-645
Longhi, M.S.; Wu, Y.; Moss, A.C.; Quintana, F.J.; Robson, S.C. 2014: Mo1726 Failure of Bilirubin-Mediated Immunosuppression Can Be Linked to Increased Efflux From Cells Driven by Heightened Activation of Mdr1 Glycoprotein on T-Cells in Crohn's Disease. Gastroenterology 146(5): S-645
Longhi, M.S.; Kalbasi, A.; Vaughn, B.P.; Wegiel, B.; Moss, A.C.; Quintana, F.J.; Robson, S.C. 2014: Mo1727 Impaired Expression of the Aryl Hydrocarbon Receptor and Cd39 Is Associated With Heightened Pathogenicity of T Helper Type 17 Cells in Crohn's Disease. Gastroenterology 146(5): S-645
Dhawan, S.; Duarte, J.; Hilbers, F.; de Jonge, W. 2014: Mo1728 Regulation of Intestinal Cholinergic Th17 Lymphocytes by the Sympathetic Nervous System. Gastroenterology 146(5): S-645
Ueno, A.; Jijon, H.; Traves, S.; Chan, R.; Ford, K.; Barkema, H.; Gasia, M.F.; Hundal, R.; Murdoch, T.B.; Beck, P.L.; Kaplan, G.; Iacucci, M.; Panaccione, R.; Proud, D.; Ghosh, S. 2014: Mo1729 Differential Effect of Cigarette Smoke Extract Modifies Cd103 and Cxcr3 Expressions of Monocyte-Derived Dendritic Cells From Crohn's Disease and Ulcerative Colitis Patients. Gastroenterology 146(5): S-646
Stumphy, J.E.; Metwali, A.; Winckler, S.; Ince, M.N.; Polyak, S.; Elliott, D.E. 2014: Mo1730 Helminth Colonization Increases pStat3 and Ilgr Expression in Murine Terminal Ileum Epithelial Cells. Gastroenterology 146(5): S-646
Hamada, T.; Hayashi, S.; Kadowaki, M. 2014: Mo1731 Pathogenic Role of Pi3K P85 Subunit in a Murine Colitis Model Through the Regulation of Intestinal Macrophage Functions. Gastroenterology 146(5): S-646
Guzylack, L.; Ménard, S.; Cartier, C.; Lencina, C.; Gillet, M.; Gaultier, E.; Houdeau, E. 2014: Mo1733 Perinatal Exposure to Low Dose of Bisphenol a Alters Immune Cell Differentiation At Systemic and Intestinal Level in Young Offspring Rats. Gastroenterology 146(5): S-647
Becker, E.; Stanzel, C.; Atrott, K.; Rogler, G.; Frey-Wagner, I. 2014: Mo1734 Effects of Isotretinoin Treatment on Epigenetic Programming in T Cells. Gastroenterology 146(5): S-647
Breynaert, C.M.; Arijs, I.; Cremer, J.; Van Lommel, L.; Schuit, F.C.; Rutgeerts, P.J.; Ceuppens, J.L.; Van Assche, G.A. 2014: Mo1735 Fibrogenesis Is Innate Immunity Driven in Chronic Dss Colitis and Associated With Distinct Gene Expression Patterns. Gastroenterology 146(5): S-647
Strisciuglio, C.; Miele, E.; Giugliano, F.P.; Vitale, S.; Andreozzi, M.; Vitale, A.; Cenni, S.; Staiano, A.; Troncone, R.; Gianfrani, C. 2014: Mo1736 Probiotic Bacteria Enhance Antigen Sampling and Processing by Dendritic Cells in Pediatric Ibd. Gastroenterology 146(5): S-647
Arijs, I.; Wollants, W.; Clarke, G.; Persoons, P.; Vanhove, W.; Van Lommel, L.; Machiels, K.; Van Assche, G.A.; Ferrante, M.; Schuit, F.C.; Vermeire, S.; Rutgeerts, P.J. 2014: Mo1737 The Effect of Infliximab Therapy on the Tryptophan Metabolism and Indoleamine 2,3-Dioxygenase Expression (Ido) in Patients With Inflammatory Bowel Disease. Gastroenterology 146(5): S-648
Duarte, J.; DeVries, L.C.; Hilbers, F.; de Winther, M.; Sims, M.J.; Ludbrook, V.J.; Woodrow, M.D.; Witherington, J.; D'Haens, G.R.; de Jonge, W. 2014: Mo1738 Efficacy of a Novel Jak1-Specific Inhibitor in a Mouse Model of Acute and Chronic Colitis. Gastroenterology 146(5): S-648
Moratalla, A.; Gutiérrez, A.; Sempere, L.; Zapater, P.; Almenta, I.M.; González-Navajas, J.M.; Such, J.; Frances, R. 2014: Mo1739 Anti-Tnf-Alpha Therapy Is Associated With an Increased Expression of Regulatory T Cells in Blood of Patients With Crohn's Disease. Gastroenterology 146(5): S-648
Jiang, Z.G.; Moss, A.C.; Csizmadia, V.G.; Cheifetz, A.S.; Wu, Y.; Robson, S.C. 2014: Mo1741 Crohn's Disease Is Associated With Altered Expression and Function of Plasma Membrane Ectonucleotidases. Gastroenterology 146(5): S-649
Pickert, G.; Tegeder, I.; Ferreiròs, N.; Schuppan, D. 2014: Mo1743 Cxcr3 Deficiency Enhances Intestinal Inflammation in Mice. Gastroenterology 146(5): S-650
Blois, S.M.; Fuss, I.J.; Strober, W.; Dveksler, G. 2014: Mo1744 Pregnancy-Specific Glycoprotein 1 (Psg1) Activates Tgf- and Prevents Dextran Sodium Sulfate (Dss)-Induced Colitis in Mice. Gastroenterology 146(5): S-650
Priyamvada, S.; Anbazhagan, A.N.; Kumar, A.; Gujral, T.; Borthakur, A.; Saksena, S.; Gill, R.K.; Alrefai, W.A.; Dudeja, P.K. 2014: Mo1745 All-Trans-Retinoic Acid (Atra) Counteracts Inhibition of Dra Function and Expression in Intestinal Inflammation. Gastroenterology 146(5): S-650
Kumar, A.; Gujral, T.; Gill, R.K.; Coffing, H.; Anbazhagan, A.N.; Borthakur, A.; Alrefai, W.A.; Dudeja, P.K. 2014: Mo1746 Tnf Inhibits Slc26A3 Expression via Activation of Nf-B Pathway. Gastroenterology 146(5): S-650
Yang, J.; Singh, V.; Chen, T.; Sarker, R.; Cha, B.; Zachos, N.C.; Donowitz, M. 2014: Mo1747 Nherf2/Nherf3 Hetero-Dimerization Is Required for Carbachol Inhibition of Nhe3 Activity That Involves Formation of Nhe3 Macro-Complexes. Gastroenterology 146(5): S-651
DeLisle, R.C. 2014: Mo1748 Absorptive Enterocytes Are Poorly Differentiated in the Cftr Knockout Mouse Small Intestine. Gastroenterology 146(5): S-651
Kaji, I.; Akiba, Y.; Guth, P.H.; Engel, E.; Kaunitz, J.D. 2014: Mo1749 Luminal 5-Ht Induces Hco3 Secretion via 5Ht4 Receptor Activation in Rat Proximal Colon. Gastroenterology 146(5): S-651
Singhal, M.; Soni, V.; Kumar, A.; Alrefai, W.A.; Saksena, S.; Hecht, G.A.; Dudeja, P.K.; Gill, R.K. 2014: Mo1750 Role of Shp2 Protein Tyrosine Phosphatase in Sert Inhibition by Enteropathogenic E. Coli. Gastroenterology 146(5): S-651
Ameen, N.; Jakab, R.L.; Hannig, G.; Tchernychev, B.; Arthur, D.; Silos-Santiago, I. 2014: Mo1752 Linaclotide Induces Endocytosis of the Sodium/Hydrogen Exchanger 3 (Nhe3) and Inhibits Sodium Absorption. Gastroenterology 146(5): S-652
Priyamvada, S.; Anbazhagan, A.N.; Kumar, A.; Soni, V.; Bajaj, A.; Alrefai, W.A.; Gill, R.K.; Dudeja, P.K.; Saksena, S. 2014: Mo1753 Lactobacillus Acidophilus Stimulates Intestinal P-Glycoprotein via a C-Fos/c-Jun Dependent Mechanism. Gastroenterology 146(5): S-652
Alakkam, A.; Kumar, A.; Saksena, S.; Gill, R.K.; Alrefai, W.A.; Dudeja, P.K. 2014: Mo1754 Hydrogen Peroxide Inhibits Dra (Slc26A3) Expression in Intestinal Epithelial Cells by Transcriptional Mechanism. Gastroenterology 146(5): S-652
Sheikh, I.A.; Chatterjee, T.; Hayashi, M.; Saha, D.R.; Chakrabarti, P.; Chakrabarti, M.K.; Kazi, M.H. 2014: Mo1755 Recombinant Accessory Cholera Enterotoxin (Ace) of Vibrio Cholera Induces Diarrhea by Stimulation of a Chloride Channel and Inhibition of the Na+/ Glucose Co-Transporter Sglt1. Gastroenterology 146(5): S-652
Gujral, T.; Kumar, A.; Priyamvada, S.; Gill, R.K.; Alrefai, W.A.; Hecht, G.A.; Dudeja, P.K. 2014: Mo1757 Trafficking of Slc26A3 (Dra) in Intestinal Epithelial Cells: Effect of Epec Infection. Gastroenterology 146(5): S-653
Kozan, P.; Marchelletta, R.; Barrett, K.E.; Sivagnanam, M. 2014: Mo1758 Knock-Down of the Congenital Tufting Enteropathy Gene, Epcam, Results in Barrier and Ion Transport Dysfunction in Intestinal Epithelial Cells. Gastroenterology 146(5): S-653
Malhotra, P.; Muthusamy, S.; Gavin, D.P.; Luo, A.Y.; Saksena, S.; Gill, R.K.; Dudeja, P.K.; Alrefai, W.A. 2014: Mo1760 Histone Deacetylase Inhibition Decreases the Expression of Intestinal Cholesterol Transporter Niemann Pick-C1-Like 1 (Npc1L1). Gastroenterology 146(5): S-653
Anbazhagan, A.N.; Priyamvada, S.; Kumar, A.; Gujral, T.; Jayawardena, D.; Thaqi, M.; Mugarza, E.; Onyuksel, H.; Dudeja, P.K. 2014: Mo1762 A Novel Role of Glp-1 Nanomedicine in Amelioration of Gut Inflammation. Gastroenterology 146(5): S-654
Bannert, K.; Bodammer, P.; Glamann, J.; Bovensiepen, K.; Lamprecht, G. 2014: Mo1763 Sorting Nexin 27 (Snx27) Is a Member of Nherf (Na+/H+ Exchanger Regulatory Factor) Family of Pdz Adaptor Proteins. Gastroenterology 146(5): S-654
Palaniappan, B.; Arthur, S.; Sundaram, U. 2014: Mo1764 Protein Kinase G Mediated Regulation of Na-Glucose Co-Transport in Na:H Exchange Silenced Intestinal Epithelial Cells. Gastroenterology 146(5): S-654
Chatterjee, I.; Kumar, A.; Gill, R.K.; Alrefai, W.A.; Dudeja, P.K. 2014: Mo1765 3D Cell Culture of CaCo2: A Better Model to Study the Functionality and Regulation of Intestinal Ion Transporters. Gastroenterology 146(5): S-654
Wang, A.; Grinchuk, V.; Smith, A.; Qin, B.; Urban, J.F.; Lu, N.; Ramalingam, T.R.; Wynn, T.A.; Shea-Donohue, T.; Zhao, A. 2014: Mo1767 Genetic Deletion of Il-25 Increases Susceptibility to High-Fat Diet-Induced Metabolic Dysfunction in Mice. Gastroenterology 146(5): S-655
Spahis, S.; Sane, A.T.; Lejoly, C.; Garofalo, C.; Marcil, V.; Delvin, E.; Sinnett, D.; Seidman, E.G.; Levy, E. 2014: Mo1768 Sar1b Overexpression Modulates Intestinal Cholesterol Metabolism in Mice on High-Fat Diet. Gastroenterology 146(5): S-655
Karrar, A.; Lingam, S.; Younossi, E.; Hunt, S.L.; Younoszai, Z.; Stepanova, M.; Goodman, Z.D.; Younossi, Z.M. 2014: Mo1769 Pentraxins Are Independently Associated with non Alcoholic Steatohepatitis (Nash). Gastroenterology 146(5): S-655
Nakamura, K.; Fukunishi, S.; Sujishi, T.; Yokohama, K.; Ohama, H.; Tsuchimoto, Y.; Asai, A.; Tsuda, Y.; Higuchi, K. 2014: Mo1770 A Novel, Potent, and Long-Lasting Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Inhibits the Development of Hepatic Steatosis. Gastroenterology 146(5): S-655
Fischer, B.; Martin, J.; Steinhilber, D.; Ulrich-Rückert, S.; Stein, J. 2014: Mo1771 Adiponectin Antagonises Leptin-Induced Hepcidin Expression in Human Liver Cells: New Insights Into Obesity-Associated Iron Deficiency. Gastroenterology 146(5): S-656
Fukunishi, S.; Sujishi, T.; Yokohama, K.; Ohama, H.; Tsuchimoto, Y.; Asai, A.; Tsuda, Y.; Higuchi, K. 2014: Mo1772 Lipopolysaccharides Can Accelerate the Development of Nonalcoholic Fatty Liver Disease, Caused by the Up-Regulation of Lipogenic Gene Expressions. Gastroenterology 146(5): S-656
Ovink-Wilbrink, J.A.K.; Troost, F.; Bernards, N.; Mujagic, Z.; Pijls, K.; Bessems, B.A.; Nienhuijs, S.W.; Stronkhorst, A.; Masclee, A. 2014: Mo1773 Gastroduodenal Permeability Is Increased in Obesity but Normalizes After Sleeve Gastrectomy. Gastroenterology 146(5): S-656
Yokohama, K.; Fukunishi, S.; Ohama, H.; Sujishi, T.; Tsuchimoto, Y.; Asai, A.; Tsuda, Y.; Higuchi, K. 2014: Mo1774 Sitagliptin Can Inhibit the Acceleration of the Development in Nafld Caused by Lipopolysaccharides Through Inhibiting Expression of Myd88 and NfB. Gastroenterology 146(5): S-656
Keaton, M.; Doyle, K.; Wang, L.; Mehta, R.; Younoszai, Z.; Birerdinc, A.; Elarainy, H.A.; Baranova, A.; Younossi, Z.M. 2014: Mo1776 Potential Factors Involved in the Differentiation of Bat From Wat in Morbidly Obese Patients With Non-Alcoholic Fatty Liver Disease (Nafld). Gastroenterology 146(5): S-657
LePard, K.J.; Cellini, J.; Tran, B.C.; Naik, K.; Fullmer, R. 2014: Mo1777 Location of Glucose Transporter Glut2 in Beta Cell Membrane, Not Beta Cell Mass, Determines Glycemic Control in 4 and 16 Week Old Female Kk and Kkay Mice. Gastroenterology 146(5): S-657
Claessen, C.; Canals, M.; Lieu, T.; Bornstein, J.C.; Bunnett, N.W.; Poole, D.P. 2014: Mo1778 Agonist-Dependent Delta Opioid Receptor Trafficking and Signaling in Myenteric Neurons. Gastroenterology 146(5): S-657
Ni, Y.; Sinnett-Smith, J.; Rozengurt, E. 2014: Mo1779 Identification of a Novel Stimulus-Dependent Phosphorylation in the Nterminal Region of Protein Kinase D1 (Pkd1) in Intestinal Epithelial Cells. Gastroenterology 146(5): S-657
Wang, J.; Ming, M.; Ni, Y.; Sinnett-Smith, J.; Rozengurt, E. 2014: Mo1780 Dissociation of Gpcr-Stimulated Dna Synthesis From Dephosphorylation of Yap at Ser-127. Gastroenterology 146(5): S-658
Nuche-Berenguer, B.; Moreno, P.; Jensen, R.T. 2014: Mo1781 The p-21-Activated Kinase, Pak2, Is Present in Pancreatic Acinar Cells and Activated by Numerous Gastrointestinal Hormones and Growth Factors. Gastroenterology 146(5): S-658
Takeda, H.; Ohnishi, S.; Muto, S.; Nakagawa, K.; Sadakane, C.; Saegusa, Y.; Nahata, M.; Yamada, C.; Hattori, T.; Sakamoto, N. 2014: Mo1782 Association of Abnormal Ghrelin Dynamics With Delayed Gastric Emptying in Acute Restraint-Stressed Mice. Gastroenterology 146(5): S-658
Li, J.; Song, J.; Weiss, H.L.; Gao, T.; Townsend, C.M.; Evers, B.M. 2014: Mo1783 Class Iii Pi3K (Hvps34) Is Involved in Ampk-Regulated Neurotensin Secretion Independent of mTorc1 Signaling. Gastroenterology 146(5): S-659
Mantey, S.A.; Maderdrut, J.L.; Coy, D.; Jensen, R.T. 2014: Mo1784 Identification of Selective Agonists for the Hpac1 Receptor. Gastroenterology 146(5): S-659
Mahajan, S.; Liao, M.; Barkan, P.; Takahashi, K.; Bhargava, A. 2014: Mo1785 Urocortin 3 Expression At Baseline and During Inflammation in the Colon: Corticotropin Releasing Factor Receptors Cross-Talk. Gastroenterology 146(5): S-659
Yang, S.; Yu, M.; Cheng, Y.; Sun, L.; Xiao, W.; Sun, L.; Chen, G.; Zhang, C.; Ma, Y.; Yang, H. 2014: Mo1786 Hif-1 Plays a Gut-Injurious Role in Interferon- Induced Intestinal Epithelial Barrier Dysfunction. Gastroenterology 146(5): S-659
Wallace, L.; de Heuvel, E.; Waschek, J.; Sigalet, D.L. 2014: Mo1788 Vasoactive Intestinal Polypeptide and Neuronal Nitric Oxide Synthase Act via Parallel Pathways As Mediators of Glp-2 Anti-Inflammatory Activity. Gastroenterology 146(5): S-660
Fischer, B.; Martin, J.; Steinhilber, D.; Stein, J.; Ulrich-Rückert, S. 2014: Mo1789 Sulforaphane Inhibits Expression of the Central Iron Regulator Hepcidin Stat3-Independently in an Inflammatory Cell Model. Gastroenterology 146(5): S-660
Agoston, A.T.; Dulai, P.S.; Strauss, A.C.; Fudman, D.I.; Hagen, C.; Abrams, J.A.; Forcione, D.G.; Jajoo, K.; Saltzman, J.R.; Odze, R.D.; Lauwers, G.Y.; Gordon, S.R.; Lightdale, C.J.; Rothstein, R.I.; Srivastava, A. 2014: Mo1815 Predictors of Durable Treatment Response After Radiofrequency Ablation for Barrett's Esophagus Associated Intramucosal Adenocarcinoma. Gastroenterology 146(5): S-660
Li, N.; Pasricha, S.; Cotton, C.C.; Wolf, W.A.; Spacek, M.; Moist, S.E.; Shaheen, N.J. 2014: Mo1817 Dysplasia in the Gastric Cardia Is Not Uncommon Among Patients Who Are Successful Treated by Radiofrequency Ablation for Dysplastic Barrett's Esophagus -A Prospective Study. Gastroenterology 146(5): S-661
Ishioka, M.; Tawaraya, S.; Jin, M.; Matsuhashi, T.; Hatakeyama, N.; Onochi, K.; Koizumi, S.; Sawaguchi, M.; Watanabe, N.; Fujiwara, J.; Takahashi, K.; Suzuki, Y.; Fujita, A.; Mashima, H.; Ohnishi, H. 2014: Mo1818 Progress in the Feasibility of Endoscopic Submucosal Dissection for the Treatment of Gastric Tube Cancer After Esophagectomy. Gastroenterology 146(5): S-661
Cummings, L.C.; Kou, T.D.; Schluchter, M.D.; Chak, A.; Cooper, G.S. 2014: Mo1819 Endoscopic Versus Surgical Therapy for High Grade Dysplasia and Early Esophageal Cancers in an Older Population. Gastroenterology 146(5): S-661
Walp, K.K.; Hallquist, S.P.; Bults, A.; Fukami, N.; Forcione, D.G.; Shaheen, N.J.; Smith, M.S. 2014: Mo1821 Liquid Nitrogen Spray Cryotherapy Can Be Used Safely in Retroflexion for Treatment of Lesions at the Esophagogastric Junction and Gastric Cardia. Gastroenterology 146(5): S-662
Gemignani, L.; Savarino, E.; Dulbecco, P.; Giambruno, E.; Bodini, G.; Furnari, M.; Giacchino, M.; Mastracci, L.; Grillo, F.; Savarino, V. 2014: Mo1822 Diagnostic Accuracy and Inter/Intra-Observer Agreement Between Endoscopists With Different Expertise, Before and After a Short Training, for the Detection of Gastric Intestinal Metaplasia by Means of Narrow Band Imaging With Magnifying Endoscopy. Gastroenterology 146(5): S-662
Torresini, R.J.; Mazzoleni, L.E.; Sander, G.B.; Francesconi, C.F.; Meurer, L.; Uchôa, D.M.; da Silva, V.D.; DeBona, L.R.; Prolla, J.C. 2014: Mo1824 Pattern of Gastric Intestinal Metaplasia (Gim) in Dyspeptic Adults. Gastroenterology 146(5): S-663
Torresini, R.J.; Mazzoleni, L.E.; Sander, G.B.; Francesconi, C.F.; Meurer, L.; Uchôa, D.M.; da Silva, V.D.; Milbradt, T.C.; Prolla, J.C. 2014: Mo1825 Membrane Protein Cd44v6 Is Not Expressed in Gastric Intestinal Metaplasia in a Sample of Helicobacter pylori Dyspeptic Adult Patients. Gastroenterology 146(5): S-663
Krajciova, J.; Stefanova, M.; Maluskova, J.; Kollar, M.; Spicak, J.; Martinek, J. 2014: Mo1826 Is a Complete Remission of Intestinal Metaplasia a Suitable Endpoint in Patients Undergoing Radiofrequency Ablation (Rfa)? Long-Term Results of Rfa Treatment in 62 Consecutive Patients. Gastroenterology 146(5): S-663
Midani, D.; Kataria, R.; Smith, M.S. 2014: Mo1827 Radiofrequency Ablation of Esophageal Gastric Heterotopia Leads to Improvement in Atypical Reflux Symptoms As Well As Eradication of Oxyntic and Metaplastic Mucosa. Gastroenterology 146(5): S-664
Dellon, E.S.; Speck, O.; Woodward, K.; Covey, S.; Rusin, S.; Gebhart, J.H.; Chen, X.L.; Woosley, J.T.; Shaheen, N.J. 2014: Mo1828 Major Basic Protein, Eotaxin-3, and Mast Cell Tryptase Staining for Diagnosis of Eosinophilic Esophagitis: A Prospective Study. Gastroenterology 146(5): S-664
Molina-Infante, J.; Arias-Arias, A.; Rodríguez-Sánchez, J.; Barrio, J.; Sanchez-Cazalilla, M.; Lucendo, A.J. 2014: Mo1830 Optimized Four-Food Elimination Diet (Dairy, Gluten, Egg and Legumes) Followed by Rescue Six-Food Elimination Diet for Adult Eosinophilic Esophagitis: A Spanish Multicenter Study. Gastroenterology 146(5): S-665
Philpott, H.; Gibson, P.R.; Nandurkar, S.; Royc, S.G. 2014: Mo1831 Trans-Nasal Gastroscopy Without Sedation for Eosinophilic Esophagitis; Safe, Effective and the Ideal Method of Assessment?. Gastroenterology 146(5): S-665
Wolf, W.A.; Green, D.J.; Hughes, J.T.; Cotton, C.C.; Woosley, J.T.; Shaheen, N.J.; Dellon, E.S. 2014: Mo1832 What Cut-Point Should Be Used to Define a Histologic Response to Topical Steroid Use in Eosinophilic Esophagitis? A Data-Driven Approach Using Symptoms and Endoscopic Findings. Gastroenterology 146(5): S-665-S-666
Wolf, W.A.; Green, D.J.; Hughes, J.T.; Cotton, C.C.; Woosley, J.T.; Shaheen, N.J.; Dellon, E.S. 2014: Mo1833 Dilation of Strictures Prior to Therapy Predicts Histologic Non-Response to Topical Steroids in Eosinophilic Esophagitis. Gastroenterology 146(5): S-666
Jensen, E.T.; Martin, C.F.; Kappelman, M.; Dellon, E.S. 2014: Mo1834 Health Care Utilization and Costs Related to Eosinophilic Esophagitis in the United States Represent a Significant Burden of Disease. Gastroenterology 146(5): S-666
Rodríguez-Sánchez, J.; Molina-Infante, J.; Barrio, J.; Pérez-Martínez, I.; Rubiales, B.M. 2014: Mo1835 Correlation of Clinical and Endoscopic Eosinophilic Esophagitis Activity With Histological Remission. Gastroenterology 146(5): S-667
Gil-Simon, P.; Armentia, A.; Vargas, A.L.; Armentia, B.M.; Rubiales, B.M.; Sánchez-Ocaña, R.; Ortiz, J.C.G.ía; Santamarta, F.S.; Nieto, M.A.T.; Vega, J.M.; Perez-Miranda, M.; Atienza, R.; Barrio, J. 2014: Mo1836 Usefulness of Micro-Arrays Technology in Ethiological Diagnosis of Eosinophilic Esophagitis. Gastroenterology 146(5): S-667
Gil-Simon, P.; Armentia, A.; Vargas, A.L.; Armentia, B.M.; Rubiales, B.M.; Sanchez-Ocaïña, R.; Ortiz, J.C.G.ía; Santamarta, F.S.; Nieto, M.A.T.; Vega, J.M.; Perez-Miranda, M.; Atienza, R.; Barrio, J. 2014: Mo1837 Efficacy of Immunotherapy and Alergen-Molecular-Study-Led Diet Treatments in Eosinophilic Esophagitis. Gastroenterology 146(5): S-667
Herzlinger, M.; Lu, S.; Matoso, A.; Noble, L.; Yang, D.; Leleiko, N.S.; Resnick, M. 2014: Mo1838 15-S-Hete: A Noninvasive Serological Marker for Eosinophilic Esophagitis?. Gastroenterology 146(5): S-667
Green, D.J.; Wolf, W.A.; Hughes, J.T.; Cotton, C.C.; Woosley, J.T.; Shaheen, N.J.; Dellon, E.S. 2014: Mo1840 Most Patients Demonstrate Correlation Between Symptoms, Endoscopic Findings, and Histology in Response to Topical Steroid Treatment in Eosinophilic Esophagitis. Gastroenterology 146(5): S-668
Singla, M.B.; Brizuela, D.; Maydonovitch, C.; Achem, S.R.; Moawad, F.J. 2014: Mo1842 Comparison of Inflammatory Versus Fibrostenotic Phenotype in Eosinophilic Esophagitis. Gastroenterology 146(5): S-669
Mangla, S.; Hamilton, M.J.; Hsu Blatman, K.S.; Hornick, J.L.; Chan, W.W. 2014: Mo1843 Mast Cell Densities on Esophageal Mucosal Biopsies Were Higher in Eosinophilic Esophagitis Versus Proton Pump Inhibitor-Responsive Esophageal Eosinophilia in Adults. Gastroenterology 146(5): S-669
Lipka, S.; Keshishian, J.; Kumar, A.; Richter, J. 2014: Mo1845 Nsaid's, Aspirin, Alcohol, Smoking, and Gerd Is There an Effect on the Eosinophilic Esophagitis Phenotype?. Gastroenterology 146(5): S-670
Krarup, A.L.; Vyberg, M. 2014: Mo1847 Increased Incidence of Eosinophilic Esophagitis in a Danish Region After Changed Biopsy Protocol for Patients With Dysphagia. Gastroenterology 146(5): S-671
Schoepfer, A.; Straumann, A.; Panczak, R.; Kuehni, C.; Romero, Y.; Maurer, E.; Alexander, J.A.; Hirano, I.; Gonsalves, N.; Furuta, G.; Dellon, E.S.; Leung, J.; Moawad, F.J.; Collins, M.H.; Bussmann, C. 2014: Mo1848 Development of an Endoscopy-and Histology-Based Activity Index for Eosinophilic Esophagitis. Gastroenterology 146(5): S-671
Kern, E.; Taft, T.; Moy, N.; Zalewski, A.; Gonsalves, N.; Hirano, I. 2014: Mo1850 Importance of Endoscopically Identified, Esophageal Features for Clinical Outcomes in Adults With Eosinophilic Esophagitis. Gastroenterology 146(5): S-672
Kern, E.; Lin, D.; Larson, A.; Taft, T.; Zalewski, A.; Hirano, I. 2014: Mo1851 The Use of Esophageal Brushings to Detect Esophageal Eosinophilia in Patients With Eosinophilic Esophagitis. Gastroenterology 146(5): S-672
Genta, R.M.; Spechler, S.J. 2014: Mo1853 Low Prevalence of Eosinophilic Esophagitis in Hispanics and Asians in the United States. Gastroenterology 146(5): S-673
Reed, C.; Woosley, J.T.; Dellon, E.S. 2014: Mo1854 Clinical Characteristics, Treatment Outcomes, and Resource Utilization in Children and Adults With Eosinophilic Gastroenteritis. Gastroenterology 146(5): S-673
Chu, C.; Ronquillo, N.R.; Chennuri, R.; Adley, B.P.; Borgen, K.R.; Schwartz, A.; Berman, J.; Gunasekaran, T.S. 2014: Mo1856 Eosinophilic Esophagitis (EoE): Dysphagia Predominant and Abdominal Pain Predominant. Is the Esophageal Histology Different in These Two Groups?. Gastroenterology 146(5): S-674
Moawad, F.J.; Chehade, M.; Green, D.J.; Ljuldjuraj, T.; Achem, S.R.; Brizuela, D.; Gupta, S.K.; Dellon, E.S. 2014: Mo1857 The Influence of Gender on Features of Eosinophilic Esophagitis: A Multi-Center Study. Gastroenterology 146(5): S-674
Moawad, F.J.; Dellon, E.S.; Ljuldjuraj, T.; Green, D.J.; Brizuela, D.; Achem, S.R.; Chehade, M.; Gupta, S.K. 2014: Mo1858 Racial Differences Impact the Clinical Presentation and Endoscopic Features of Eosinophilic Esophagitis: A Multi-Center Study. Gastroenterology 146(5): S-674
Clayton, S.B.; Colizzo, J.M.; Richter, J. 2014: Mo1860 Elevated Intrabolus Pressure on High Resolution Manometry Distinguishes Fibrostenotic and Inflammatory Esosinophilic Phenotypes. Gastroenterology 146(5): S-675
Schoepfer, A.; Straumann, A.; Panczak, R.; Kuehni, C.; Romero, Y.; Maurer, E.; Alexander, J.A.; Hirano, I.; Gonsalves, N.; Furuta, G.; Dellon, E.S.; Leung, J.; Moawad, F.J.; Collins, M.H.; Bussmann, C. 2014: Mo1861 Development of a Symptom-Based Activity Index for Eosinophilic Esophagitis. Gastroenterology 146(5): S-675
Taft, T.; Keefer, L. 2014: Mo1862 Illness Stigma Perception in the Eosinophilic Gastrointestinal Disorders (Egids). Gastroenterology 146(5): S-675
Taft, T.; Keefer, L. 2014: Mo1864 Healthcare Utilization and Health Related Quality of Life in the Eosinophilic Gastrointestinal Disorders. Gastroenterology 146(5): S-676
Taft, T.; Keefer, L. 2014: Mo1865 Treatment Adherence in the Eosinophilic Gastrointestinal Disorders. Gastroenterology 146(5): S-676
Taft, T.; Keefer, L. 2014: Mo1866 Internalized Stigma and Stigma Resistance in the Eosinophilic Gastrointestinal Disorders (Egids). Gastroenterology 146(5): S-676
Leung, J.; Mehrzad, R.; Alejos, A.R.; Hesterberg, P.E.; Yuan, Q.; Hundal, N.V.; Shreffler, W.G.; Katz, A.J. 2014: Mo1867 Clinical Outcomes of Rescue Treatment for Eosinophilic Esophagitis. Gastroenterology 146(5): S-676
Mehrzad, R.; Katz, A.J.; Yuan, Q.; Hesterberg, P.E.; Shreffler, W.G.; Alejos, A.R.; Fiore, J.; Leung, J. 2014: Mo1868 Safety of Serial Endoscopies in Patients With Eosinophilic Esophagitis Undergoing Dietary Therapy: Our Own Experience and a Literature Review. Gastroenterology 146(5): S-677
von Arnim, U.; Wex, T.; Miehlke, S.; Link, A.; Malfertheiner, P. 2014: Mo1869 Inverse Correlation of H. pylori and Eosinophilic Esophagitis. Gastroenterology 146(5): S-677
Yoon, S.Y.; Jung, H.-K.; Park, S.; Sung, S.H.; Lee, M.-J.; Kim, S.-E.; Shim, K.-N.; Jung, S.-A.; Kim, T.H.; Yi, S.Y.; Yoo, K.; Moon, I.H. 2014: Mo1870 Impact of Clinical and Morphologic Characteristics on the Natural History of Eosinophils-Related Gastrointestinal Diseases. Gastroenterology 146(5): S-677
Bhatia, E.G.; Cass, A.L.; Markowitz, J.E. 2014: Mo1871 Markedly Increased Prevalence of Inflammatory Bowel Disease Among Pediatric and Adolescent Patients With Eosinophilic Esophagitis. Gastroenterology 146(5): S-677
Stover, J.; Wolf, B. 2014: Mo1872 Practice Patterns and Clinical Impact Utilizing a Novel Genetic Test in the Treatment and Surveillance of Eosinophilic Esophagitis. Gastroenterology 146(5): S-677
An, M.; Annese, V.; Bredenoord, A.J.; Varannes, S.B.; Busch, O.R.; Costantini, M.; Dousset, B.; Elizalde, J.I.; Romario, U.F.; Gaudric, M.; Merla, A.; Smout, A.J.; Tack, J.F.; Zaninotto, G.; Boeckxstaens, G.E. 2014: Mo1874 Long-Term Results of the European Achalasia Trial: Pneumatic Dilation Versus Laparoscopic Heller Myotomy. Gastroenterology 146(5): S-678
Chen, C.-L.; Yi, C.-H.; Liu, T.-T. 2014: Mo1875 Effect of Repeated Esophageal Infusion of Capsaicin-Contained Red Pepper Sauce on Secondary Peristalsis in Humans. Gastroenterology 146(5): S-678
Yamasaki, T.; Takimoto, M.; Kono, T.; Kondo, T.; Toyoshima, F.; Sakurai, J.; Tozawa, K.; Ikehara, H.; Tomita, T.; Oshima, T.; Fukui, H.; Watari, J.; Miwa, H. 2014: Mo1878 Intra-Venous Corticotropin Releasing Hormone (Crh) Administration Increased Esophageal Electrical Sensitivity in Normal Subjects. Gastroenterology 146(5): S-679
Huang, L.; Rezaie, A.; Basseri, B.; Chang, C.; Pimentel, M. 2014: Mo1879 Natural Manometric Course of Jackhammer Esophagus and Its Determinants -A Large-Scale Database Analysis. Gastroenterology 146(5): S-679
Carlson, D.; Lin, Z.; Lin, C.-Y.; Yim, B.H.; Pandolfino, J.E. 2014: Mo1881 Reproducibility of Manual and Automated Measurements of Esophageal Bolus Flow Time, a Measurement of Esophageal Function Utilizing High-Resolution Impedance Manometry. Gastroenterology 146(5): S-680
Capovilla, G.; Salvador, R.; Costantini, M.; Nicoletti, L.; Zaninotto, G.; Savarino, E. 2014: Mo1882 Validation of the Chicago Classification for the Diagnosis of Primary Esophageal Motility Disorders Based on Outcome Data -A Prospective, Randomized, Double Blind, Crossover Study Comparing the Solid-State and Water-Perfused System. Gastroenterology 146(5): S-680
Capovilla, G.; Savarino, E.; Costantini, M.; Nicoletti, L.; Zaninotto, G.; Salvador, R. 2014: Mo1884 Inter-Rater and Inter-Device Agreement for the Diagnosis of Primary Esophageal Motility Disorders Based on Chicago Classification Between Solid-State and Water-Perfused Hrm System -A Prospective, Randomized, Double Blind, Crossover Study. Gastroenterology 146(5): S-681
Ravi, K.; Katzka, D.A.; Geno, D.M. 2014: Mo1886 Esophageal Cancer Screening in Achalasia: Is There a Consensus?. Gastroenterology 146(5): S-682
Cisternas, D.; Candia, R.A.; Marin, I.; Serra, J.; de Leon, A.R.; de la Serna, J.P.; Sevilla, C.; Hani, A.C.; Rodriguez, A.; Leguizamo, A.M.; Valdovinos, M.A.; Meixueiro, A.; Zavala, M.A.; Remes-Troche, J.M.; Jaramillo, R.C. 2014: Mo1888 Contraction Amplitude Is a Relevant Predictor of Bolus Transit During Sitting Viscous Solution Swallows in Healthy Individuals: Preliminary Results of a Multicenter Study Using High Resolution Impedance Manometry (Hrim). Gastroenterology 146(5): S-683
Muta, K.; Ihara, E.; Bai, X.; Tanaka, Y.; Nakamura, K.; Akiho, H.; Takayanagi, R. 2014: Mo1889 Acotiamide, a Novel Prokinetic Drug, Reduces Both Esophageal Body Contractility and the Tone of the Lower Esophageal Sphincter. Gastroenterology 146(5): S-683
Shoji, H.; Isomoto, H.; Yoshida, A.; Kanda, T.; Minami, H.; Takeshima, F.; Inoue, H.; Nakao, K. 2014: Mo1890 MicroRna130a Is Highly Expressed in the Esophageal Mucosa of Esophageal Achalasia. Gastroenterology 146(5): S-683
Awad, R.A.; Camacho, S.; Manjarrez, D.A. 2014: Mo1892 Are Esophageal Mucosal and Motor Alterations Related to Esophageal Visceral Hypersensitivity in Untreated Achalasia Patients?. Gastroenterology 146(5): S-684
Lin, Z.; Lin, C.-Y.; Mogni, B.; Friesen, L.; Kahrilas, P.J.; Pandolfino, J.E. 2014: Mo1893 Esophageal Impedance Topography (Eit) Parameters Correlate With Dysphagia Symptoms in Patients With Non-Obstructive Dysphagia. Gastroenterology 146(5): S-684
Lin, Z.; Nicodème, F.; Carlson, D.; Lin, C.-Y.; Yim, B.H.; Kahrilas, P.J.; Pandolfino, J.E. 2014: Mo1895 Bolus Flow Time Through Esophagogastric Junction (Egj) Derived During High-Resolution Impedance-Manometry (Hrim) Studies: A Novel Parameter for Assessment of Esophageal Bolus Transit. Gastroenterology 146(5): S-685
Brueckner, J.; Schneider, A.; Goelder, S.; Messmann, H. 2014: Mo1897 Endoscopic Mucomyotomy of Zenker's Diverticulum With Hook Knife and Overtube. Gastroenterology 146(5): S-686
Halland, M.; Ravi, K.; Barlow, J.M.; Amindra, A.S. 2014: Mo1898 Correlation Between the Radiological Observation of Tertiary Waves on an Esophagram and Findings of High Resolution Manometry. Gastroenterology 146(5): S-686
Kornienko, E. 2014: Mo1899 Viral Infection in Chronic Esophagitis in Children. Gastroenterology 146(5): S-686
Kuribayashi, S.; Iwakiri, K.; Kawada, A.; Hoshino, S.; Kawami, N.; Takenouchi, N.; Hosaka, H.; Shimoyama, Y.; Kawamura, O.; Yamada, M.; Kusano, M. 2014: Mo1901 A Comparison of the High Resolution Manometry Systems Manoscan and Starlet (a New System With Unisensor Catheter). Gastroenterology 146(5): S-687
Arora, Z.; Sudish, M.C.; Lopez, R.; Birgisson, S. 2014: Mo1902 High Resolution Manometry Findings in Lung Transplant Recipients Before and After Lung Transplant. Gastroenterology 146(5): S-687
Im, J.P.; Kim, D.; Chung, S.J.; Park, M.J.; Kim, S.G.; Kim, J.S.; Jung, H.C. 2014: Mo1903 Prospective Investigation of Visceral Obesity and Incident and Recurrent Colorectal Adenoma. Gastroenterology 146(5): S-687
Toden, S.; Okugawa, Y.; Hur, K.; Jascur, T.; Shakibaei, M.; Boland, C.R.; Goel, A. 2014: Mo1904 Curcumin Inhibits Epithelial-to-Mesenchymal Transition and Enhances 5-Fluorouracil Sensitivity by Targeting Specific miRnas in Chemoresistant Colorectal Cancer. Gastroenterology 146(5): S-688
Kinross, J.; Muirhead, L.J.; Mirnezami, R.; Veselkov, K.; Jiminez, B.; Marchesi, J.; Nicholson, J.K.; Darzi, A.W. 2014: Mo1905 Microbiome-Metabonome Linked Analysis of Ascending Colon Cancer by 1Hnmr Mas Spectrometry and 16S rRna Gene Analysis (Metataxonomics). Gastroenterology 146(5): S-688
Ananthakrishnan, A.N.; Du, M.; Brenner, H.; Slattery, M.L.; Berndt, S.I.; Chang-Claude, J.; Fuchs, C.; Gallinger, S.; Giovannucci, E.; Harrison, T.A.; Hoffmeister, M.; Hou, L.; Nan, H.; Newcomb, P.A.; Potter, J.D. 2014: Mo1906 Red Meat Is Associated With Risk of Colorectal Cancer, Independent of Nat2 Genetic Background: a Pooled Analysis of 13 Studies. Gastroenterology 146(5): S-688
Tesori, V.; Puglisi, M.A.; Gasbarrini, A.; Gasbarrini, G. 2014: Mo1907 Ampk Activation in Colon Cancer Cells Inhibits the Malignant Phenotype Inducing Differentiation: Potential Use of Metformin in the Treatment of Colorectal Cancer. Gastroenterology 146(5): S-688
Davies, L.; Blake, P.A.; Beamish, A.; Karran, A.; Thomas, C.E.; Witherspoon, J.; Howell, G.; Barlow, R.C.; Lewi, W.G. 2014: Mo1909 Prognostic Significance of Bioelectrical Impedance Analysis Defined Body Composition in Upper Gastrointestinal Cancer. Gastroenterology 146(5): S-689
Lee, C.S.; Murphy, D.J.; McMahon, C.; Nolan, B.; Cullen, G.; Mulcahy, H.; Sheahan, K.; Fennelly, D.; Ryan, E.J.; Doherty, G. 2014: Mo1910 Visceral Adiposity Is a Risk Factor for Poor Prognosis in Colorectal Cancer Patients Receiving Adjuvant Chemotherapy. Gastroenterology 146(5): S-689
Majdi-Yazdi, S.; Zenebe, A.; Nunlee-bland, G.; Paydar, M.; Laiyemo, A.O.; Sanderson, A.K.; Begum, R.; Brim, H.; Nouraie, M.; Semati, M.; Ashktorab, H. 2014: Mo1911 Association of Type 2 Diabetes and Colorectal Polyps and Adenomas. Gastroenterology 146(5): S-689
Tantau, A.; Tantau, M. 2014: Mo1912 The Prevalence of Colorectal Adenomas and Advanced Neoplasms Detected Through Pan-Chromocolonoscopy in Patients With Non-Alcoholic Fatty Liver Disease (Nafld). A Prospective Study. Gastroenterology 146(5): S-689
Fujiwara, K.; Inoue, T.; Yorifuji, N.; Iguchi, M.; Sakanaka, T.; Narabayashi, K.; Okada, T.; Nouda, S.; Kakimoto, K.; Ishida, K.; Kawakami, K.; Abe, Y.; Takeuchi, T.; Umegaki, E.; Higuchi, K. 2014: Mo1913 Influence of a Dipeptidyl Peptidase-4 Inhibitor on Intestinal Neoplasia Formation in Apc Min/+ Mice Fed a High Fat Diet. Gastroenterology 146(5): S-690
Tobi, M.; Yang, Y.-X.; Antaki, F.; Rambus, M.; Lawson, M.J. 2014: Mo1914 Thiazolidinediones but Not Metformin Significantly Reduce Colorectal Neoplastic Lesions in Diabetics At Risk for Colorectal Neoplasia. Gastroenterology 146(5): S-690
Asciutti, S.; Ferretti, E.; Valloscuro, S.; Pires, M.M.; Llacuna, L.; Esposito, D.; Liscio, P.; Macchiarulo, A.; Camaioni, E.; Pellicciari, R.; Aaronson, S.A. 2014: Mo1915 Novel Wnt-Targeted Therapy Inhibitors for Hepatocellular Carcinoma. Gastroenterology 146(5): S-690
Hamaya, Y.; Guarinos, C.; Tseng-Rogenski, S.; Jover, R.; Carethers, J.M. 2014: Mo1916 Emast Within Stage Ii/Iii Colorectal Cancers Reduces the Effectiveness of Adjuvant 5-Fluorouracil on Patient Survival. Gastroenterology 146(5): S-690
Zhao, C.-M.; Hayakawa, Y.; Westphalen, C.B.; Muthupalani, S.; Johannessen, H.; Andersen, G.; Fox, J.G.; Wang, T.C.; Chen, D. 2014: Mo1917 Preclinical Trial of Botulinum Toxin Type a Injection in the Treatment of Gastric Cancer. Gastroenterology 146(5): S-691
Barak, N. 2014: Mo1918 Mesna Ameliorates Acute Radiation Injury to the Anus. Gastroenterology 146(5): S-691
Dryden, G.W.; Vanchinathan, S.; Suttles, J.; Egilmez, N.K. 2014: Mo1919 Effect of Directly Injecting Cytokine-Containing Microbeads on a Endoscopically Initiated Model of Colon Cancer. Gastroenterology 146(5): S-691
Ikematsu, H.; Fukuoka, S.; Ito, M.; Kojima, M.; Imajoh, M.; Osera, S.; Odagaki, T.; Oono, Y.; Yano, T.; Kaneko, K. 2014: Mo1920 The Investigation Regarding Endoscopic and Pathological Response for Neo-Adjuvant Chemotherapy or Chemoradiotherapy in Patients With Low Rectal Cancer. Gastroenterology 146(5): S-691-S-692
Corral, J.E.; Delgado-Hurtado, J.J.; Dominguez, R.L.; de Cuellar, M.V.; Cruz, C.B.; Morgan, D.R. 2014: Mo1921 The Descriptive Epidemiology of Gastric Cancer in Central America and Comparison With U. S. Hispanic Populations. Gastroenterology 146(5): S-692
Rahman, R.N.; Ibdah, J.A. 2014: Mo1922 A Four-Decades Epidemiological Study of Pancreatic Cancer in the Usa: Increasing Incidence in Recent Years. Gastroenterology 146(5): S-692
Sharon, C.; Patel, J.; Patel, N.J.; Baranwal, S.; Patel, B.B. 2014: Mo1923 Inhibition of Insulin-Like Growth Factor Receptor Activity Attenuates Colon Cancer Stem Cells Growth and Self-Renewal by Targeting Mevlonate-Isoprenoid Metabolism. Gastroenterology 146(5): S-692
Beamish, A.; Davies, L.; Karran, A.; Thomas, C.E.; Witherspoon, J.; Blake, P.A.; Barlow, R.C.; Foley, K.; Howell, G.; Roberts, A.; Lewis, W.G. 2014: Mo1925 Prognostic Significance of Ct Muscle Density in Upper Gi Cancer. Gastroenterology 146(5): S-693
Lee, J.M.; Keum, B.; Lee, J.S.; Kim, S.H.; Nam, S.J.; Choi, H.S.; Kim, E.S.; Jeen, Y.T.; Lee, H.; Chun, H.J.; Um, S.H.; Kim, C.D.; Ryu, H.S. 2014: Mo1926 Selenium Supplement Ameliorates Chemotherapy-Induced Mucositis in Rat Small Intestine. Gastroenterology 146(5): S-693
Hirata, M. 2014: Mo1928 Chemotherapy With Bevacizumab for Advanced or Metastatic Colorectal Cancer. Gastroenterology 146(5): S-694
Weygant, N.; Qu, D.; Berry, W.L.; May, R.; Chandrakesan, P.; Owen, D.; Ali, N.; Janknecht, R.; Sureban, S.M.; Houchen, C.W. 2014: Mo1929 Small-Molecule Parkinson's Disease Kinase Inhibitor Lrrk2-in-1 Demonstrates Potent Anti-Cancer Activity Through Inhibition of Dclk1. Gastroenterology 146(5): S-694
Kubota, E.; Williamson, C.T.; Lees-Miller, S.P.; Bebb, G. 2014: Mo1930 Atm and P53 Expression Level Correlate With Sensitivity to Olaparib in Gastric Cancer. Gastroenterology 146(5): S-694
Foley, K.; Karran, A.; Thomas, C.E.; Chan, D.S.; Blake, P.A.; Fielding, P.; Roberts, A.; Lewis, W.G. 2014: Mo1931 Prognostic Significance of 18F-Fdg Pet/Ct Defined Tumour Parameters in Patients With Esophageal Cancer. Gastroenterology 146(5): S-694
Read, M.; Bernardi, M.-P.; Liu, D.; Fennell, C.M.; Ramsay, R.G.; Heriot, A.; Duong, C.; Phillips, W.A.; Clemons, N.J. 2014: Mo1933 Development of Esophageal and Anal Cancer Patient Derived Tumor Xenograft (Pdtx) Models Using a Novel Implantation Technique. Gastroenterology 146(5): S-695
Gleeson, F.C.; Kipp, B.R.; Voss, J.S.; Campion, M.B.; Henry, M.; Sciallis, A.P.; Graham, R.; Lazaridis, K.; Vasmatzis, G.; Levy, M.J. 2014: Mo1934 Treatment Naive Locally Advanced Rectal Cancer Lymph Node Kras Mutation Profile As Revealed by Eus Fna Cytology Next-Generation Sequencing: An Additional Piece to the Puzzle. Gastroenterology 146(5): S-695
Katsha, A.M.; Arras, J.; Belkhiri, A.; El-Rifai, W. 2014: Mo1936 Aurka Regulates Stat3 Activity Through Jak2 in Human Gastric and Esophageal Cancer. Gastroenterology 146(5): S-696
Park, J.M.; Kim, J.H.; Kim, I.-W.; Choi, M.-G. 2014: Mo1937 Enhanced Efficacy of Photodynamic Therapy Through Inhibition of Atpbinding Cassette Sub Family G Member 2 in Colon Cancer. Gastroenterology 146(5): S-696
Cheng, X.; Zhu, L.; Zhang, Q.; Ding, Y.; Ye, J.; Tu, S. 2014: Mo1938 Survivin Inhibitor Ym155 Inhibits Cell Miration and Invasion in Gastric and Colon Cancer Cells Through Inhibition of Metastasis-Related Genes. Gastroenterology 146(5): S-696
Bücker, R.; Schulz, E.; Wiegand, S.; Siegmund, B.; Troeger, H.; Schulzke, J.D. 2014: Mo1940 E. Coli -Hemolysin (HlyA) Mediates Colonic Inflammation. Gastroenterology 146(5): S-697
Faherty, C.S.; Wu, T.; Morris, C.; Grassel, C.; Rasko, D.; Harper, J.; Shea-Donohue, T.; Fasano, A.; Barry, E. 2014: Mo1941 Further Characterization of the Shigella Flexneri Effector OspD3 (ShEt2) Reveals A Unique Expression Profile That Does Not Require OspC1. Gastroenterology 146(5): S-697
Canipe, A.; Blevins, M.; Chidumayo, T.N.; Koethe, J.; Bestawros, M.; Bala, J.; Shepherd, B.; Heimburger, D. 2014: Mo1942 Increased Intestinal Microbial Translocation Is Associated With Heightened Systemic Inflammation in Undernourished, Hiv-Infected Adults in Sub-Saharan Africa. Gastroenterology 146(5): S-697
Wu, L.-L.; Peng, W.-H.; Kuo, W.-T.; Huang, C.-Y.; Ni, Y.-H.; Lu, K.-S.; Turner, J.R.; Yu, L.C.H. 2014: Mo1943 Gut Bacterial Endocytosis Is Dependent on Mlck-Activated Brush Border Fanning by Ifn. Gastroenterology 146(5): S-697
Walker, M.M.; Talley, N.J.; Jones, M.P.; Andreasson, A.; Engstrand, L.; Inganas, L.; Nyhlin, H.; Kjellstrom, L.; Agreus, L. 2014: Mo1944 Eosinophils and Lymphoid Follicles Are Histological Markers for Colonic Spirochaetosis. Gastroenterology 146(5): S-698
Hyser, J.; Crawford, S.E.; Ettayebi, K.; Zeng, X.; Blutt, S.E.; Broughman, J.R.; Opekun, A.R.; Graham, D.Y.; Donowitz, M.; Estes, M.K. 2014: Mo1945 Human Intestinal Enteroids As a Model System for the Study of Enteric Virus Pathogenesis. Gastroenterology 146(5): S-698
Hodges, K.; Hecht, G.A. 2014: Mo1946 Interaction of Epec EspF With 14-3-3 Drives the Redistribution of the Polarity Protein Par1b Leading to Disruption of Epithelial Tight Junctions. Gastroenterology 146(5): S-698
Zhu, C.; Zhang, W.; Boedeker, E.C. 2014: Mo1948 Toward a Broadly Protective Vaccine Against Enterotoxigenic E.coli (Etec) Infections. Gastroenterology 146(5): S-699
Iida, T.; Naito, Y.; Takagi, T.; Katada, K.; Mizushima, K.; Higashimura, Y.; Onozawa, Y.; Horii, Y.; Suzuki, K.; Horie, H.; Uehara, Y.; Inada, Y.; Fukuda, W.; Kamada, K.; Uchiyama, K. 2014: Mo1949 Rapamycin Protects Intestinal Ischemia/Reperfusion-Induced Remote Lung Injury in Mice. Gastroenterology 146(5): S-699
Filaretova, L.; Zelena, D.; Morozova, O.; Amagase, K.; Bagaeva, T.; Takeuchi, K. 2014: Mo1950 Enterobacterial Invasion Occurred in Association With Indomethacin-Induced Enteropathy May Trigger Adverse Cardiovascular Events With Consequent Survival Impairment in Rats. Gastroenterology 146(5): S-699
Vaishnavi, C.; Singh, M.; Thapa, B.R. 2014: Mo1952 Phenotypic and Genotypic Identification of Campylobacters in Diarrheal Patients and Poultry in and Around Chandigarh, India. Gastroenterology 146(5): S-700
Limketkai, B.N.; Parian, A.M.; Jain, A.; Hutfless, S. 2014: Mo1953 Rising Incidence of Intestinal Infections in Inflammatory Bowel Diseases: A Nationwide Analysis. Gastroenterology 146(5): S-700
Chen, G.; Qiu, Y.; Xiao, W.; Cheng, Y.; Sun, L.; Sun, L.; Yu, M.; Peng, K.; Xu, C.; Zhang, C.; Yang, H. 2014: Mo1955 Notch Signaling Pathway Protects Intestine From Ischemia/Reperfusion Injury in Rats Through Stat3 Signaling. Gastroenterology 146(5): S-701
Sherid, M.; Sifuentes, H.; Samo, S.; sulaiman, S.; Husein, H.; Tupper, R.S.; Vainder, J.A.; Spurr, C.L.; Sridhar, S. 2014: Mo1956 Isolated Right Colon Ischemic Colitis Has Different Features and Outcomes Compared to Non-Right Colon Ischemic Colitis: A Multicenter Community Study. Gastroenterology 146(5): S-701
Sherid, M.; Sifuentes, H.; Samo, S.; sulaiman, S.; Husein, H.; Tupper, R.S.; Vainder, J.A.; Spurr, C.L.; Sridhar, S. 2014: Mo1957 Characteristics of Recurrent vs. Non-Recurrent Ischemic Colitis: A Multicenter Community Study. Gastroenterology 146(5): S-701
Sherid, M.; Sifuentes, H.; Samo, S.; sulaiman, S.; Husein, H.; Tupper, R.S.; Vainder, J.A.; Spurr, C.L.; Sridhar, S. 2014: Mo1958 Characteristics of Inpatient vs. Outpatient-Onset Ischemic Colitis: A Multicenter Community Study. Gastroenterology 146(5): S-701
Rajput, I.; Lodge, P.; Sandle, G.I. 2014: Mo1959 Basolateral Ikca Channel Inhibition by Octreotide Prevents the Increase in Mucosal Permeability Induced by Chemical Hypoxia in Human Colon: Implications for Preventing Sepsis After Major Abdominal Surgery. Gastroenterology 146(5): S-702
Gonzalez, L.M.; Magness, S.T.; Lund, P.K.; Blikslager, A. 2014: Mo1960 Intestinal Epithelial Cells Expressing Biomarkers of Crypt Base Columnar or Reserve Stem Cells Show Differential Resistance to Ischemia-Reperfusion Injury. Gastroenterology 146(5): S-702
Garcia-Compean, D.; Gonzalez, J.A.; Jaquez-Quintana, J.O.; Barrera Villarreal, E.J.; Maldonado, H.J. 2014: Mo1961 Clinical and Biochemical Predictors of Identification of Bleeding Digestive Mucosal Lesions by Wireless Capsule Endoscopy (Wce) in Patients With Obscure Gastrointestinal Bleeding (Ogib). Gastroenterology 146(5): S-702
El-Halabi, M.M.; Jones, C.; Chaaban, S.; Mansour, N.M.; Salyers, W.J. 2014: Mo1963 Under-Diagnosing and Under-Treating Iron-Deficiency in Hospitalized Patients With Acute Gastrointestinal Bleeding: Retrospective Cohort Preliminary Results. Gastroenterology 146(5): S-703
Edwards, A.L.; Pamboukian, S.V.; George, J.F.; Mel Wilcox, C.; Peter, S. 2014: Mo1965 Lack of Influence of Pulsatility on Gastrointestinal Bleeding in Patients With Continuous Flow Left Ventricular Assist Devices. Gastroenterology 146(5): S-703
Harki, J.; Vergouwe, Y.; Spoor, J.A.; Kuipers, E.J.; Mensink, P.; Bruno, M.J.; van Noord, D.; Tjwa, E.T. 2014: Mo1967 Development of a Prediction Model to Assess the Risk of Chronic Gastrointestinal Ischemia in Referred Patients. Gastroenterology 146(5): S-704
Lasa, J.S.; Olivera, P.A.; Senderovsky, M.T.; Fanjul, I.; Moore, R.; Dima, G.; Zubiaurre, I.; Peralta, A.D.; Prizont, R.; Soifer, L.O. 2014: Mo1968 Increased Prevalence of Cardiovascular Risk Factors in Patients With Colonic Vascular Ectasias: A Case-Control Study. Gastroenterology 146(5): S-704
Karlsdottir, B.R.; Hreinsson, J.P.; Möller, P.H.; Ragnarsson, G.; Bjornsson, E. 2014: Mo1969 The Incidence and Outcome of Ischemic Colitis in a Population Based Setting. Gastroenterology 146(5): S-705
Bonfrate, L.; Krawczyk, M.; Grattagliano, I.; Ruggiero, V.; Wang, D.Q.; Palasciano, G.; Lammert, F.; Portincasa, P. 2014: Mo1970 Consistent Amelioration of Fructose Intolerance Symptoms in Adults Following a Re-Education Program. Gastroenterology 146(5): S-705
DeJonge, A.M.; Norris, K.S.; Hernandez, K.; Elser, H.; Opekun, A.R. 2014: Mo1971 Sucrase-Isomaltase Genetic Variant Carriers can be Symptomatic. Gastroenterology 146(5): S-705
Aujla, U.I.; Arfan, R.; Nimba, A.N.; Mahmood, A.; Zar, S. 2014: Mo1972 Role of SeHcat Scanning in Diagnosis of Bile Salt Malabsorption: a University Hospital Experience. Gastroenterology 146(5): S-706
Shivaji, U.N.; Chowdhury, F.U.; Ford, A.C. 2014: Mo1973 Prevalence of Bile Acid Malabsorption As a Cause of Diarrhoea in Consecutive New Patient Referrals to a Gastroenterology Clinic. Gastroenterology 146(5): S-706
Ewart, M.; Richards, E. 2014: Mo1974 Clinical Utility of the Disaccharidase Immunoassay: A Three-Year Retrospective Study. Gastroenterology 146(5): S-706
Perets, T.T.; Shporn, E.; Aizic, S.; Kelner, Y.; Levy, S.; Niv, Y.; Dickman, R. 2014: Mo1975 A Diagnostic Approach to Patients With Suspected Lactose Malabsorption. Gastroenterology 146(5): S-706
Garcia-Compean, D.; Jaquez-Quintana, J.O.; Gonzalez, J.A.; Lavalle-Gonzalez, F.J.; Maldonado, H.J.; Villarreal-Perez, J.Z. 2014: Mo1976 Plasma Levels Cytokine Imbalance in Compensated Cirrhotic Patients With Impaired Glucose Tolerance and Diabetes Mellitus. A Prospective Study. Gastroenterology 146(5): S-707
Singal, A.K.; Chen, N.; Kuo, Y.F. 2014: Mo1977 Alcohol Use After Liver Transplantation: Analysis of Niddk Liver Transplant Database. Gastroenterology 146(5): S-707
Kakati, D.D.; Raff, E.; Shoreibah, M.G.; Singal, A.K. 2014: Mo1978 Cholecystectomy Does Not Worsen Outcomes in Steatohepatitis Related Liver Disease. Gastroenterology 146(5): S-707
Amieva-Balmori, M.; Loza, S.M.; Dorsey, F.Z.; Remes-Troche, J.M. 2014: Mo1980 Meld-Na Versus Discriminant Function Index (Dfi) At Admission for Mortality Prediction in Mexican Patients With Alcoholic Hepatitis. Gastroenterology 146(5): S-708
Eltawil, N.A.; Moses, J.; Alkhouri, N. 2014: Mo1981 Alanine Aminotransferase Values in Obese Children With Nonalcoholic Fatty Liver Disease Diagnosed With Liver Ultrasonography. Gastroenterology 146(5): S-708
Cocciolillo, S.; DiTullio, A.M.; Pagliaro, M.; Tavani, R.; di Berardino, M.; Sepe, A.; Ladisa, A.; Grossi, L.; Ciccaglione, A.F.; Parruti, G.; Marzio, L. 2014: Mo1983 Observational Trial Through Contrast Enhanced Ultrasound (Ceus) and Fibro Scan of Patients With Non Alcoholic Steato-Hepatitis (Nash) and Dyslipidemia (Type 2A or 2B) Undergoing Simvastatin Treatment. Gastroenterology 146(5): S-709
Shen, H.; Lipka, S.; Mustacchia, P. 2014: Mo1984 The Relationship Between Nonalcoholic Fatty Liver Disease and Colorectal Adenomas. Gastroenterology 146(5): S-709
Nakamura, Y.; Kasashima, S.; Hara, T.; Fujita, M.; Nagahara, H. 2014: Mo1986 The Serum Indirect Bilirubin Inversely Associated With the Incidence of Nafld. Gastroenterology 146(5): S-710
Elsheikh, E.; Younoszai, Z.; Otgonsuren, M.; Younossi, E.; Lam, B.P.; Cable, R.; Jeffers, T.; Frost, S.; Raybuck, B.; Younossi, Z.M. 2014: Mo1987 Angiogenic Growth Factors in Patients With Nonalcoholic Fatty Liver Disease (Nafld) and Coronary Artery Disease. Gastroenterology 146(5): S-710
Elsheikh, E.; Younoszai, Z.; Otgonsuren, M.; Younossi, E.; Jeffers, T.; Frost, S.; Raybuck, B.; Younossi, Z.M. 2014: Mo1988 Factors Associated With Statins Use in Patients With Nonalcoholic Fatty Liver Disease (Nafld) and Coronary Artery Disease (Cad). Gastroenterology 146(5): S-710